




DENGUE VIRUS INFECTION UPREGULATES EXPRESSION OF CRACC, 





Lim Say Liang, Daniel 





A THESIS SUBMITTED 
 
FOR THE DEGREE OF DOCTOR OF PHILOSOPHY 
DEPARTMENT OF MICROBIOLOGY 












I hereby declare that this thesis is my original work and it has been written by me in its 
entirety. I have duly acknowledged all the sources of information which have been used in 
the thesis. 
  




Lim Say Liang, Daniel 






I would like to express my heartfelt gratitude to Dr. Justin Wong Soon Boon, for 
initially being my honours year project supervisor – this was how my post-graduate journey 
began and only made possible by his tutelage and unending patience. Justin’s inceptions of 
the smallest ideas to the coveting of grandest experiments have driven my research thus far 
and his passion for science is something I can only hope to emulate earnestly. 
Both Prof. Mary Ng and Dr. Ooi Eng Eong have generously contributed dengue 
isolates and reagents that were crucial to this project and I am thankful to them. 
My special acknowledgement goes out to Li Na, who had started out the dengue 
project as well as to Wong Wee Cheng, who had performed the primary CRACC experiments. 
It was a great learning experience for all of us which bore fruit at the end.  
I am most grateful to Hazel Yeong, our laboratory officer, for she maintains the lab in 
a faultless manner, facilitating my work every day. 
Cheers to past and present members of the JW Lab – Timothy, Xavier, Amos, Victoria, 
Alvin, Cassandra, Geraldine, Wei Bing, Chen Yu, Matilda, Karen, Ka Hang and Hui Qing . I 




Table of Contents 
 
Declaration ................................................................................................................................... I 
Acknowledgments....................................................................................................................... II 
Table of Contents ....................................................................................................................... III 
Summary ....................................................................................................................................VI 
List of Tables..............................................................................................................................VII 
List of Figures ...........................................................................................................................VIII 
List of Abbreviations .................................................................................................................. XI 
1. Introduction ......................................................................................................................... 1 
1.1. Dengue .......................................................................................................................... 2 
1.1.1. Transmission and control of dengue .................................................................... 6 
1.2. Dengue virus ................................................................................................................. 7 
1.3. Immuno-pathogenesis of severe dengue ................................................................... 10 
1.4. Adaptive immune responses to dengue..................................................................... 14 
1.5. Innate immune responses to dengue ......................................................................... 17 
1.6. Dendritic cells and their involvement in DenV infection............................................ 21 
1.7. Natural killer cells and their involvement in DenV infection...................................... 29 
1.8. NK cells interact with DCs in vivo ............................................................................... 37 
1.9. SLAM family of immunoreceptors .............................................................................. 39 
1.9.1. SLAM ................................................................................................................... 44 
1.9.2. CD48 and 2B4 ...................................................................................................... 47 
1.9.3. Ly9 ....................................................................................................................... 50 
1.9.4. CD84 .................................................................................................................... 51 
1.9.5. NTB-A .................................................................................................................. 52 
1.9.6. CRACC.................................................................................................................. 54 
IV 
 
1.10. Aims of this study ....................................................................................................... 56 
2. Materials and Methods ..................................................................................................... 57 
2.1. Generation of virus stocks .......................................................................................... 58 
2.2. Titration of virus stocks .............................................................................................. 58 
2.3. Isolation of human NK cells and generation of MoDCs.............................................. 59 
2.4. DenV infection of DCs and their co-cultures with NK cells......................................... 60 
2.5. Generation of stable cell lines .................................................................................... 61 
2.6. Co-cultures of MoDCs with stable cell lines ............................................................... 63 
2.7. Antibodies ................................................................................................................... 63 
2.8. Immuno-fluorescence staining and flow cytometry .................................................. 66 
2.9. Cytotoxicity assay ....................................................................................................... 67 
2.10. Measurement of cytokine levels in cell culture supernatant  ..................................... 67 
2.11. Microarray gene profiling of DenV-infected DCs ....................................................... 68 
2.12. RT-PCR for CRACC ....................................................................................................... 69 
2.13. Statistical analyses ...................................................................................................... 70 
3. Results Part I ...................................................................................................................... 71 
3.1 Naïve primary human NK cells produce IFN-γ and degranulate in response to 
DenV1-infected DCs .................................................................................................... 72 
3.2 Naïve human NK cells suppress DenV1 replication in infected DCs........................... 76 
3.3 Microarray profiling reveals upregulation of NK cells activators in DenV1-infected 
DCs .............................................................................................................................. 78 
3.4 DenV1-infected DCs produce type I IFNs and TNF-α but not other monokines  ........ 83 
3.5 NK cell IFN-γ response towards DenV1-infected DCs is dictated by synergism 
between TNF-α and type I IFNs  .................................................................................. 86 
3. Results Part II ..................................................................................................................... 90 
3.6 DenV1-infected DCs do not express ligands for most NK cell activating receptors  ... 91 
V 
 
3.7 NK cell IFN-γ response towards DenV1-infected DCs is not elicited by FasL 
retrograde signalling ................................................................................................... 96 
3.8 NK cell lysis of DenV1-infected DCs is influenced by synergism between TNF-α and 
type I IFNs and occurs through Fas-mediated apoptosis ........................................... 99 
3.9 DenV1 infection of DCs causes upregulation of CRACC but not other SLAM family 
receptors ................................................................................................................... 103 
3.10 IFN-γ response of NK cells is partially mediated by CRACC-CRACC interactions with 
DenV1-infected DCs .................................................................................................. 108 
3.11 Ligation of CRACC on NK cells enhances IFN-γ production ...................................... 110 
3. Results Part III .................................................................................................................. 112 
3.12 CRACC expression in MoDCs is under the influence of STAT1 and Toll-like receptor 
signalling ................................................................................................................... 113 
3.13 Autocrine action of TNF-α and type I IFNs upregulates CRACC on DenV1-infected 
DCs ............................................................................................................................ 117 
3.14 MoDCs express only the functional splice form of CRACC ....................................... 120 
3.15 CRACC negatively regulates pro-inflammatory cytokine production in MoDCs ...... 122 
3.16 CRACC interferes with NF-κB activation in a myeloid cell line ................................. 128 
3.17 Summary of findings ................................................................................................. 131 
4. Discussion ........................................................................................................................ 132 
5. References ....................................................................................................................... 162 







Dysfunctional adaptive immune responses can contribute to dengue severity but the innate 
cellular immune responses toward dengue remains unclear. NK cells are innate lymphocytes 
involved in antiviral defence. In this study, we demonstrate that naïve human NK cells co-
cultured with dengue virus (DenV)-infected monocyte-derived dendritic cells (DCs) 
produced IFN-γ and lysed infected cells. Type I IFNs and TNF-α produced by DenV-infected 
DCs were crucial, since blocking IFNAR combined with TNF-α neutralization completely 
abolished the IFN-γ response in these co-cultures. Furthermore, both cytokines acted in an 
autocrine manner to upregulate CRACC, a homotypic activating ligand/receptor for NK cells, 
on infected and bystander DCs. In accordance with transwell experiments which suggested 
that membrane-bound ligands were also important for NK cell recognition of infected DCs, 
masking CRACC during co-culture partially reduced the NK cell IFN-γ response. Contrary to 
its lymphocytic activation role, CRACC ligation suppressed production of IL-6, IL-8 and IL-
12p70 in DCs challenged with LPS and IFN-γ. Together, our study demonstrates synergy 
between type I IFNs and TNF-α in triggering NK cell anti-DenV responses and defines a role 
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Dengue is the most important arthropod-borne viral disease in the world, with an estimated 
50-100 million infections occurring annually (World Health Organization, (WHO 2009). 
Infection by dengue virus (DenV) can be asymptomatic or characterized by a self -limiting 
fever (WHO 2009). The disease manifests as a severe form in 1% reported cases, resulting in 
about 20000 deaths, with mortality highest in children (WHO 2009). With increasing 
population densities around the world over the past 50 years, the incidence of dengue has 
experienced an alarming 30-fold increase. According to the World Health Organization 
(WHO), prior to 1970, only 9 countries had reports of severe dengue. However, the 
countries with documented cases of severe dengue have since quadrupled. The distribution 
of the Aedes mosquito vector encompasses the tropical and subtropical regions and has 
been correlated to dengue morbidity (Halstead 2008). These endemic areas include the 
Americas, Southeast Asia, the Eastern Mediterranean, Western Pacific region and rural 
Africa (Fig. 1.1). This puts about 2.5 billion people at risk from contracting dengue. In 
Singapore, cyclical epidemics of dengue still occur despite an aggressive vector control  
campaign (Lee, Lai et al. 2010). 14006 dengue cases with 27 deaths were reported during 
the most recent outbreak in 2005 (Koh, Ng et al. 2008). 
Dengue places tremendous health, economic and social burden on endemic regions, often 
afflicting poor populations where water quality, sanitation and access to healthcare are 
inadequate (Cattand, Desjeux et al. 2006). It has been estimated that, 264 disability-
adjusted life years per million population per year are lost to dengue (Cattand, Desjeux et al. 
2006). A prospective multi-country study conducted in 2005 estimated that it costs US$514 
per ambulatory case and US$1394 per hospitalized case of dengue. Overall, the cost of 
3 
 
dengue for these countries was estimated to be $1.8 billion (Suaya, Shepard et al. 2009). 
Combined with vector control, vaccine development and loss of man hours due to illness, 
the global economic cost of dengue is great. 
 
 
FIGURE 1.1 Countries and areas at risk of dengue transmission. Mainly tropical and 
subtropical regions (orange) are at risk. Figure reproduced from the World Health 
Organization website.  
 
 
Dengue is characterized by a sudden onset of high fever and infected individuals express a 
variety of symptoms including retro-orbital pain, joint and muscle aches, rash and flushed 
skin (WHO 2009). The febrile phase lasts up to 8 days, and may resolve without any specific 
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treatment. In a minority of individuals, dengue hemorrhagic fever (DHF) develops during 
defervescence, with manifestations of capillary leakage accompanied by thrombocytopenia, 
altered homeostasis and liver damage. Increased capillary permeability allows the fluid 
component of blood to escape into the peritoneum and pleural cavity, leading to 
hypovolemia (Halstead 2007). By this time, circulatory failure sets in and dengue enters into 
a life-threatening stage termed: dengue shock syndrome (DSS). Despite intense ongoing 
research, there is currently no vaccine approved for use. In addition, there is no specific 
medication for treating dengue and patients are usually managed with palliative care, 
although severe dengue patients require fluid replacement therapy. Until recently, clinicians 
used guidelines established by WHO in 1997 to define DHF and DSS for patient care. As the 
classifications relied on observations from paediatric studies, there were increasing reports 
of severe dengue in adults not conforming to these classifications (Bandyopadhyay, Lum et 
al. 2006). Revised guidelines were released in 2009 and emphasized on the warning signs of 





 TABLE 1.1 Traditional and revised world health organization classifications for severity of dengue. (WHO 2009)










Fever and two symptoms of the following, 
 Nausea, vomiting 
 Rash 
 Aches and pains 




 Fever or history of acute fever 
 Hemorrhagic manifestations: 








In addition to criteria above,  
 Abdominal pain 
 Persistent vomiting  
 Clinical fluid accumulation 
 Mucosal bleeding 
 Lethargy 
 Liver enlargement (>2cm) 
 Increase in haematocrit concurrent with rapid 






 Rapid and weak pulse 
 Cold, clammy skin 
Severe 
dengue 
Dengue with at least one of the following criteria, 
 Severe plasma leakage leading to: 
o Shock 
o fluid accumulation with respiratory distress 
 Severe bleeding 
 Severe organ involvement 
 Liver damage: aspartate aminotransferase test 
(AST) or alanine aminotransferase test (ALT) of ≥ 
1000 
 Impaired consciousness 
 Failure of the heart or other organs 
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1.1.1. Transmission and control of dengue 
 
Dengue is mainly transmitted by the highly domesticated Aedes aegypti, to a lesser extent 
by Aedes albopictus and uncommonly, by Aedes polynesiensis and Aedes scutellaris (Rodhain 
and Rosen 2001). The tendency of Aedes mosquitoes to feed on humans, in a densely 
populated areas, favour it as a dengue vector (Jansen and Beebe 2010). The transmission of 
DenV into humans occurs across the dermis when the Aedes mosquito takes a blood meal. 
After an incubation period of 5-7 days, a high titre viremia of 105-106 units per ml develops 
and sustains for up to 12 days (Chan and Johansson 2012). During this viremic period, 
mosquitoes feeding on the infected individual can become infected as well. After an 
extrinsic incubation period, these infected mosquitoes then serve to disseminate the virus 
throughout their life span, continuing the cycle. 
Currently, prevention of dengue relies heavily on source reduction. This is a community-
based effort in the elimination of artificial places where mosquitoes can lay their eggs. In 
turn, public education is required to raises awareness of the disease and its mode of 
transmission. Surveillance of vectors and monitoring of minor dengue outbreaks 
complement the application of insecticides in the combat of dengue. There is difficulty in 
producing a tetravalent vaccine capable of providing lifelong immunity to all 4 serotypes of 
DenV, due to the concerns of antibody-dependent enhancement causing immuno-pathology 
instead. Hence, interventions into the natural cycle of dengue are also being studied. For 
example, disruption of DenV infection of mosquitoes can be achieved through 




1.2. Dengue virus 
 
The causative agent of dengue is DenV, a flavivirus  of the Flaviviridae family (Halstead 2007). 
Other flaviviruses include the yellow fever, West Nile and Japanese encephalitis viruses. The 
four serotypes of DenV (DenV1-4) share an amino acid homology of 62-67% (Westaway 
1997). These related viruses possess a positive-sense single-stranded RNA genome of about 
11kb in length. The viral genome is capped at the 5’ end and is initially translated as a single 
polyprotein, which is then cleaved by viral and host proteases to yield 3 structural proteins: 
envelope (E), capsid (C) and pre-membrane (prM) as well as the 7 non-structural (NS) 
proteins: NS1, NS2A, NS2B, NS3, NS4A, NS4B and NS5 (Fig. 1.2). The association of the viral 
genome with C proteins forms the nucleocapsid. The prM proteins are precursors for the 
membrane (M) proteins and, together with the E glycoproteins, are inserted into the lipid-
bilayer containing the nucleocapsid, forming a spherical virion of about 40-50nm in 
diameter (Mukhopadhyay, Kuhn et al. 2005). The prM protein may function as a chaperone 
to assist the formation of the E protein while the E protein is shown to be responsible for 
cellular attachment as well as fusion with the plasma membrane (Chan, Tan et al. 2012). The 
E protein is antigenically significant as it is recognised by neutralizing antibodies (Leclerc, 





FIGURE 1.2 Arrangement of the dengue virus genome. The dengue virus RNA genome 
encodes a single open reading frame which when translated, yields a single polyprotein 
which is cleaved by viral and host proteases to produce 3 structural and 7 NS proteins. 
Figure adapted from (Vasilakis, Cardosa et al. 2011). 
 
Although the cellular receptor for dengue virus has not yet been identified, several co-
receptors have been shown to facilitate viral entry into host cells, including heparin sulphate 
(van der Schaar, Rust et al. 2007), Dendritic Cell-Specific Intercellular adhesion molecule-3-
Grabbing Non-integrin (DC-SIGN) (Lozach, Burleigh et al. 2005), CD4 and mannose receptor 
(Bartenschlager and Miller 2008; Hidari and Suzuki 2011). After successful fusion of the 
virion with the plasma membrane and endocytosis, the acidification of the endosomal 
lumen leads to conformation change in the E proteins, releasing the nucleocapsid into the 
cytoplasm (Clyde, Kyle et al. 2006). The nucleocapsid then un-coats in the cytoplasm, 
allowing for initiation of viral translation. During translation, the viral polyprotein is both co- 
and post-translationally cleaved by cellular proteases and NS2B/NS3 (Falgout, Pethel et al. 
1991; Amberg, Nestorowicz et al. 1994). The DenV replication complex assembles at the 
endoplasmic reticulum (ER) and involves NS5, a RNA-dependent RNA polymerase (Yap, Xu et 
al. 2007). The DenV proteins undergo modifications such as glycosylation at the Golgi 
apparatus, whereby prM is cleaved by furin and the E proteins homodimerize (Perera and 
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Kuhn 2008). Assembly of the virion then occurs at the ER and infectious viral progeny are 
exocytosed via secretory vesicles (Perera and Kuhn 2008). 
The NS proteins have diverse roles in DenV replication. NS1 interacts with NS4A and 
probably play a role in DenV pathogenesis (Lindenbach and Rice 1999; Chen, Lin et al. 2009). 
NS2A cleaves NS1 and NS2B (Hori and Lai 1990); NS4A and NS5 (Miller, Kastner et al. 2007; 
Yap, Xu et al. 2007) are involved in the formation of the viral replication complex while NS2B 
and NS3 are cofactors involved in the proteolytic processing of other NS proteins  (Falgout, 
Pethel et al. 1991; Amberg, Nestorowicz et al. 1994). NS3 also exhibits helicase and RNA 
triphosphatase activities (Flamand, Megret et al. 1999). NS2A and NS4B have been 





1.3. Immuno-pathogenesis of severe dengue 
 
The pathogenesis for severe dengue is unknown but is probably influenced by bo th viral and 
host determinants (Herrero, Zakhary et al. 2012). Several immune mechanisms have been 
postulated to contribute to the pathogenesis of severe dengue infections. 
The antibody-dependent enhancement (ADE) hypothesis proposes that cross-reactive 
(heterotypic) antibodies induced in a primary infection can enhance secondary dengue 
infection (Halstead, Nimmannitya et al. 1970). The hypothesis is based on observations of 
Thai children who, afflicted with a heterologous DenV serotype in secondary dengue 
infections, were more likely to display increased disease severity (Sangkawibha, 
Rojanasuphot et al. 1984; Burke, Nisalak et al. 1988). Serological testing also showed that 
newborn babies who had acquired maternal anti-dengue IgG antibodies had increased risk 
of developing severe dengue (Kliks, Nimmanitya et al. 1988). The ADE hypothesis is also 
supported by experiments in which dengue infection was enhanced in non-human primates 
following passive transfer of antibodies (Halstead 1979). The mechanism of ADE involves 
binding of dengue virions by sub-neutralizing levels of IgG antibodies, which subsequently 
facilitates infection of target cells that express Fc receptors (Mady, Erbe et al. 1991). 
Dengue infection under ADE conditions may result in higher levels of viremia (Moi, Lim et al. 
2011). Because viremia has been shown to positively correlate with dengue severity 
(Murgue, Roche et al. 2000; Wang, Chao et al. 2003; Endy, Nisalak et al. 2004), ADE may 
result in severe dengue. 
The original antigenic sin hypothesis also relies on secondary dengue infections by a 
heterologous serotype. In this hypothesis, cross-reactive memory T cells from a primary 
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infection proliferate preferentially over naïve T cells which possess higher avidity for the 
secondary DenV serotype, causing ineffective clearance of infected cells (Rothman 2011). 
This was observed in Thai children who had low frequencies of DenV-specific CD8+ cells 
compared to activated T cells which recognised other previously encountered DenV strains 
(Mongkolsapaya, Dejnirattisai et al. 2003). DenV-specific memory T cells in secondary 
infections were cross-reactive against the different dengue serotypes by recognition of 
common epitopes of the NS proteins (Kurane, Dai et al. 1993; Gagnon, Zeng et al. 1996). 
Hence, there are now efforts to identify HLA subtypes specific for DenV epitopes. It may be 
possible to establish associations between HLA type and susceptibility to severe dengue 
(Stephens, Klaythong et al. 2002; Zivna, Green et al. 2002; Fernandez-Mestre, 
Gendzekhadze et al. 2004). 
Molecular mimicry of DenV might also explain thrombocytopenia observed in severe 
dengue cases. It has been found that cross-reactive antibodies that target DenV NS1 protein 
can also bind platelets (Falconar 1997), causing their destruction through complement 
activation and also inhibiting ADP-induced platelet aggregation (Lin, Lei et al. 2001). 
Furthermore, the titre of such auto-antibodies was observed to be increased in severe 
dengue patients compared to dengue fever (DF) cases (Lin, Lei et al. 2001). These 
observations were replicated in a murine study where anti-platelet antibody generation 
coincided with the manifestation of thrombocytopenia (Huang, Li et al. 2000). Lastly, DenV 
infection may act directly on the bone marrow and suppress platelet synthesis, resulting in 
thrombocytopenia (La Russa and Innis 1995). Together, these mechanisms induce 
thrombocytopenia and platelet destruction, possibly resulting in haemorrhage observed 
during severe dengue. 
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While dysregulation of the adaptive immune response may account for several aspects of 
severe dengue, there exist severe dengue cases arising from primary infection (Vaughn, 
Green et al. 2000; Wichmann, Hongsiriwon et al. 2004). 
Aberrant cytokine production induced during DenV infection is commonly cited as a cause of 
severe dengue. Compared to DF patients, severe dengue cases exhibit increased serum IFN-
γ and TNF-α (Iyngkaran, Yadav et al. 1995; Braga, Moura et al. 2001; Restrepo, Isaza et al. 
2008). Both IFN-γ and TNF-α are able to activate myeloid cells such as monocytes and 
macrophages, which in turn release high levels of IL-6, IL-8 and TNF-α. While nitric oxide 
produced by activated macrophages has been shown to inhibit DenV replication (Charnsilpa, 
Takhampunya et al. 2005), its over-production may damage endothelial cells and lead to 
capillary leakage. The pro-inflammatory role of TNF-α in dengue pathology is underscored 
by its ability to increase vascular permeability – this is demonstrated by in vitro experiments 
where conditioned supernatant from DenV-infected macrophages induced permeability in 
endothelial cell monolayers (Carr, Hocking et al. 2003). Furthermore, neutralization of TNF-α 
in murine models of DenV infection rescued mice from severe dengue (Chen, Hofman et al. 
2007). Upon DenV infection, TNF-α-induced ICAM-1 expression on endothelial cells can 
synergise with the IL-8-mediated recruitment and activation of neutrophils at the 
endothelium (Anderson, Wang et al. 1997). Infiltration of neutrophils followed by their 
degranulation has been shown to alter micro-vascular permeability, contributing to plasma 
leakage (Juffrie, van Der Meer et al. 2000). Moreover, a dengue-induced cytokine storm can 
further exacerbate disease severity. IL-12 is a monokine produced following viral infection 
and is required for the activation of NK and CD8+ T cells, favouring the Th1 response and 
promoting the clearance of infected cells  (Trinchieri 1995). DenV appears to interfere with 
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the Th1 pathway as IL-12 levels were reported to be reduced in severe dengue cases 
compared to DF cases (Pacsa, Agarwal et al. 2000). In addition, DenV can subvert the type I 
IFN response (Diamond, Roberts et al. 2000; Umareddy, Tang et al. 2008).  
While other factors such as DenV virulence and host physiology contribute to the pathology 
of the disease (Herrero, Zakhary et al. 2012), it is immediately clear that the dysregulation of 
the immune response is involved. DenV-induced disruption of hemostasis and vascular 
integrity, compounded by cytokine storm and immune deviation probably work in concert 




1.4. Adaptive immune responses to dengue 
 
The ADE and original antigen sin theories discussed earlier are malformed adaptive immune 
responses to DenV infection. Yet, T cells remain essential in the clearance of viral infections. 
CD4+ T helper (Th) cells interact with antigen-presenting cells in the induction of an effective 
adaptive response, such as the activation and proliferation of CD8+ cytotoxic T cells which 
function to kill virus-infected cells. T cell receptor (TCR) recognition of DenV E and C proteins 
leading to cellular activation has been reported (Rothman, Kurane et al. 1989; Rothman, 
Kurane et al. 1996). In addition, T cells from dengue patients were determined to recognise 
DenV NS protein epitopes, including NS1 and NS3 (Kurane, Brinton et al. 1991; Mathew, 
Kurane et al. 1996). T cells from DenV-infected patients were found to upregulate 
expression of CD69 (an early marker of activation) and the frequency of CD69+ T cells were 
increased in severe dengue patients (Green, Pichyangkul et al. 1999). In the same study, 
severe dengue patients were found to have reduced absolute numbers of T and B cells, 
compared to DF patients. A previous study focussing on quantitation of lymphocyte subsets 
during severe dengue also found that frequencies of CD3+, CD4+ and CD8+ cells were 
markedly reduced compared to DF patients (Fadilah, Sahrir et al. 1999). 
In vitro DenV antigen-mediated proliferation of T cells obtained during acute infection was 
observed to be impaired, compared to autologous T cells obtained 6 months post-
convalescence (Mathew, Kurane et al. 1999). Proliferation of these T cells was only restored 
when they were co-cultured with irradiated autologous convalescent PBMCs, suggesting 
that DenV infection suppressed accessory cell support of T cell growth (Mathew, Kurane et 
al. 1999).  
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Maturation and activation of T cells normally requires engagement of their TCR but in some 
instances can be mediated by TCR-independent means. This bystander mode of activation, 
previously observed in HSV and HIV infections, was also observed in whole blood samples 
from DenV infected children (Suwannasaen, Romphruk et al. 2010). Such bystander-
activated T cells shared similar kinetics as NK cells by rapidly producing IFN-γ 12h after 
infection and neutralization of IL-12 in whole blood samples abrogated this bystander effect  
(Suwannasaen, Romphruk et al. 2010). Cytotoxic T lymphocytes were noted to non-
specifically lyse bystander cells, producing TNF-α and IFN-γ in the process (Gagnon, Ennis et 
al. 1999). 
B cells were demonstrated to be permissive to DenV infection but this was contradicted by a 
later study (Lin, Wang et al. 2002; Kou, Quinn et al. 2008). Regardless of their infectability, B 
cells are probably poor hosts for DenV due to the low progeny virus generated in face of 
high MOI used in the experiments. More importantly, cross -reactive B cells generated 
during primary DenV infections are acknowledged to persist in secondary infections . The 
preferential expansion of cross-reactive memory B cells may lead to the precedence of 
poorly-neutralizing IgG antibodies in interaction with DenV virions (Mathew, West et al. 
2011; Garcia-Bates, Cordeiro et al. 2013). This demonstrates the original antigenic sin theory 
and also sets the stage for ADE in dengue pathogenesis. Yet, evidence shows that high 
frequencies of circulating plasmablasts specific for DenV E protein are present in secondary 
infections. These cells can perhaps clear DenV infection more effectively by targeting the E 
protein, which has highly conserved epitopes in all four serotypes (Xu, Hadinoto et al. 2012). 
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Taken together, these findings suggest that T and B cells responses may be modulated 
during DenV infection and while they are essential in clearance of infection, may also 




1.5. Innate immune responses to dengue 
 
Innate immunity is the forefront barrier to establishment of infection, relying on the broad-
based receptor-mediated recognition of pathogens. In comparison to the adaptive immune 
response, induction of innate immunity is nearly immediate and is thought not to generate 
immunological memory. Principal players in the innate arm of immunity include 
complement, pathogen pattern receptors (PPRs), cytokines, lymphocytes such as NK and γδ 
T cells as well as cells of the myeloid and polymorphonuclear lineage. Investigations into the 
innate immune responses toward dengue have shed light on disease pathology. 
PPRs recognise pathogen-associated molecular patterns (PAMPs) which are structural 
motifs shared within groups of pathogens, and activate immune responses. Toll-like 
receptors (TLRs) are a family of PPRs involved in pathogen recognition. TLRs 3, 7 and 8 
recognise viral RNA while TLR9 is able to detect unmethylated CpG sequences commonly 
found in viral and bacterial genomes (Hemmi, Kaisho et al. 2003). In accordance with their 
role in viral recognition, they are found intracellularly in phagocytic cells such as 
macrophages and dendritic cells (DCs) (Blasius and Beutler 2010). TLRs 3, 7 and 8 have been 
observed to co-localise with endocytosed dengue virions and drive the production of IL-8 in 
U937, a human monocytic cell line (Tsai, Chang et al. 2009). In the same study, TLR3 
recognition of DenV also resulted in type I IFN release and helped suppress viral replication 
in infected HEK293 fibroblast cells (Tsai, Chang et al. 2009). A similar observation for TLR3 
has also been reported for West Nile virus infection (Daffis, Samuel et al. 2008), indicating 
its importance in the restriction of flavivirus replication. 
The RIG-1-like family of intracellular PPRs are RNA helicases and include RIG-1, MDA5 and 
LGP2 (Loo and Gale 2011). Binding of RIG-1 (Retinoic acid-inducible gene I) and MDA5 
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(melanoma differentiation-associated gene 5) to viral RNA induces their translocation to the 
outer mitochondrial membrane, eliciting IRF signalling and resulting in type I IFN 
transcription (Onoguchi, Yoneyama et al. 2011). Following DenV infection, both RIG-1 and 
MDA5 were observed to be upregulated in keratinocytes, activating several antiviral genes 
in the process (Surasombatpattana, Hamel et al. 2011). Silencing of RIG-1 or MDA5 in Huh7 
hepatocytes enhanced DenV replication while their over-expression inhibited DenV 
replication and upregulated IFN-β production (Nasirudeen, Wong et al. 2011).  
C-type lectins are yet another class of PPRs, with CLEC5A notably able to interact with DenV 
(Chen, Lin et al. 2008). This interaction induced pro-inflammatory cytokine release in both 
human and murine macrophages (Chen, Lin et al. 2008). In the same report, murine CLEC5A 
binding to DenV was found to result in excessive systemic TNF-α which was associated to 
plasma leakage and increased mortality. 
The complement system is a series of plasma proteins which act in concert to opsonise 
pathogens and induce a pro-inflammatory response. Activation of complement occurs 
through 3 main pathways: classical, alternate and the mannose-binding lectin (MBL). These 
pathways culminate in the formation of a C3 convertase which processes other complement 
proteins to produce anaphylatoxins, recruit phagocytotic cells and lyse cells through 
formation of the membrane attack complex (MAC). Complement activation during dengue 
infection is critical due to the production of anaphylactic C3a, C4a and C5a as they can 
increase vascular permeability and induce plasma leakage, features of severe dengue. In 
support of this, C3 catabolism was observed to be increased in severe dengue patients 
(Bokisch, Top et al. 1973) and systemic concentrations of complement anaphylatoxins 
correlated with disease severity (Churdboonchart, Bhamarapravati et al. 1983). Furthermore, 
DenV infectivity may be enhanced by complement receptor (CR)-3 (CD11b) binding of 
19 
 
complement-fixed DenV (Cardosa, Porterfield et al. 1983). DenV NS1 has been involved 
complement-mediated severe disease pathology. Secretory NS1 deposited on endothelial 
cells has been demonstrated to activate complement and cause endothelial damage 
(Avirutnan, Punyadee et al. 2006). To complement this study, NS1 was found to assist in the 
formation of the MAC by blocking the activity of its negative regulator, clusterin (Kurosu, 
Chaichana et al. 2007). Paradoxically, NS1 can also antagonize the complement system by 
binding to C4b directly (Avirutnan, Hauhart et al. 2011). Other reports suggest that 
complement is protective toward DenV instead – complement activation inhibited the 
effects of ADE on DenV infection of primary macrophages (Yamanaka, Kosugi et al. 2008) 
and the MBL pathway was described to be able to specifically neutralize DenV serotype 2 
(Avirutnan, Hauhart et al. 2011). 
Production of type I IFNs follow viral detection by host receptors discussed earlier. They 
serve to limit the spread of infection by the induction of antiviral interferon stimulated 
genes (ISGs) such Protein kinase R (Content 2009). The viral evasion of interferon activity 
has led to both virus and IFN co-evolution, with numerous types (ie. IFN-α, -β, -ε, -ω) and 
subtypes of IFNs (IFNA1, IFNA2 and IFNA4 to name a few) having arisen (Goodbourn, 
Didcock et al. 2000; Bekisz, Schmeisser et al. 2004). It is not surprising that DenV has also 
developed mechanisms to subvert the interferon response at several levels. The DenV 
NS2B-NS3 complex has been found to prevent the transcription of IFN-β (Rodriguez-Madoz, 
Belicha-Villanueva et al. 2010) while NS5 strategically blocks type I IFN-mediated signalling 
by degrading STAT2 (Ashour, Laurent-Rolle et al. 2009; Mazzon, Jones et al. 2009). Notably, 
DenV can only establish infection in mice which are knocked-out for type I IFN receptors or 
STAT2 (Johnson and Roehrig 1999; Perry, Buck et al. 2011). The observations that DenV NS5 
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cannot inhibit murine STAT2 activity and the inability of DenV to infect human cells 
transfected with murine STAT2 (Ashour, Morrison et al. 2010) confirm that DenV has 
evolved to undermine the critical human interferon antiviral response. 
Neutrophils are important innate defenders against bacterial infections and their 
degranulation releases defensins as well as reactive oxygen species which are toxic to 
pathogens (Nathan 2006). While neutrophils are refractory to infection by DenV 
(Theofilopoulos, Brandt et al. 1976), they have been observed to adhere strongly to DenV-
infected endothelial cells (Butthep, Bunyaratvej et al. 1993). Due to the cytokine milieu 
induced during dengue, neutrophils may be activated by increased local IL-8, leading to their 
extravasation and degranulation. This in turn promotes endothelial permeability and 
vascular leakage, possibly resulting in shock (Juffrie, van Der Meer et al. 2000). 
Thus far, these findings indicate that the interaction between innate immunity and DenV 
can influence the disease outcome. Dendritic and natural killer cells are also critical innate 





1.6. Dendritic cells and their involvement in DenV infection 
 
Dendritic cells (DCs) are an important link between innate and adaptive immunity. They are 
widely distributed in tissues and have been described as sentinels against pathogens. Upon 
uptake of antigen, DCs undergo maturation and migrate to the lymphoid tissues. By 
presentation of antigens to T cells, DCs prime the adaptive immune response. Even though 
it is becoming clear that DCs are a heterogeneous set of cells , their classifications are still 
uncertain (Shortman and Liu 2002; Steinman and Hemmi 2006; Kushwah and Hu 2011). This 
is due to difficulty in their isolation, gaps in knowledge of their development, as well as 
overlapping properties between DCs subsets. Various subsets of DCs have been detected in 
peripheral blood, primary and secondary lymphoid organs as well as in tissue interstitia such 
as the dermis of the skin. Even as the list of DC subsets grows, a common observation is that 
these subsets have diverse phenotypes and functions to stimulate discrete immune 
responses.  
Human myeloid DCs in peripheral blood are characterised by their expression of both CD11c 
and IL-3R (Romani, Gruner et al. 1994). The myeloid origin of these cells is indicated by their 
expression of CD13 and myeloid-specific CD33, and such DCs have conventional functions 
such as antigen presentation and production IL-12 in response to viral infections (Fadilah 
and Cheong 2007). Human plasmacytoid DCs (pDCs) are also found in peripheral blood but 
are distinguished from blood myeloid DCs by their expression of both BDCA-2 and BDCA-4 
(Zhang and Wang 2005) and the absence of CD11c and IL-3R expression (Fadilah and Cheong 
2007). They possess critical antiviral activity because of their ability to detect viruses 
through TLRs 7, 8 and 9 (other TLRs are absent) and to robustly produce type I IFNs during 
viral infection (Ito, Wang et al. 2005). However, their antigen presentation capability is only 
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modest (Tel, van der Leun et al. 2012). Interestingly, pDCs (as well as thymic DCs) have 
experienced somatic rearrangement of the immunoglobulin genes during their development, 
suggesting that they may be of lymphoid origin (Ardavin, Wu et al. 1993; Shigematsu, Reizis 
et al. 2004). Follicular DCs (FDCs) are of mesenchymal origin and categorized as DCs due to 
their morphology (van Nierop and de Groot 2002). FDCs are found in the secondary 
lymphoid organs, restricted to germinal centres where B cells undergo affinity maturation 
and differentiation into plasma cells  (Cyster 2010). As part of the germinal centre reaction, 
they promote survival of B cell clones with high specificity for pathogen and delete non-
specific or auto-reactive B cells through apoptosis (Cyster 2010). FDCs function as APCs 
without requiring MHC class II presentation, instead relying on microvesicles bound on CR1 
and CR2 instead (Denzer, van Eijk et al. 2000).  
There are 2 main subsets of DCs present in the skin - Langerhans cells (LCs) and interstitial 
DCs. Both human LCs and interstitial DCs are derived from a common CD34+ hematopoietic 
progenitor cell (Caux, Vanbervliet et al. 1996; Gatti, Velleca et al. 2000). While similar in 
many aspects, LCs differ from interstitial DCs by the expression of langerin and Birbeck 
granules as well as the absence of CD11b (Mackensen, Herbst et al. 1995; Valladeau, 
Dezutter-Dambuyant et al. 2003). Interstitial DCs are more akin to blood myeloid DCs as 
they both develop directly from CD14+ monocytes (Caux, Vanbervliet et al. 1996). In 
contrast, LCs are generated from a pool of epidermal precursors, identified as a subset of 
peripheral myeloid DCs which have migrated into the epidermis (Merad, Manz et al. 2002). 
These common myeloid-derived DCs are phenotypically “immature” in steady state 
conditions and their flux between tissues is low but observable. Immature DCs (imDCs) in 
the periphery uptake antigens via a repertoire of sensors including TLRs, DC-SIGN, mannose 
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receptor, Fcγ receptors and DEC-205 (Steinman and Hemmi 2006). In addition, DCs capture 
antigen through phagocytosis and macropinocytosis (Steinman, Inaba et al. 1999). 
Encounter with pathogens triggers transcription of pro-inflammatory genes, leading to 
maturation of the DC to fulfil its professional APC role. Maturing DCs upregulate MHC class I 
and II molecules as well as co-stimulatory CD80 and CD86 for interaction with both naïve 
and memory T cells. In the process, DCs become refractory to antigen uptake but gain the 
ability to home to secondary lymphoid organs through afferent lymphatic vessels. This is 
enabled by upregulation of CCR7, an important chemokine receptor responding to CCL19 
and CCL21 (Dieu-Nosjean, Vicari et al. 1999). Mature DCs trafficking to the paracortical T cell 
area in the lymph node position themselves for interaction with CD4+ and CD8+ T cells. DC 
production of CCL18 and CCL22 attracts both naïve and memory T cells for sampling of 
peptides loaded on MHC class I and II molecules (Adema, Hartgers et al. 1997; Katou, Ohtani 
et al. 2001). This is helped by DC upregulation of ICAM-1 and LFA-3, which bind with T cell 
LFA-1 and CD2 respectively, stabilising the DC-T cell interfaces (Scheeren, Koopman et al. 
1991). TCR recognition of the peptide-MHC complex is insufficient for productive activation 
of naïve T cells. The process also requires co-stimulation given by CD80 and CD86, without 
which results in T cell anergicity (Lohr, Knoechel et al. 2004). In turn, DCs stimulated by T cell 
CD40L gain increased longevity and produce cytokines that support T cell proliferation and 
differentiation (Wong, Josien et al. 1997). In addition, DC expression of 4-1BB and OX40 
ligands has been found to maintain CD8+ memory T cells and drive T helper cell migration to 




Importantly, the DC cytokine secretion profile is dependent on the DC subtype and 
pathogen species, resulting in polarization of the T cell response. Accordingly, DCs which 
have encountered bacterial or viral pathogens produce IL-12, favouring an appropriate Th1 
response and generation of IFN-γ-producing CD4+ T cells. IFN-γ confers resistance to further 
infection while activating phagocytes to eliminate intracellular pathogens. The Th1 pathway 
also expands CD8+ cytotoxic effector T cells which aid in the killing of infected cells. In 
contrast, DCs activated by extracellular pathogens such as helminths skew towards the Th2 
response, enabling humoral immunity (Bozza, Gaziano et al. 2002; MacDonald, Straw et al. 
2002). Without direct microbial encounter, DCs can be also matured by local pro-
inflammatory cytokine milieu induced by infection or tissue injury. Necrotic cells releasing 
heat shock proteins and TNF-α as well as type I IFNs secreted by pDCs are such examples 
(Basu, Binder et al. 2000; Colonna, Trinchieri et al. 2004). 
DCs can also induce tolerogenic responses. DCs have been observed to produce IL-10 and 
TGF-β, anti-inflammatory cytokines which modulate the induction of adaptive immunity  
(Zhou and Tedder 1995). By not providing co-stimulation, DCs can delete antigen-specific T 
cells which may be auto-reactive (Calder, Bondeson et al. 2003). Furthermore, matured 
myeloid DCs can prime and expand IL-10-producing CD4+ T regulatory cells (Jonuleit, Schmitt 
et al. 2000).  
The initial events of DenV infection are unclear but dermal DCs, in addition to macrophages 
and monocytes, are hypothesized to be targets for DenV infection (Kou, Quinn et al. 2008; 
Miller, de Wet et al. 2008). This is reasonable given that such cells can be localized in the 
dermis, where DenV is inoculated when the mosquito takes a blood meal. The expression of 
both DC-SIGN and Fcγ receptors on myeloid DCs for antigen capture renders DCs susceptible 
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to DenV infection. DC-SIGN has been implicated in receptor-mediated endocytosis, being 
shown to interact with DenV E protein and facilitate internalization of DenV into DC -SIGN-
expressing cells (Tassaneetrithep, Burgess et al. 2003; Lozach, Burleigh et al. 2005). 
Furthermore, Fcγ receptors can promote DenV entry in an ADE fashion. Indeed, DCs are 
prime targets for DenV infection in vivo as demonstrated by their good infectivity in 
cadaveric human skin explants (Wu, Grouard-Vogel et al. 2000). The depression of pDCs 
numbers was first observed in children with severe dengue (Pichyangkul, Endy et al. 2003). 
A later study saw absolute numbers of both myeloid and plasmacytoid DCs significantly 
reduced in dengue patients compared to controls, with their frequencies inversely 
correlated to the level of DenV viremia (De Carvalho Bittencourt, Martial et al. 2012). 
Another study observed that in dengue patients, the peripheral frequencies of myeloid DCs 
and pDCs fluctuated during the course of infection (Tsai, Jen et al. 2011). Interestingly, at 
day 5 of illness, there was a sharp decrement of myeloid DCs accompanied by a 3-fold 
increase in pDCs. While the clinical significance of this observation is unclear, the authors 
hypothesized that these subsets of DCs acted independently in flux between tissues, to 
present antigen or inhibit DenV through type I IFN production.  
Faced with difficulty of isolating human DCs from tissue, monocyte-derived DCs (MoDCs) 
generated by differentiation of peripheral blood monocytes with IL-4 and GM-CSF are 
favoured for in vitro experiments by DenV researchers  (Sallusto and Lanzavecchia 1994; 
Gluckman, Canque et al. 1997; Lutz 2004). MoDCs resemble interstitial DCs by morphology 
and express markers such as CD1a as well as receptors for endocytosis such as DC-SIGN and 
Fcγ receptors.  
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DenV infection of MoDCs results in their maturation. DenV-infected DCs were documented 
to upregulate CD40, CD80, CD83, CD86 and MHC class II molecules , (Ho, Wang et al. 2001) 
as well as CCR7 (Wu, Ho et al. 2009), suggesting that they were poised to prime the adaptive 
immune response. However, it should be noted that infected DCs did not mature to the 
same extent as uninfected bystander DCs, assessed by differences in B7 and MHC molecule 
expression (Dejnirattisai, Duangchinda et al. 2008). Bystander DCs were also proposed to be 
activated by paracrine cytokines and exosomes secreted by DenV-infected DCs (Martins Sde, 
Silveira et al. 2012). The cytokine secretion profile of DenV-infected DCs (as well as 
bystander DCs) was mainly pro-inflammatory, consisting of type I IFNs, TNF-α, IL-6 and IL-8 
(Nightingale, Patkar et al. 2008). While it is noted that these cytokines can induce a 
heightened state of inflammation to limit the spread of DenV, excessive systemic TNF-α is 
associated with endothelial damage and haemorrhage in severe dengue. RANTES and CXCL-
10 are chemokines highly produced by DenV-infected DCs (Chen and Wang 2002; Becerra, 
Warke et al. 2009) as well as by DenV-infected endothelial cells (Lin, Chiu et al. 2005). In fact, 
CXCL-10 was detected to be significantly elevated in dengue patients (de-Oliveira-Pinto, 
Gandini et al. 2012) and shown to inhibit dengue infection of hepatocytes (Chen, Lu et al. 
2006). It is likely that through these chemokines, DCs enhance recruitment of immune cells 
to the endothelium. Furthermore, recent work has shown that infected DCs over-produced 
matrix metalloproteinase (MMP)-2 and MMP-9 in a murine vascular leakage model 
(Luplertlop, Misse et al. 2006). This resulted in endothelial cell loss of expression adhesion 
molecules, PECAM-1 and VE-cadherin, which are essential for maintenance of vascular 
integrity. Taken together, DCs apparently have the potential to exacerbate the inflammation 
already induced at the endothelium and cause severe dengue pathology.  
27 
 
DenV can modulate the immune response of infected DCs in a strain and serotype-specific 
manner, with DenV2 commonly shown to inhibit type I IFN production and signalling in DCs 
(Munoz-Jordan, Sanchez-Burgos et al. 2003; Umareddy, Tang et al. 2008; Rodriguez-Madoz, 
Belicha-Villanueva et al. 2010; Chase, Medina et al. 2011). In contrast to other virus 
infections, DenV-infected DCs hardly produced IL-12 but upregulated secretion of IL-10 
(Palmer, Sun et al. 2005; Nightingale, Patkar et al. 2008). IL-10 may inhibit the host defence 
to DenV by depressing DC expression of MHC class I and II molecules as well as co-
stimulatory molecules, antagonizing the action of IL-12 in the induction of a functional 
cytotoxic T cell response (Demangel, Bertolino et al. 2002). Furthermore, IL-10 can induce T 
cell anergy directly (Maris, Chappell et al. 2007). Systemic levels of IL-10 are increased in 
dengue-infected patients (Green, Vaughn et al. 1999), although it is unclear whether DCs or 
other cell types are the predominant producers of IL-10 in vivo. 
T cells can respond to dengue-infected DCs, although these responses may be blunted. 
Possible mechanisms can include infection-induced cytopathology and upregulation of FasL 
to increase DC apoptosis rate (Silveira, Meyer et al. 2011), as well as viral suppression of the 
bone marrow to prevent the generation of DCs (Albuquerque, Silva Junior et al. 2009). 
However, the effects of DenV on expression of co-stimulatory molecules and cytokines by 
DCs (described above) probably play a significant part in affecting T cell responses by 
diminishing help for T cell activation. In one study, infected DCs induced proliferation of 
naïve CD4+ T cells, which failed to produce IFN-γ and TNF-α (Chase, Medina et al. 2011). 
However, it may be possible to overcome DenV-mediated suppression of DC function. 
Activated T cells were able to counter DenV suppression of DC maturation, as co-culturing 
DCs with activated T cells resulted in increased CD86 expression, matching that of bystander 
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DCs (Dejnirattisai, Duangchinda et al. 2008). This enhancement may be mediated by the 
CD40-CD40L axis, since CD40 ligation on DCs increased IL-12 production and decreased DC 
apoptosis. IL-12 production by DenV-infected DCs can also be enhanced by IFN-γ (Libraty, 
Pichyangkul et al. 2001), so the cellular immunity that can be generated by DenV-infected 
DCs might be especially sensitive to interactions between DCs and cellular sources of IFN-γ, 




1.7. Natural killer cells and their involvement in DenV infection 
 
Natural killer (NK) cells are innate lymphocytes involved in the eradication of virus-infected 
cells and tumours. NK cells develop from common lymphoid progenitor cells (Yoon, Chung 
et al. 2007) and are innate-like due to their ability to respond to transformed cells without 
prior sensitization (Trinchieri 1989). In humans, conventional NK cells are divided into two 
subsets based on their surface density of CD56 (NCAM-1). CD56bright NK cells are rare in 
circulation, but found mostly in lymphoid tissue and do not express Fcγ receptors (CD16). In 
contrast, the CD56dim subset is numerous in peripheral blood and expresses CD16 to 
perform antibody-dependent cellular cytotoxicity (ADCC). It is generally accepted that the 
CD56bright NK cells are localized in lymphoid tissues due to L-selectin expression and help 
shape the immune response through robust cytokine secretion, while CD56dim NK cells are 
involved in peripheral immune-surveillance and readily perform cytotoxicity (Cooper, 
Fehniger et al. 2001). Although IL-22-secreting mucosal NK cells as well as uterine NK cells in 
pregnancy have also been described (Hanna, Goldman-Wohl et al. 2006; Vivier, Spits et al. 
2009), only the conventional NK cells will be reviewed in this section.  
NK cells possess an array of activating receptors that function in immune-surveillance. In 
addition, NK cells host inhibitory receptors which temper their activity, and these receptors 
are most prominently represented by the killer-cell immunoglobulin-like receptors (KIRs). 
No single receptor can determine the activation state of the NK cell – instead the sum of 
inhibitory and activating signals given at any time dictates whether the NK cell mounts a 
response (Bryceson, March et al. 2006). The only exception to this is crosslinking of CD16 
during ADCC, which has been shown to override all other inhibitory signals  (Bryceson, 
March et al. 2006). 
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The repertoire of activating receptors in NK cells includes and is not limited to CD16, NKG2D, 
DNAM-1, natural cytotoxic receptors (NCRs, receptors being NKp30, NKp44, NKp46 and 
NKp80) and members of the SLAM family (reviewed in a later section). The ligands of the 
NCRs remain vague, but NKp44 and NKp46 have been found to bind influenza hemagglutinin 
(Arnon, Lev et al. 2001; Mandelboim, Lieberman et al. 2001), while HCMV pp65 protein was 
shown to interact with NKp30 (Arnon, Achdout et al. 2005). Apart from viral protein 
recognition, the NCRs enable NK cells to mark transformed or damaged cells for deletion. 
Proteins such as vimentin and BAT3 localized intracellularly in healthy cells may be exposed 
following cellular damage and these proteins are recognised by NKp46 and NKp30 
respectively (Garg, Barnes et al. 2006; Pogge von Strandmann, Simhadri et al. 2007). Indeed, 
NK cells can sense stressed or transforming cells which have upregulated ULBP1-3 ligands 
through the NKG2D receptor (Gasser, Orsulic et al. 2005). In addition to the ULBPs, NKG2D 
recognises MICA/B, molecules also found to be upregulated on tumours (Kato, Tanaka et al. 
2007; Weiss-Steider, Soto-Cruz et al. 2011). NK cells can also assist the adaptive immune 
response through ADCC, attacking diseased cells that are opsonised by IgG. The Fc portions 
of immobilized IgG engage and crosslink multiple Fcγ receptors which then signal the NK cell 
to degranulate and lyse the opsonised cell. 
The KIR proteins are highly polymorphic and recognise groups of HLA alleles. KIR2DL1, 
KIR2DL2 and KIR2DL3 bind the HLA-C group of molecules while KIR3DL1 and KIR3DL2 
receptors bind HLA-A and HLA-B as ligands (Biassoni 2009). It should be noted that while 
MHC class I molecules act as inhibitory ligands, they can also be recognised by activating 
receptors including other members of the KIR family or related receptors (e.g. CD160). 
Because NK cells do not require prior sensitization in the elimination of diseased cells, they 
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may inadvertently cause injury to normal healthy cells. Thus, during their development, NK 
cells are educated to be tolerant towards self through signals given by MHC class I 
molecules. NK cells which do not express at least one self HLA-specific KIR become anergic 
while those recognising MHC molecules mature and acquire full effector function 
(Yokoyama and Kim 2006). This is reversed when mature NK cells are in circulation – they 
are released from inhibition to perform cytotoxicity on diseased cells that lack MHC class I 
expression (“missing self recognition”), but spare healthy cells with normal MHC class I 
expression (Ljunggren and Karre 1990). Viruses commonly downregulate MHC expression on 
infected cells to evade detection by cytotoxic T cells (Hengel, Flohr et al. 1996; Murray, 
Constandinou et al. 1998; Ali, Lubong et al. 2004). However, such infected cells cannot 
effectively engage the KIRs on NK cells, thus tilting the balance towards activation. Loss of 
inhibition is usually insufficient for NK cell killing, but NK cell activation is authorized by 
diseased cells upregulating ligands for activating NK cell receptors. 
Human activating NK cell receptors frequently associate with accessory proteins such as the 
TCR ζ chain, FcεRIγ and DAP10 for signal transduction (Biassoni 2009). This is achieved by 
the accessory proteins bearing Immunoreceptor Tyrosine Activation Motifs (ITAMs), or in 
the case of DAP10, a YINM signalling motif (Billadeau and Leibson 2002; Lanier 2009). 
Engagement of activating receptors results in the phosphorylation of critical tyrosine 
residues of the accessory proteins, which then recruit adaptor proteins, culminating in the 
activation of PI3K, PLCγ, Vav, Rho, Rac and MAPK proteins (Watzl and Long 2010). These 
events facilitate calcium flux and actin reorganization, required for immune synapse 
formation and degranulation. In contrast, the KIRs and other inhibitory receptors do not 
require accessory proteins for signalling but have intrinsic Immunoreceptor Tyrosine 
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Inhibitory Motifs (ITIMs) which recruit SHP-1 and SHP-2 tyrosine phosphatases (Bolland and 
Ravetch 1999). The presence of SHP phosphatases selectively de-phosphorylate early 
components of the activating pathway (e.g. Vav-1), preventing induction of NK cell 
cytotoxicity (Le Drean, Vely et al. 1998). Another signalling motif is utilised by SLAM family 
receptors for signal transduction and will be discussed later. 
Apart from membrane-bound ligands, the activity of NK cells is also influenced by cytokines. 
Type I IFNs, IL-12, IL-15, IL-18 and IL-27 released by virus-infected cells or produced by 
activated DCs serve to enhance NK cell cytotoxicity and cytokine secretion, while anti-
inflammatory cytokines such as TGF-β and IL-10 diminish NK cell responses (Rook, Kehrl et al. 
1986; Nakamura, Okamura et al. 1993; Hunter, Gabriel et al. 1997; Shibata, Foster et al. 
1998). 
Activated NK cells also upregulate surface expression of TRAIL and FasL, which ligate with 
death receptors on target cells to mediate cytotoxicity. Binding of these ligands to their 
receptors triggers apoptosis on the target cell through a caspase-dependent pathway 
(Falschlehner, Schaefer et al. 2009). Alternatively, activated NK cells lyse target cells through 
degranulation, a process involving targeted release of cytotoxic granzymes and perforin 
(Clement, Haddad et al. 1990). Perforins facilitate the entry of granzymes, which are serine 
proteases, into the target cell cytoplasm. By cleavage of caspases, granzymes also induce 
apoptosis of the target cell. Degranulation and expression of death ligands are not mutually 
exclusive events, because studies have shown FasL to be stored in lytic granules and 
exposed to NK cell surface following degranulation (Bossi and Griffiths 1999). 
In tandem with their antiviral role, NK cells secrete IFN-γ, an important cytokine having 
established roles in antiviral defence. Ligation of the IFN-γ receptor triggers 
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homodimerisation of STAT1 and transcriptional activation of genes that bear upstream 
gamma activating sequences (GAS). Transcription of IFN-γ stimulated genes serves to limit 
virus infection by upregulation of PKR and ADAR (inhibitors of viral protein synthesis), 
promotion of MHC class I and II presentation of foreign peptides to T cells  for induction of 
adaptive immunity, halting cellular division and upregulation of death receptors in infected 
cells (Schroder, Hertzog et al. 2004). Furthermore, IFN-γ induces production of 
chemoattractants such as CXCL-10 and MIP-1α, for trafficking of other effector cells to the 
site of inflammation.  
By orchestrating cytokine secretion and cell-mediated cytotoxicity towards infected cells, NK 
cells can suppress early viral replication. The importance of NK cell in antiviral defence is 
underscored by in vivo studies where the absence of NK cells or their defective responses 
predisposed individuals with increased susceptibility to severe viral infections (Biron, Byron 
et al. 1989; Joncas, Monczak et al. 1989). The NK cell responses towards various virus 
infections has been summarized and published by Biron et al. and is presented in Table 1.2 
(Biron, Nguyen et al. 1999). Even from this dated review, we can appreciate the 
indispensible role of NK cells in viral defence. 
Yet, the role of human NK cells in dengue infection is not well defined and relevant 
literature is scarce. Peripheral NK cells isolated from dengue patients were found to be 
activated during dengue infection by having increased surface expression of CD69 (Green, 
Pichyangkul et al. 1999; Azeredo, De Oliveira-Pinto et al. 2006). An in vitro study revealed 
that NKp44 is able to bind the E protein of WNV and DenV. However, the interaction 
between NKp44 and DenV E protein was approximately 5 times weaker (Hershkovitz, 
Rosental et al. 2009). This could be explained by differences in structure and ability to 
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dimerize between the 2 flaviviruses’ E proteins (Kanai, Kar et al. 2006). In the same study, 
NK cell lines responded to WNV-infected cells through NKp44 signalling, by secretion of IFN-
γ and degranulation. Unfortunately, the researchers did not pursue whether NK cells could 
be activated by DenV infection or the E protein. Murine NK cells were determined to be 
recruited to sites of inflammation by mast cells and suppressed DenV replication. This was 
inferred from increased DenV titres in the draining lymph nodes of host animals that were 
depleted for mast cells (St John, Rathore et al. 2011). Another study demonstrated that 
murine NK cells actively proliferated and produced IFN-γ during primary dengue infection 
(Shresta, Sharar et al. 2005). However, it is unknown if primary human NK cells are able to 
respond in a similar manner to DenV-infected primary human cells, and the factors which 
govern the response have not been elucidated. Furthermore, severe dengue is associated 
with high viral load (Wang, Chao et al. 2003) and may be indicative of malformed NK cell-




TABLE 1.2. Summary of published findings on the role of NK cells in viral infections. 





    Adenoviruses Sensitivity of virus-transformed cells to NK cell-mediated cytolysis 
in vitro correlates inversely with oncogenicity 
 
Arenaviridae  
    LCMV Induction of cytotoxicity but not IFN-γ production; viral titres do 
not increase upon depletion of NK cells 
 
    Pichinde virus Induction of cytotoxicity; depletion of NK cells increases 
replication of NK-susceptible virus strains 
 
Coronaviridae  
    MHV Induction of cytotoxicity; contrasting reports on effects of NK cell 
depletion on susceptibility to infection that may be attributable to 
differences in strain variants 
 
Herpesviridae  
    HSV-1 Depletion of NK cells increases susceptibility; low cytotoxicity or 
NK cell deficiency in humans leads to disseminated infections  
 
    VZV NK cell deficiency in humans associates with disseminated 
infection 
 
    MCMV 
 
Induction of both cytotoxicity and IFN-γ production; depletion or 
deficiency of NK cells increases susceptibility; resistance gene, 
Cmv-1, links with NK gene complex 
 
    HCMV Low cytotoxicity associates with increased mortality following 
bone marrow transplantation; NK cell deficiency in humans leads 
to disseminated infection 
 
    EBV 
 
 
Humans with Chediak-Higashi Syndrome exhibit severe chronic 
infections; persistent defective cytotoxicity associates with chronic 




    Influenza virus Depletion of NK cells increases morbidity and mortality; induction 






    Papillomaviruses NK cell deficiency in humans correlates with recurrent cervical 
carcinoma in situ and condylomata 
 
Paramyxoviridae  
    Measles, mumps and 
Sendai viruses 




    Coxsackie virus Induction of cytotoxicity; depletion of NK cells increases viral 
replication and results in more severe myocarditis  
 
    EMCV Induction of cytotoxicity; correlation of resistance to diabetogenic 
virus strain in female Swiss mice with induction of IFN-γ 
production; abrogation of resistance in C57BL/6J male mice with 
NK cell depletion 
 
    TMEV Susceptibility of mouse strain correlates with lower NK cell 
cytotoxicity; depletion of NK cells in resistant mouse strain 
increases severity of encephalitis 
 
Poxviridae  
    Vaccinia virus Induction of cytotoxicity; depletion of NK cells increases viral 
replication 
 
    Ectromelia virus Depletion of NK cells increases viral titres; resistance in different 




    HTLV-1 NK cells mediate cytotoxicity against virus-infected cells 
 
    HIV Immune-complex armed NK cells mediate lysis against CD4+ T 
cells; NK cells from infected patients produce antiviral CC 
chemokines in vitro; cytotoxicity, but not ADCC, decreases over 
the course of infection 
 
Rhabdoviridae  
    VSV Induction of cytotoxicity; poor in vivo tumorigenicity of 
persistently infected cell lines correlates with susceptibility to NK 
cell cytotoxicity in vitro 
 
Togaviridae  
    Sindbis virus Induction of cytotoxicity; lack of correlation between NK cell 





1.8. NK cells interact with DCs in vivo 
 
NK cells and DCs have been noted to crosstalk in vivo to the mutual benefit of their function  
(Fernandez, Lozier et al. 1999; Gerosa, Baldani-Guerra et al. 2002). Maturing DCs that have 
uptaken antigen secrete cytokines such as IL-12 that enhance NK cell cytotoxicity as well as 
IFN-γ production. Similarly, activated pDCs secreting type I IFNS have also been 
demonstrated to support NK cell activity (Romagnani, Della Chiesa et al. 2005). IL-15, an 
important cytokine in NK cell proliferation and activation, has been shown to bind the IL-
15Rα chain expressed on DCs. By trans-presenting the bound IL-15 to NK cells, DCs increase 
the potency of IL-15 in NK cell activation (Lucas, Schachterle et al. 2007). Likewise, 
membrane-bound TNF-α on DCs was also shown to prime NK cells for cytotoxicity (Xu, 
Chakrabarti et al. 2007). DCs also produce IL-18, a cytokine capable of inducing NK cell 
cytotoxicity and upregulation of CCR7 for trafficking to the secondary lymphoid organs 
(Fehniger, Shah et al. 1999; Mailliard, Alber et al. 2005). In turn, activated NK cells produce 
cytokines such as IFN-γ, TNF-α and GM-CSF as well as supply necrotic material from the lysis 
of diseased cells in promotion of DC maturation (Cooper, Fehniger et al. 2001; Moretta, 
Marcenaro et al. 2005). Notably, the type of pathogen and cytokine milieu dictates whether 
NK cells should favour the Th1 response by producing IFN-γ. In a Th2 environment with 
predominance of IL-4, production of IFN-γ by NK cells was impaired and there was reduced 
proliferation of IL-2-producing CD4+ T cells (Agaugue, Marcenaro et al. 2008).  
More interestingly, NK cells are known to kill imDCs through a process called “editing”. NK 
cells which were exposed to DCs incubated with E. coli lysed imDCs but not the infected DCs 
which had upregulated MCH class I expression (Ferlazzo, Morandi et al. 2003). Such a 
process may ensure that DCs migrating to the lymph nodes are fit to present antigen and 
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invoke an adaptive immune response, in contrast to sub-optimal levels of antigen 
presentation that may prime low affinity T cells or induce tolerance instead (Marcenaro, 
Ferranti et al. 2005). NKp30, but not the other NCRs, has been implicated in the editing of 
DCs as antibody-mediated blocking of NKp30 reduced lysis of autologous imDCs (Ferlazzo, 
Tsang et al. 2002).  
The requirement of NK-DC crosstalk in rejection of viruses has been documented in in vitro 
experiments. DCs in influenza-infected mice depleted for NK cells were impaired in viral 
antigen uptake and failed to migrate to the lymph nodes to stimulate a functional T cell 
response (Ge, Ho et al. 2012). In humans, influenza-infected DCs upregulated ULBP1-3 and 
type I IFNs, stimulating NK cells to secrete IFN-γ and lyse infected DCs (Draghi, Pashine et al. 
2007). Blocking NKp46 also reduced the NK cell response, indicating that influenza virus had 
upregulated NKp46 ligands on infected DCs. Both human and murine CMV infections, NK 
cells were stimulated by infected DCs to produce cytokines and exert cytotoxicity. This was 
achieved by NK cells recognising DNAM-1 and NKp46 ligands as well as IL-12, IL-18 and type 
I IFN cytokines over-expressed by the infected DCs (Orange and Biron 1996; Andoniou, van 
Dommelen et al. 2005; Magri, Muntasell et al. 2011). Yet, literature on NK cells interacting 
with DenV-infected DCs is absent. Given that DCs are prime targets for DenV infection and 
the intimacy of these cell types in regulation of innate immune responses , a study (like the 





1.9. SLAM family of immunoreceptors 
 
There are now 9 members of the Signalling Lymphocytic Activation Molecule (SLAM)-related 
receptor family: the prototypic SLAM, CD48, Ly9, 2B4, CD84, NTB-A, CRACC, BLAME and 
SF2001. SLAM-related receptors are type I transmembrane proteins that belong to the CD2 
subset of the immunoglobulin (Ig) superfamily. They possess a membrane-proximal C2-type 
Ig constant domain and an N-terminal Ig variable domain, with the exception of Ly9 which 
has the extracellular domains duplicated (Fig. 1.4). The SLAM family of receptors are located 
on the long arm of chromosome 1 (Iq23) in humans. Due to the arrangement of the genes, it 
is probable that the receptors arose from repeated duplications of a common ancestral 
gene. Because little is known about BLAME and SF2001, the remainder of this section will 





FIGURE 1.3. Structures of human SLAM family receptors. SLAM family receptors typically 
have an N-terminal Ig variable domain and a membrane-proximal Ig C2 domain. Such 
receptors possess ITSMs in their cytoplasmic tails for adaptor protein binding. Structure for 
CD48 is not shown. Figure adapted from (Cannons, Tangye et al. 2011). 
 
The SLAM family of receptors are homophilic – they can act as their own ligand, with the 
exception of CD48 and 2B4, which are binding partners (Cannons, Tangye et al. 2011). The 
affinity of SLAM for itself was observed to be the lowest among the receptors, with Kd of 
about 200µM, followed by CD48-2B4, NTB-A homophilic interactions and CD84 self affinity 
the strongest in the sub-µM range (Mavaddat, Mason et al. 2000; Cao, Ramagopal et al. 
2006; Velikovsky, Deng et al. 2007; Yan, Malashkevich et al. 2007). Signal transduction in 
SLAM-related receptors is mediated by adaptor proteins binding to unique tyrosine-based 
signalling motifs in their cytoplasmic tails. These motifs are termed immunoreceptor 
tyrosine-based switch motifs (ITSMs) and have a consensus sequence of TxYxxV/I (where x 
represents any amino acid). In contrast to ITAMs (which recruit protein kinases) and ITIMs 
(which recruit phosphatases), ITSMs exert dual functions of cellular activation and inhibition 
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by being able to recruit both kinases (e.g. Fyn) and phosphatases (e.g. SHP-1). Signal 
transduction is mediated by SAP, a 14kDa adaptor protein containing a Src homology (SH)-2 
domain which recognises the phosphorylated ITSM (Sayos, Wu et al. 1998). However, 
CRACC cannot associate with SAP and instead relies on Ewing's sarcoma/FLI1-activated 
transcript 2 (EAT-2) for signal transduction (Cruz-Munoz, Dong et al. 2009). Mice express a 
third SLAM family signal transducer, EAT-2 related transducer (ERT), which exists as a 
pseudogene in humans and is not expressed (Calpe, Erdos et al. 2006). Ligation of a SLAM-
related receptor results in ITSM tyrosine phosphorylation and recruitment of SAP; although 
an unphosphorylated SLAM ITSM has been shown to be sufficient to bind SAP, with 
phosphorylation improving the binding (Poy, Yaffe et al. 1999). Fyn is the principal tyrosine 
kinase recruited to the ITSM after SAP binding (Chan, Lanyi et al. 2003) while other Src 
kinases such as Lck, Fgr and Lyn are shown to be involved (Mikhalap, Shlapatska et al. 1999; 
Mikhalap, Shlapatska et al. 2004; Simarro, Lanyi et al. 2004). Recruitment and activation of 
Fyn then results in phosphorylation of tyrosine residues available the receptor’s cytoplasmic 
portion. In the absence of SAP, SLAM-related receptors instead recruit SHP-1 and SHP-2 
phosphatases for downstream signalling, indicating that the presence of SAP may sterically 
hinder SHP binding to the ITSM (Sayos, Wu et al. 1998). This was further demonstrated in 
studies where over-expression of SHP proteins led to their competition with SAP for binding 
to the ITSM. In SAP knockout mice, SHP-1 accumulated to immune synapses where they 
were presumably recruited by SLAM-related receptors (Zhao, Cannons et al. 2012).  
The importance of SLAM-related receptors in immunity is underscored by the link between 
X-linked lymphoproliferative (XLP) disease and loss-of-function mutations in the SH2D1A 
gene (Arico, Imashuku et al. 2001). A follow-up study by another group described the 
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product of this gene to bind with SLAM and named it SAP (Sayos, Wu et al. 1998). XLP is a 
severe immune disorder first characterized by EBV infection. Affected individuals display 
abnormally high B cell proliferation and hypogammaglobulinemia (Engel, Eck et al. 2003), 
absence of NKT cells (Pasquier, Yin et al. 2005), with NTB-A- and 2B4-mediated cytotoxicity 
impaired in NK and cytotoxic T cells (Parolini, Bottino et al. 2000; Sharifi, Sinclair et al. 2004). 
The latter observations may explain why the abnormally proliferating EBV-infected B cells 
are not kept in check. 
The SLAM family of receptors are widely expressed on cells of hematopoietic origin and no 
receptor is confined to a single cell type (Table 1.3). SLAM-related receptors have varying 
functions in different subsets of cells, given the heterogeneous expression of adaptor 
proteins as well as their ability to influence other receptors. More often, they are involved in 
fine-tuning of the immune responses. Descriptions of each SLAM family receptor will be 




TABLE 1.3. Expression pattern of SLAM family receptors. Gene name of each SLAM-related 
receptor is given. Omp - outer membrane protein. 1 Recent work has shown BLAME to be 
expressed on macrophages and functions to inhibit NADPH oxidase activity (Wang, Abadia-
Molina et al. 2012). Table adapted with modifications from (Cannons, Tangye et al. 2011) 
 





SLAM, measles virus 
hemagglutinin, Gram 




Hematopoietic stem cells (HSCs), thymocytes, B 
cells, T cells, DCs, macrophages, platelets, T 
follicular helper (TFH) cells 
SLAMF2 
CD48 
2B4, CD2, E. coli 
FimH 
 







Thymocytes, T cells, TFH cells, NKT cells, B cells, 







HSCs, NK cells, γδ T cells, activated CD8+ T cells, 







NK cells, NKT cells, B cells, T cells, monocytes, 






Thymocytes, NK cells, B cells, T cells, DCs, 


























The importance of SLAM in immunity is underscored by XLP disease and molluscum 
contagiosum virus (MCV) infections. MCV has evolved several decoy proteins to downplay 
the immune response – its genome codes for homologue receptors to IFN-γ and IL-1β 
(Alcami and Smith 1995), as well as SLAM (Bugert, Melquiot et al. 2000). Deletion of these 
homologues in mutant strains of MCV has resulted in reduced pathogenicity (Spriggs 1996), 
reiterating the involvement of SLAM in immunity. SLAM was first observed to be rapidly 
upregulated on activated naïve and memory T cells, suggesting that its role in early T cell 
activation (Cocks, Chang et al. 1995). Indeed, later studies demonstrated that SLAM was 
able to stimulate T cell proliferation in an IL-2-independent manner as well as their 
production of IFN-γ (Aversa, Chang et al. 1997; Howie, Okamoto et al. 2002). SLAM was also 
identified to co-localize with the TCR upon T cell activation (Howie, Simarro et al. 2002). 
While it may appear from these results that SLAM promotes the Th1 pathway, an additional 
study proved otherwise. Both SAP and Fyn-deficient CD4+ T cells showed impaired PKC-θ 
recruitment to the immune synapse and activation, while SLAM engagement in normal T 
cells promoted PKC-θ activity and IL-4 production (Cannons, Yu et al. 2004). Hence, in 
normal T cells, SAP is required downstream of SLAM to activate PKC-θ and eventually NF-κB, 
for transcription of Th2 genes. In support of SLAM-mediated Th2 polarization, germinal 
centre T follicular helper cells were demonstrated to rely on SLAM interaction for IL-4 
production and stimulation of IgG production by B cells (Yusuf, Kageyama et al. 2010). Since 
SLAM has been established to favour the Th2 pathway, it is inconsistent for SLAM-activated 
T cells to increase IFN-γ production in observations given earlier. An explanation is that the 
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SLAM activating antibodies used in these pilot experiments were actually antagonistic, 
thereby explaining the increased IFN-γ production.  
On the topic of SLAM blocking/activating antibodies, the discrepancy of results published on 
the SLAM effect on DCs has to be noted. Bleharski et al showed that CD40L stimulation 
results in DC upregulation of SLAM and concluded using SLAM agonist antibodies that SLAM 
ligation stimulates pro-inflammatory cytokine production in DCs (Bleharski, Niazi et al. 2001). 
Their results were contradicted by the Réthi group, who showed that CD40L-activated DCs 
were inhibited from producing IL-6, IL-12 and TNF-α when their SLAM receptors was 
activated by SLAM over-expressing cells (Rethi, Gogolak et al. 2006). SLAM is probably an 
anti-inflammatory receptor in DCs and antibodies against it should be carefully evaluated for 
their agonistic/antagonistic activity by comparison to SLAM-knockdown cells or co-culture 
with SLAM over-expressing cell lines. 
Macrophages are also known to express SLAM. Murine macrophages that were deficient for 
SLAM were observed to mount defective responses to LPS challenge, with notable 
reductions of IL-12, TNF-α and nitric oxide production compared to normal macrophages 
(Wang, Satoskar et al. 2004). SLAM activation was also demonstrated to positively control 
IL-6 production in macrophages. A recent report revealed that SLAM can function as a 
macrophage bacterial receptor by recognition of E. coli outer membrane protein (Omp) and 
induces NADPH oxidase activity for killing of phagocytosed pathogens (Berger, Romero et al. 
2010).  
It was found that upon aggregation, SLAM molecules found on murine platelets were 
strongly tyrosine-phosphorylated (Nanda, Andre et al. 2005). SLAM was then ascertained to 
function as an adhesion molecule in platelets as SLAM-knockout mice had defective 
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thrombus formation. Interestingly, in SAP-deficient aggregated platelets, the ITSM of SLAM 
remained phosphorylated and signalling may have been mediated by other SAP-related 
adaptors such as EAT-2 or ERT.  
SLAM has also been implicated in the development of NKT cells, as mice that were deficient 
for the receptor had reduced NKT cell numbers (Griewank, Borowski et al. 2007). This 
reduction was further exacerbated in mice missing both SLAM and Ly108 (mouse 
homologue of NTB-A), with the authors suggesting that SLAM and Ly108 homotypic 
interactions complemented each other, in mediating SAP-dependent cellular maturation.  
The existence of isoforms of SLAM-related receptors is a recurring theme. SLAM has been 
detected as a secreted isoform, with the transmembrane region deleted (Punnonen, Cocks 
et al. 1997; Isomaki, Aversa et al. 1999), as well as an isoform with the cytoplasmic region 
truncated (Cocks, Chang et al. 1995). The presence of SLAM isoforms may serve to induce 
separate cellular responses or act as decoy proteins in competition with functional SLAM 





1.9.2. CD48 and 2B4 
 
Broadly expressed on hematopoietic cells, CD48 expression can be upregulated following 
viral infection (Parolini, Bottino et al. 2000) or cytokine stimulation with type I IFNs and IFN-
γ (Tissot, Rebouissou et al. 1997). In addition to CD2, 2B4 has been documented to be a 
binding partner for CD48 (Arulanandam, Moingeon et al. 1993; Brown, Boles et al. 1998) 
However, the affinity of CD48 for CD2 is 6-9 times lower than its affinity for 2B4 (Brown, 
Boles et al. 1998). Hence NK cells, which express both CD2 and 2B4, are activated through 
2B4 preferential binding to CD48 (Lee, Forman et al. 2006). The cytoplasmic region of CD48 
is devoid of any ITSM and hence cannot recruit SAP related adaptors for downstream 
signalling (Calpe, Wang et al. 2008).  
Polymorphisms in the human SLAMF4 gene result in 2 isoforms of 2B4, with an isoform 
having additional 5 amino acids in the extracellular Ig V region (Kumaresan and Mathew 
2000). It is probable that the isoforms differ in binding capacity to CD48 (Mathew, Rao et al. 
2009). The activating role of 2B4 for NK cells has been widely studied. 2B4 is expressed on 
all NK cells (Valiante and Trinchieri 1993), and has dual activating and inhibitory roles, 
depending on the species, context of maturation and activation of the NK cell. 
Murine 2B4 was initially shown to be activating in function. Antibody-directed crosslinking 
of 2B4 in early experiments appeared to induce degranulation and IFN-γ production in NK 
and γδ T cells (Garni-Wagner, Purohit et al. 1993; Schuhmachers, Ariizumi et al. 1995). 
However, when murine NK cells were cultured with CD48-bearing tumour cells, they were 
less efficient in killing and produced less IFN-γ, compared to co-cultures with CD48-negative 
targets (Lee, McNerney et al. 2004). A study by Mooney et al supports 2B4 as an inhibitory 
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receptor. Using similar methods as Lee et al, this group demonstrated CD48-expressing cell 
lines inhibited murine NK cell cytolysis while addition of 2B4 and CD48 blocking antibodies 
relieved the inhibition (Mooney, Klem et al. 2004). Hence, these studies on murine 2B4 
called for reinterpretation of earlier work which suggested that murine 2B4 was an 
activating NK cell receptor. Intriguingly, Mooney et al also reported that 2B4-mediated 
inhibition of NK cell cytotoxicity was independent of SAP binding. Indeed, 2B4 was shown to 
be able to bind EAT-2 and ERT and NK cells from mice knocked out for the 2 adaptors 
displayed enhanced killing and secretion of IFN-γ (Roncagalli, Taylor et al. 2005). Yet, work 
by Wang et al showed the contrary as EAT-2 knockout mice were unable to exert 
cytotoxicity through 2B4. Furthermore, EAT-2 was determined to be responsible for Vav-1 
recruitment and its phosphorylation (Wang, Calpe et al. 2010). These confounding results 
have not been resolved and at the present, can only be attributed to differences in the 
genetic background of the mice employed in the studies. 
It was observed that 2B4 is only inhibitory in immature human NK cells (Sivori, Falco et al. 
2002). Hence, Sivori et al hypothesized that 2B4 ligation prevents autolysis in maturing 
human NK cells which have not acquired inhibitory KIRs. In corroboration with this study, 
immature murine NK cells generated in vitro from multipotent bone marrow progenitor 
cells were also inhibited from killing by 2B4 ligation (Lee, McNerney et al. 2004). The 
cytotoxic potential of these immature murine NK cells was only rescued when blocking 
antibodies against target cell CD48 were administered. Yet, in contrast to their murine 
counterpart, 2B4 in matured human NK cells mostly acts as an activating receptor. The 
disparity between human and murine 2B4 function has not been resolved. While there are 
doubtful effects of using agonistic/antagonistic antibodies, co-culturing NK cells with CD48-
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bearing targets also has its limitations. It has been suggested that murine NK cells showed 
reduced cytotoxicity towards CD48-negative targets because there was lack of 2B4 
stimulation in the immune synapse with target cells; sub-stimulation of 2B4 (outside the 
immune synapse) given by neighbouring CD48-expressing NK cells may instead lead to 
recruitment of EAT-2 or ERT which then inhibited cytotoxicity (Lee, Forman et al. 2006).  
Human NK cells were noted to produce IFN-γ and exert cytotoxicity when stimulated 
through 2B4 ligation with CD48 (Valiante and Trinchieri 1993; Nakajima, Cella et al. 2000; 
Stark and Watzl 2006). Yet, 2B4 engagement alone had little effect on resting NK cells – it 
functioned as a co-receptor to enhance cytotoxicity in NK cells that were stimulated through 
other activating receptors such as NKG2D or the NCRs (Bryceson, March et al. 2005; 
Bryceson, March et al. 2006). As mentioned earlier, CD48 is widely expressed on 
haematopoietic cells. Hence, even when surrounded by CD48-bearing immune cells, 2B4 
engagement alone will not lead to deleterious activation of NK cells. The status of 2B4 is 
relegated to a co-receptor due to the low intracellular levels of SAP in resting NK cells. Thus 
only in activated NK cells can SAP can be dramatically induced, allowing 2B4-mediated 






Unique amongst the SLAM family receptors, Ly9 possesses 2 sets of Ig V and C2 domains in 
its extracellular portion and has the longest cytoplasmic tail, carrying 9 tyrosine residues  in 
total (Fig. 1.4). Ly9 is expressed on several immune cell types including NK cells and DCs. 
However, little is known for its functions in immune regulation. 
Ly9 was first described to participate in T-B cell interactions as revealed by localization of 
Ly9 at the immune synapses (Romero, Zapater et al. 2005). Later work showed that Ly9 may 
favour the Th2 response as Ly9-deficient murine T cells were defective in IL-4 production 
and proliferation (Graham, Bell et al. 2006). As with most SLAM-related receptors, Ly9 uses 
the SAP adaptor for recruiting signalling proteins such as Fyn (Simarro, Lanyi et al. 2004) as 
well as Grb2 (Martin, Del Valle et al. 2005). Interestingly, not observed for other SLAM-
related receptors, antibody-mediated crosslinking of Ly9 caused its internalization in T and B 
cells (Del Valle, Engel et al. 2003). The relevance of this Fcγ receptor-mediated endocytosis 
of Ly9 is unclear as yet. In a very recent report, Ly9 was reported to negatively control 






Expressed on a variety of immune cells, CD84 can either recruit SAP (Sayos, Martin et al. 
2001) or EAT-2 (Tangye, van de Weerdt et al. 2002) for signal transduction in humans. There 
are 2 subsets of B cells in the human spleen, characterized by the surface expression of 
CD84 (Tangye, van de Weerdt et al. 2002). CD84hi splenic B cells were differentiated 
compared to their CD84low counterpart, as they were larger in size, expressed CD27, had 
experienced somatic mutation of the Ig variable region genes and readily proliferated. 
However, whether CD84 actually participated in the differentiation of CD84hi B cells has not 
been investigated. CD84 is further implicated in humoral immunity as demonstrated by its 
requirement in the establishment and maintenance of TFH-B cell contacts in the germinal 
centre – mice that were knocked out for CD84 had reduced numbers of plasma cells and 
showed impaired antibody production (Cannons, Qi et al. 2010). The frequency of IL-21-
producing TFH cells was reduced, suggesting defects in their function to interact with B cells. 
In addition, CD84 ligation in T cells was found to recruit SAP and Lck in enhancing T cell 
proliferation (Tangye, Nichols et al. 2003). It was demonstrated that for murine NK cells, 
CD84 ligation recruited EAT-2 for enhanced killing of CD84-bearing target cells (Wang, Calpe 
et al. 2010). However, it should be noted that human NK cells do not express CD84 (Tangye, 
van de Weerdt et al. 2002). Altogether, CD84 probably functions as an activating receptor 
for lymphocytes. In contrast, CD84 ligation has an inhibitory effect on human mast cells as 
given by reduction in production of IL-8 and GM-CSF as well as inhibition of degranulation 
(Alvarez-Errico, Oliver-Vila et al. 2011). The study also showed that the inhibitory effects of 






Aptly named as due to its expression on NK, T and B cells, NK-T-B-antigen (NTB-A) is also 
found on DCs and neutrophils, functioning as an activating receptor. The function of NTB-A 
in NK cells has been elucidated by Bottino et al who showed, through redirected lysis assays, 
that NTB-A ligation enhanced NK cell killing of EBV-infected cells (Bottino, Falco et al. 2001). 
NTB-A recruited SAP for signal transduction but was also found to co-immunoprecipitate 
with SHP-1 and SHP-2 in NK cells treated with sodium pervanadate. Furthermore, in the 
absence of SAP, NTB-A became inhibitory as its crosslinking inhibited CD16-triggered 
cytotoxicity in NK cells from XLP patients. Yet in another study, SAP appeared to be 
dispensable for cytotoxicity as its knock-down in NK cells did not influence killing of target 
cells (Eissmann and Watzl 2006). A reason given for the contradicting results is that the 
phenotype of XLP patient-derived NK cells differs from those isolated from healthy donors. 
The development of NK cells may be shaped by signals given from SLAM, 2B4 and NTB-A 
(Flaig, Stark et al. 2004; Calpe, Wang et al. 2008). Thus, a deficiency in SAP could lead to 
defects in NK cell development and reversed NTB-A function. This may also favour an 
alternative NTB-A isoform which still retains signalling capacity but has inhibitory function 
instead. Overall, NTB-A enables NK cells to perform cytolysis of EBV-infected B cells; in SAP-
defective XLP patients, NK cells may instead contribute to disease pathology by being 
inhibited by NTB-A (Bottino, Falco et al. 2001). 
Similar to SLAM, NTB-A also influences CD4+ T cell polarization to the Th2 phenotype.  
Experiments performed on murine splenic CD4+ T cells with deleterious mutations in Ly108 
(the murine homologue of NTB-A) showed impaired IL-4 production following stimulation, 
with IFN-γ secretion unaffected (Howie, Laroux et al. 2005). The involvement of Ly108 in the 
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induction of humoral immunity was verified when NTB-A-mutant mice failed to resolve L. 
mexicana infections, compared to wild type mice. In the same study, Ly108 was also found 
to be important in regulation of neutrophil activity – neutrophils expressing mutant Ly108 
were unable generate reactive oxygen species for clearance of phagocytosed S. 
Typhimurium. 
There are 6 isoforms of human NTB-A (Calpe, Wang et al. 2008) while the murine Ly108 
exists as 2 isoforms: Ly108.1 and Ly108.2, with Ly108.1 being shown to stimulate less 
calcium flux in B cells (Kumar, Li et al. 2006). In the murine model for lupus, Ly108.1, but not 
Ly108.2, was highly expressed on B cells. Importantly, Ly108.2 was the isoform detected to 
sensitise immature B cells to deletion and RAG re-expression. Hence, NTB-A/Ly108 may be 






Most of the research on CRACC (CD2-like Receptor-Activating Cytotoxic Cells, CS1) has been 
focussed on NK cells. Resting human NK cells express 2 isoforms of CRACC whose levels 
remain unchanged after stimulation with IL-2 (Lee, Boles et al. 2004). The shorter splice 
variant has a truncated cytoplasmic region and lacks the ITSM. This shorter isoform, being 
unable to bind its signal transducers, is probably non-functional. CRACC ligation on NK cells 
has been reported to enhance IFN-γ secretion and killing of target cells (Tassi and Colonna 
2005; Stark and Watzl 2006; Cruz-Munoz, Dong et al. 2009). Interestingly, when MHC class I 
blocking antibodies were administered to NK cell-only cultures, there was increased 
autolysis of NK cells, which was then inhibited in presence of CRACC blocking antibodies 
(Stark and Watzl 2006). This suggests that NK cell cytotoxicity can be induced by 
neighbouring NK cells which also expressed CRACC (as well as through the NTB-A and 
CD48/2B4 axes). 
Although it is generally accepted that human CRACC binds the EAT-2 adaptor, its 
recruitment of SAP is uncertain (Veillette 2006; Cannons, Tangye et al. 2011). Only in a study 
involving over-expression of SAP was it observed to immunoprecipitate with CRACC (Tovar, 
del Valle et al. 2002). Regardless, CRACC is able to activate NK cells independently of SAP as 
shown by preservation of its activity in XLP patients (Bouchon, Cella et al. 2001). Because 
EAT-2 association with 2B4 probably inhibits NK cell activity (Roncagalli, Taylor et al. 2005; 
Lee, Forman et al. 2006), it is surprising that human CRACC requires EAT-2 for induction of 
cytotoxic responses – CRACC activation is associated with EAT-2 recruitment and 
phosphorylation of PLC-γ, leading to activation of PI3K (Tassi and Colonna 2005). The 
perplexing issue of EAT-2 having both inhibitory and activating functions when coupled to 
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different SLAM-related receptors has not been resolved but work on murine CRACC by Cruz-
Munoz et al has been insightful. The function of murine CRACC was similarly activating but 
cytotoxicity mediated by NK cells was inhibited in the absence of EAT-2 (Cruz-Munoz, Dong 
et al. 2009). The authors showed through point mutations that a tyrosine residue in the 
cytoplasmic region of murine CRACC, not found in humans, had recruited factors which 
switched CRACC function to inhibitory. The factors were ascertained not to be SHP-1, SHP-2 
or SHIP but a yet to be identified signalling molecule. 
CRACC expression is low or absent in immature DCs (Bouchon, Cella et al. 2001; Tovar, del 
Valle et al. 2002). During the search for activating ligands upregulated on DenV-infected DCs, 
we noted increased CRACC expression. Furthermore, influenza virus-infected DCs were also 
observed to increase CRACC expression (Bouchon, Cella et al. 2001), suggesting that CRACC 





1.10. Aims of this study 
 
1. Characterize NK cell responses towards DenV-infected DCs. 
Although individual observations of NK cell and DC responses during dengue 
infection have been catalogued, there is hardly any research in amalgamating the 
two, to characterize naïve human NK cell responses towards DenV-infected 
monocyte-derived DCs. This is especially important as NK cells crosstalk with DCs in 
shaping innate immunity. This study will focus on NK cell effector functions such as 
the production of IFN-γ and cell-mediated cytotoxicity. 
2. Decipher how NK cells are activated during DenV infection 
DenV infection may induce DCs to express surface markers or secrete cytokines that 
are required for NK cell activation. The factors (cell-bound and soluble) that regulate 
the NK cell response to dengue-infected DCs have not been described in the 
literature. 
3. Examine the role of CRACC ligation in NK cells and DCs 
In search of DC membrane-bound factors which activated NK cells during dengue, 
upregulation of CRACC expression was observed on DenV-infected DCs. CRACC acts 
as its own ligand, and has been demonstrated to be an activating receptor on NK and 
T cells. Thus, DenV-infected DCs may induce NK cell cytotoxicity through CRACC 
ligation. Furthermore, the role of CRACC on DCs has not been described yet; the 












2.1. Generation of virus stocks 
 
Dengue virus serotype 1 strain S3638 (DenV1-S3638, a generous gift from Dr. Ooi Eng Eong, 
Duke-NUS) was propagated in the C6/36 mosquito cell line by inoculating the C6/36 
monolayer with 1ml of virus in a 75cm2 tissue culture flask. Viral adsorption was allowed for 
2h at 28oC before addition of 9ml of RPMI 1640 medium (Hyclone Laboratories Inc., Logan, 
Utah, USA) supplemented with 2% heat-inactivated fetal bovine serum (Thermo Fisher 
Scientific, Waltham, MA, USA), 1% HEPES and 2mM L-glutamine (both from Gibco, Carlsbad, 
CA, USA). This growth medium mixture is henceforth referred to as infection medium. 6 
days post-infection (P.I.), the cell-free culture supernatant was collected after centrifugation 
at 10000 x g for 10min, aliquoted and stored at -80oC as virus stocks. Amplified stocks of 
DenV1-07K4383 and DenV3-05K4176 were kindly provided by Prof. Mary Ng, Department of 
Microbiology, NUS. 
 
2.2. Titration of virus stocks 
 
Limiting dilution plaque assay was then carried out using BHK-21 cells (baby hamster kidney 
fibroblasts, generously gifted by Dr. Sylvie Alonso, Department of Microbiology, NUS) to 
determine the titre of the virus stocks. BHK-21 cells were seeded in 24-well plates to achieve 
full confluency on the day of infection. 10-fold dilutions of the DenV stock were then 
performed using infection medium, giving a dilution range from neat to 10-6. Plated cells 
were then carefully washed with HBSS and 150µl of diluted virus was added to each well. 
Infection was performed in quadruplicates for each dilution factor at 37oC for 2h, after 
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which viral supernatant was aspirated and infection medium containing 1% 
carboxymethylcellulose (Mw: 2.5x10
5, Sigma-Aldrich, St. Louis, MO, USA) was overlaid onto 
the cells. 1 week P.I., the cell monolayers were fixed with 4% paraformaldehyde and stained 
with 200µl of 0.5% crystal violet. Plaque clearings were scored visually and DenV 
concentration was calculated by the formula: (average numbe r of plaques x dilution 
factor)/0.15 and given as PFU/ml. 
 
2.3. Isolation of human NK cells and generation of MoDCs 
 
Heparinized peripheral blood was drawn from consenting donors to perform autologous co-
cultures. Buffy coat packs obtained from National University Hospital  of Singapore were also 
a source of PBMCs for other experiments. PBMCs were obtained by subjecting peripheral 
blood to density gradient separation with Ficoll-Paque (GE Healthcare Bio-Sciences AB, 
Uppsala, Sweden), followed by several rounds of washing with PBS. NK cells and monocytes 
were enriched from PBMCs by magnetic separation using the NK isolation kit II and CD14 
MicroBeads respectively (both from Miltenyi Biotech, Bergisch Gladbach, Germany). The 
purity of isolated NK cells and monocytes were typically greater than 95% as judged by flow 
cytometry analysis of purified cells . 
NK cells were cultured overnight in complete medium (RPMI 1640 supplemented with 10% 
heat-inactivated fetal bovine serum, 1% HEPES, 2mM L-glutamine, 100U/ml penicillin and 
100µg/ml streptomycin). Both antibiotics were from Gibco. NK cells were cultured at a 
concentration of 1-2x106 cells/ml in a 24-well plate. Monocytes were differentiated into DCs 
by culture in complete media supplemented with 500U/ml of recombinant human IL-4 and 
60 
 
800U/ml of GM-CSF (both from eBioscience, San Diego, CA, USA). DCs were consistently 
kept at 3x106 cells per 2ml of differentiating media in each well of a 6-well plate. 
Differentiating monocytes were fed every 2 days by having half of its culture medium 
replaced with fresh cytokine-containing media. After 7 days, the loosely adherent DCs were 
harvested by vigorous pipetting and gentle scraping. The phenotype of the immature DCs 
were routinely assessed by flow cytometry and found to be CD1a+, DC-SIGN+, CD14-/low and 
CD83-/low, and is presented in the appendix A1. 
 
2.4. DenV infection of DCs and their co-cultures with NK cells  
 
Immature DCs were infected with a MOI of 1. After incubation with DenV at 37oC with 
occasional shaking for 2h, DCs were washed once with infection medium and re-suspended 
with infection medium to a concentration of 106 cells/ml. Mock-infected DCs were similarly 
prepared by incubation with DenV1-S3638 which was previously heat-inactivated at 55oC for 
30min. 105 DCs were seeded in each well of a round-bottom 96-well plate and cultured for 
28h. After overnight culture, NK cells were harvested and re-suspended in infection medium 
to a concentration of 106 cells/ml. 105 NK cells were added to each well of DCs and 
incubated for 2h before immunofluorescence staining was performed. In some experiments, 
Golgistop (BD Biosciences, San Jose, CA, USA) was added to inhibit protein transport to 





2.5. Generation of stable cell lines 
 
SH-SY5Y, a human neuroblastoma cell line, was obtained from ATCC (Manassas, VA, USA) 
and cultured in DMEM medium (Thermo Fisher Scientific) supplemented with 10% heat-
inactivated FBS, 1% HEPES, 2mM L-glutamine, 100U/ml penicillin and 100µg/ml 
streptomycin. THP1-Blue, a human monocytic cell line expressing a NF-κB/AP-1 inducible 
SEAP reporter gene was bought from Invivogen (San Diego, CA, USA). L-929 (a mouse 
fibroblast cell line) and 293T (a variant of the human embryonic kidney cell line expressing 
simian virus 40 large T antigen) were thawed from previously established stocks. GP2-293 
cells were purchased from Clontech Laboratories, Inc. (Mountain View, CA USA) as part of 
the Retro-X retroviral packaging system. THP1-Blue, L929, 293T and GP2-293 cells were all 
cultured in complete RPMI medium.  
The coding sequence of human CRACC was obtained from National Centre for Biotechnology 
Information (accession number: NM_021181.3 and AF390894) and the sequence 
corresponding to the matured mRNA was cloned. Whole RNA was harvested from PBMCs 
using the Qiagen RNeasy kit (Hilden, Germany) to serve as the template for the cloning of 
CRACC. cDNA then was synthesized using a M-MLV reverse transcriptase (Promega, 
Fitchburg, WI, USA) and amplified by high fidelity PCR (Kapa Biosystems Inc., Woburn, MA, 
USA) with the following primers: CS1-7R, 5’-GAGAGCAATATGGCTGGTTCCCC-3’ and CS1-
1458L, 5’- TGGTCTTCTTGCCCTCCTGGTAG-3’. The cycling conditions were as follows: initial 
denaturation at 95oC for 5min, 35 cycles of denaturation at 98oC for 20sec, annealing at 
65oC for 15sec and extension at 72oC for 1min. A final extension step was performed at 72oC 
for 5min. The 1452bp long product was purified using the NucleoSpin Gel and PCR Clean-up 
kit (Macherey-Nagel GmbH, Düren, Germany) and subjected to further high fidelity PCR 
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using the exact cycling conditions as before, using the primers: pQCXIH-CS15, 5’- 
ATTACCGGTACCATGGCTGGTTCCCCAACATGC-3’ and pQCXIH-CS13, 5’- 
TCGCGTACGCTAGATAACATTCTCATAGGCAAATAG-3’. The generated 1029bp long PCR 
product (sequence given in the appendix, A2) corresponded to the matured CRACC mRNA, 
with appropriate overhangs for cloning into the pQCXIH vector (Clontech Laboratories, Inc). 
This 2-step method was elected instead as direct PCR of this product from cDNA gave poor 
yield and non-specific products. Stbl2 competent cells (Invitrogen) were transformed to 
propagate this final pQCXIH-CRACC product. The vector drove the expression of CRACC by 
an immediate-early CMV promoter as part of a bi-cistronic message with an appended 
hygromycin resistance marker. 
Co-transfection of GP2-293, a packaging cell line, with pQCXIH-CRACC and pVSV-G was 
performed using Xfect transfection polymer (Clontech Laboratories, Inc) to produce 
retroviral particles capable of integrating the CRACC sequence into the genome of target 
cells. To create control cell lines from retrovirions, the empty pQC-XIH vector was 
introduced into GP2-293 cells instead. GP2-293 culture supernatant containing retroviral 
particles were harvested 48h post-transfection. L929, 293T, SH-SY5Y and THP-1 were at 
about 70% confluency when infected with at least 10ml of the virion-containing supernatant 
in a 75cm2 tissue culture flask in the presence of 8µg/ml of polybrene. 36h P.I., cells were 
passaged in complete medium supplemented with hygromycin (Sigma-Aldrich). L929 cells 
were selected with 700µg/ml of hygromycin, THP1-Blue cells with 600µg/ml and both SH-
SY5Y and 293T cells with 300 µg/ml. Viable cells were periodically assayed for CRACC 




2.6. Co-cultures of MoDCs with stable cell lines 
 
Prior to co-culture, selection medium was washed off and 4x104 CRACC-expressing and 
control-transduced variants of both L929 and 293T cells were resuspended in hygromycin-
free complete medium. Cells were seeded into 96-well plates in 100µl of hygromycin-free 
complete medium and allowed to rest for at least 4h. DCs were then harvested and adjusted 
to a concentration of 106 cells/ml. 100µl of DCs were added to the each well of the plated 
cell lines, resulting in a final concentration of 5x105 DCs/ml in an assay volume of 200µl. This 
was performed either in the presence or absence of 100ng/ml of LPS (Invivogen) plus 
100ng/ml IFN-γ (eBioscience). Cell-free culture supernatants were carefully harvested 16h 
later after brief centrifugation of the plates and assayed for secreted cytokines using the 




Antibodies used in this study were anti-human and used at the manufacturer’s 
recommendations unless otherwise specified. Recombinant human DNAM-1, NKG2D, 
NKp30, NKp44, NKp46 and NKp80-Fc fusion proteins were all purchased from R&D Systems 
(Minneapolis, MN, USA). Detection of ligands for the receptor-Fc chimeras was enabled by 
secondary staining using PE-conjugated F(ab’)2 fragment donkey anti- human-IgG. To detect 





TABLE 2.1. List of antibodies used in this study. Antibodies were used in 
immunofluorescence staining and to block receptor-ligand interactions (indicated by *). 1 
R&D Systems, Minneapolis, MN, USA, 2 Beckman Coulter, Brea, CA, USA, 3 eBioscience, San 
Diego, CA, USA, 4 Santa Cruz Biotechnology, Dallas, TX, USA, 5 Millipore, Billerica, MA, USA, 6 
AbD Serotec, Oxford, UK, 7 Jackson ImmunoResearch Laboratories, West Grove, PA, USA, 8 
PBL InterferonSource, Piscataway, NJ, USA, 9 MBL International Corporation,  Woburn, MA, 
USA, 10 Biolegend, San Diego, CA, USA and 11 Invitrogen, Carlsbad, CA, USA. 
 
Target Conjugate Clone Source 
BLAME PE 250014 R&D Systems1 
CD244 PE C1.7 Beckman Coulter2  
CD3 PerCP-Cy5.5 OKT3 eBioscience3 
CD48 FITC J4-57 Beckman Coulter2  
CD56 FITC and PE MEM188 eBioscience3 
CD69 FITC FN50 eBioscience3 
CD84 Biotinylated 2G7 eBioscience3 
CD107a FITC eBioH4A3 eBioscience3 
CRACC PE 162 eBioscience3 
CRACC* Unconjugated 1G10 Santa Cruz Biotechnology4 
DenV prM 
(IgG2a) 
Unconjugated HB114 HB114 hybridoma supernatant 
(kindly provided by Dr. Ooi Eng 
Eong) 
 
Fas FITC DX2 eBioscience3 
Fas* Unconjugated ZB4 Millipore5 
gp130* Unconjugated MAB228 R&D Systems1 
HLA-E PE 3D12HLA-E eBioscience3 
HLA-G FITC MEM-G/9 AbD Serotec6 






TABLE 2.1. Continued.  
Target Conjugate Clone Source 
IFN-γ APC 4S.B3 eBioscience3 
IFNAR2* Unconjugated MMHAR-2 PBL InterferonSource8 
IL-12* Unconjugated C8.6 eBioscience3 
IL-15* Unconjugated MAB247 R&D Systems1 
IL-18* Unconjugated 25-2G MBL International Corporation9 
L-selectin FITC DREG-56 eBioscience3 
Ly9 PE HLy-9.1.25 Biolegend10 
Mouse IgG1 
isotype control  
 
APC P3.6.2.8.1 eBioscience3 
Mouse IgG1 
isotype control  
 
Biotin P3.6.2.8.1 eBioscience3 
Mouse IgG1 
isotype control  
FITC P3.6.2.8.1 eBioscience3 
Mouse IgG1 
isotype control  
 




Unconjugated P3.6.2.8.1 eBioscience3 
Mouse IgG2a APC Polyclonal 
goat 
 
Beckman Coulter2  




NTB-A PE NT-7 Biolegend10 
SLAM PE A12 (7D4) Biolegend10 




2.8. Immuno-fluorescence staining and flow cytometry 
 
Co-culture samples were pelleted, re-suspended in FACS wash (PBS containing 1% BSA and 
0.05% sodium azide) and surface-stained by incubating with antibodies at 4oC for 30min. 
Samples were washed twice with FACS wash to remove unbound antibodies, fixed and 
permeabilized using the Cytofix/Cytoperm solution kit (BD Biosciences). Intracellular 
staining was performed by re-suspending the samples in Perm/Wash buffer (BD Biosciences) 
containing antibodies and incubating at 4oC for 30min. Samples were then washed twice 
with Perm/Wash buffer and stored in FACS wash.  
DC samples were similarly processed. In addition, DCs probed for membrane-bound ligands 
for DNAM-1, NKG2D or natural cytotoxicity receptors had to be incubated with recombinant 
NCR or NKG2D Fc chimeric proteins in FACS wash at 4oC for 1h, washed twice and stained 
with donkey anti-human antibodies for 20min. Samples were then washed twice before 
fixation and permeabilization. Some DC samples were stained intracellularly for infection 
rate with anti-DenV prM antibodies before washing twice. Secondary staining was 
performed with goat anti-mouse antibodies for 20min, followed by 2 washes with 
Perm/Wash buffer. Finally, DC samples were stored in FACS wash. 
All samples were acquired on a Becton Dickinson FACSCalibur and the results were analyzed 
with Flowjo (Treestar). The gating strategy for NK cells and DCs for flow cytometric analysis 





2.9. Cytotoxicity assay 
 
The DELFIA BATDA Assay was purchased from Perkin Elmer (Waltham, MA, USA). 24h P.I., 
DenV-infected DCs as well as H.I. DenV1-treated DCs were pelleted and their supernatant 
was carefully aspirated and set aside. 106 DCs were loaded with 1μl of BADTA reagent in 1ml 
of infection medium containing 50µM β-mercaptoethanol for 20min at 37oC. Loaded cells 
were then washed 3 times with infection medium and re-suspended in their original culture 
medium. 104 target DCs were incubated with NK cells using increasing E:T ratios for 3 hours 
in a 96-well round-bottomed plate with a final volume of 200μl. Upon lysis by NK cells, 
loaded DCs released TDA (hydrolyzed form of BATDA) into the supernatant. 20μl aliquots of 
cell-free supernatant from each mixture were collected and introduced to 200μl of 
Europium solution. A highly fluorescent and stable chelate of EuTDA was formed and the 
measured fluorescence correlates with the amount of cytolytic activity. A VICTOR3 
multilabel counter (Perkin Elmer) was used to resolve the fluorescence in time-dependent 
manner. Maximum TDA release was obtained by incubating loaded cells with lysis buffer 
(Perkin Elmer). Spontaneous TDA release was obtained by incubating loaded cells alone. 
Percentage Specific Release is calculated as follows: (Experimental release – Spontaneous 
release) / (Maximum release – Spontaneous release) x 100 
 
2.10. Measurement of cytokine levels in cell culture supernatant 
 
ELISAs were employed to determine the levels of cytokines secreted by DenV-infected DCs. 
Ready-SET-Go! ELISA kits specific for human IL-12p70, IL-15, IL-21, IL-27 and TNF-α were 
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purchased from eBioscience. The limits of detection of the ELISAs kits were: 4pg/ml for IL-12 
and TNF-α; 8pg/ml for IL-15 and IL-21, and 16pg/ml for IL-27. Human IFN-α ELISA kit (multi-
subtype, limit of detection: 12.5pg/ml) and Human IFN-β ELISA kit (limit of detection: 
25pg/ml) were purchased from PBL InterferonSource. The human IL-18 ELISA kit was 
purchased from MBL International and had a limit of detection of 12.5pg/ml. 
The Human Inflammatory Cytokine panel cytometric bead array (BD Biosciences) was used 
to detect cytokines secreted by DCs co-cultured with CRACC-expressing or control-
transduced cell lines. The kit allowed the simultaneous assay of secreted IL-1β, IL-6, IL-8, IL-
10, IL-12p70 and TNF-α (limit of detection in pg/ml: 7.2, 2.5, 3.6, 3.3, 1.9 and 3.7 
respectively) in culture supernatant. Samples were again acquired on a Becton Dickinson 
FACSCalibur and the results were analyzed with Flowjo (Treestar, Ashland, OR, USA). 
 
2.11. Microarray gene profiling of DenV-infected DCs 
 
Total cellular RNA from DCs was harvested using the RNeasy Mini kit with a genomic DNA 
cleanup step (Qiagen) and assessed for integrity with an Agilent Bioanalyzer. RNA samples 
with RIN greater than 7 were processed with the TotalPrep RNA Amplification Kit (Ambion, 
Carlsbad, CA, USA) according to the manufacturer’s instructions . Amplified and biotinylated 
cRNA samples were hybridized to a Human WG-6 v3 Sentrix BeadChip (Illumina, San Diego, 
USA). Hybridized chips were scanned with an Illumina BeadArray Reader and the raw gene 
transcript levels were determined with Illumina GenomeStudio software. Genespring GX 10 
(Agilent, Santa Clara, CA, USA) was used to analyze the raw data. 
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The expression profile from each group of DCs was averaged (eg. for DenV1-infected DCs, 
the gene expression signatures of DCs infected at 30%, 50% and 70% infection rates were 
combined and averaged) and one-way ANOVA was performed to detect genes significantly 
different in expression at p < 0.05 level. The Student–Newman–Keuls post-hoc test was 
carried out for pair-wise comparison between uninfected/mock-infected samples with the 
DenV1-infected samples as the baseline. 
Averaging expression data within a treatment group (eg. DenV1-infected at all infection 
rates) can mask minute changes in gene expression. Hence, pair-wise comparison was also 
performed between uninfected/mock-infected samples with DenV1-infected samples at 
each infection rate. For this method of analysis, only genes undergoing a change of 2-fold or 
greater were reported.  
 
2.12. RT-PCR for CRACC 
 
Total cellular RNA was harvested from DCs using the RNeasy kit (Qiagen) and served as the 
template. 1-step RT-PCR was carried out to determine the splice form of CRACC expressed 
by DCs using the AccessQuick RT-PCR system (Promega). The primers were first described in 
a report by Lee, Boles et al 2004: CS1F727, 5’-GTCTCTTTGTACTGGGGCTATTTC-3’ and 
CS1R955, 5’-TTTTCCATCTTTTTCGGTATTT-3’. 200ng of template RNA was used in each 
reaction and the cycling conditions were as follows: reverse transcription at 45oC for 45mins 
and initial denaturation at 95oC for 2mins, followed by 32 cycles of denaturation at 95oC for 
30sec, annealing at 54oC for 30sec and extension at 72oC for 15sec. A final extension step 
was performed at 72oC for 5mins. To ensure equal loading of RNA templates, replicate 
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reactions were set up to amplify the GAPDH housekeeping gene instead. The sequence of 
the GAPDH primers were: GAPDHFwd 5’-CCCATCACCATCTTCCAGGAG-3’ and GAPDHRev 5’-
GTTGTCATGGATGACCTTGGC-3’ and the cycling conditions were similar except for the 
annealing temperature of 62oC. Equal aliquots of the PCR reactions were then 
electrophoresed through a 2% agarose gel containing GelGreen nucleic acid stain (Biotium, 
Hayward, CA, USA). 
 
2.13. Statistical analyses 
 
Paired t-tests were performed to detect significant differences between matched samples. 
One-way ANOVA was carried out with Bonferroni’s multiple comparison post-hoc test. All 









3. Results Part I 
 
We had sought to characterize the response of naïve human NK cells to DenV-infected DCs 
through cytokine production and degranulation. Indeed, NK cells were observed to produce 
IFN-γ and degranulate. To investigate the requirements of the IFN-γ response, DenV-
infected DCs were assayed for upregulation of both soluble and membrane-bound ligands of 







3.1 Naïve primary human NK cells produce IFN-γ and degranulate in response to 
DenV1-infected DCs 
 
FIGURE 3.1.1 Naïve primary human NK cells are activated by DenV1-infected DCs to 
produce IFN-γ and degranulate. NK cells were cultured with either immature DCs 
(uninfected), DCs incubated with heat-inactivated DenV1 (Mock-infected) or DCs infected 
with DenV1-S3638 (DenV1-infected). These co-cultures were performed 28h post-infection 
of DCs. After 2h of co-culture, NK cells were assessed for (A) activation, IFN-γ production 
and (B) degranulation. Transwell experiments were also performed to examine whether the 
responses required cell contact. Anti-CD107a was added at the beginning of the co-cultures. 



















In order to characterize the anti-dengue response of NK cells, we cultured primary human 
NK cells with autologous DenV1-infected monocyte-derived DCs. NK cells were observed to 
upregulate surface expression of CD69 (Fig. 3.1.1A), an early marker of activation (Marzio, 
Mauel et al. 1999). This is consistent with findings where NK cells were activated in DenV-
infected patients (Green, Pichyangkul et al. 1999; Azeredo, De Oliveira-Pinto et al. 2006). NK 
cells also responded to DenV1-infected DCs by producing IFN-γ (Fig. 3.1.1A). However, we 
note that there was no association between IFN-γ production and CD69 expression on NK 
cells. Naïve NK cells did not produce IFN-γ or upregulate cell surface CD69 when cultured 
with autologous immature and mock-infected DCs. We observed that cell surface CD107a, a 
marker associated with degranulation (Alter, Malenfant et al. 2004), was clearly upregulated 
on NK cells cultured with DenV1-infected DCs but not with uninfected or mock-infected DCs 
(Fig. 3.1.1B). Again, we did not observe any association between surface expression CD107a 
and CD69 (data not shown). In line with previous observations, the CD56dim NK cell subset 
was preferentially cytotoxic as indicated by increased degranulation, compared to the 
CD56bright subset. Importantly, when NK cells were separated from DenV1-infected DCs 
during culture by transwell inserts, they produced little IFN-γ and did not degranulate, 
indicating the need for cellular contact (Fig. 3.1.1, A and B). To exclude that NK cells were 
only responsive to DCs infected with DenV1 S3638, we also performed such cultures with 
DCs infected with other DenV clinical isolates, DenV1-07K4383 and DenV3-05K4176, and 







FIGURE 3.1.2. Naïve primary human NK cells respond specifically to DenV1-infected DCs 
through soluble and membrane-bound factors. A, NK cells were co-cultured with either 
immature (Uninfected) DCs, DCs incubated with heat-inactivated DenV1 (Mock-infected) or 
DCs infected with DenV1-S3638 (DVDC). The cultures were simultaneously replicated with 
the conditioned supernatant first washed off and replaced with fresh RPMI-2 (fresh media). 
NK cells were also cultured alone in DVDC-conditioned supernatant. * p < 0.05, ** p < 0.01, 
n = 5 separate donors and values are shown as mean ± SE. B, NK cells were assessed for 
intracellular IFN-γ after culture with DCs having different infection rates. Symbols represent 
data from 3 separate donors. C, infection rates of DCs which were co-cultured with NK cells 
for IFN-γ response, given in B. Greater infection rates were achieved by increasing the MOI 
and are presented as mean ± SE. D, determination of DC infection rate by intracellular DenV 
prM staining, 28h post-infection. 
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While our transwell experiments showed that the NK cell response was contact-dependent, 
culture of NK cells with infected DCs where conditioned medium was replaced with fresh 
medium yielded significantly lowered IFN-γ production (Fig. 3.1.2A). We therefore 
concluded that soluble factors secreted by DenV1-infected DCs were also involved. To 
reiterate this observation, we incubated NK cells with the cell-free conditioned supernatant 
from DenV1-infected DCs and achieved significant IFN-γ production.  
We also cultured NK cells with DCs differentially infected with a range of MOI and observed 
that the NK cell production of IFN-γ correlated with the frequency of infected DCs (Fig. 
3.1.2B), Together, our results suggest that NK cells were able to recognise and respond 
specifically to DenV-infected DCs through both soluble and cell-bound factors. On a side 
note, we were able to achieve an infection rate of about 80% with a MOI of 0.1 and this 
increased to 90% with a MOI of 1 (Fig. 3.1.2C). This was made possible by progeny virus 
infecting the bystander DCs. Another explanation is that BHK cells may be less infectable 




3.2 Naïve human NK cells suppress DenV1 replication in infected DCs 
 
To demonstrate a possible role of NK cells in DenV suppression, freshly-infected DCs were 
immediately co-cultured with NK cells for 48h before quantitation of DenV. There were 
several considerations for the determination of DenV replication. While qPCR for viral mRNA 
has been established as a rapid method in determining DenV viral load in a clinical setting 
(Teles, Prazeres et al. 2005), a drawback of the assay is that it does not reveal viral progeny 
viability. Furthermore the test does not measure shed virions because the test assays RNA 
from cell lysate. Flow cytometric detection of intermediate products of viral replication such 
as the NS or prM proteins again meets with the same limitation. We therefore elected to 
harvest cell culture supernatant and titrate the virus concentration by performing plaque 
assays. 
We have earlier shown that a MOI of 0.1 could result in about 80% of the DCs being infected 
with DenV1 through secondary infection of bystander DCs by progeny virus (Fig. 3.1.2C). 
Exploiting on this observation, we infected DCs with a MOI of 0.1 before performing the co-
cultures – if NK cells were indeed purposeful in suppressing DenV replication, they would 
also prevent secondary infection of bystander DCs and lead to a discernible reduction in 
supernatant DenV. 
DCs were found to produce infectious DenV progeny virus after 48h P.I. (Fig. 3.2). Compared 
to cultures of infected DCs alone, progeny virus in supernatant was reduced when naïve NK 





FIGURE 3.2. Naïve human NK cells suppress DenV1 replication. Immediately after DenV1 
infection with an MOI of 0.1, DCs were co-cultured with naïve NK cells with increasing E:T 
ratios. As a control, infected DCs were also cultured in the absence of NK cells (Plain). 48h 
later, cell-free supernatant was collected from the co-cultures and the titre of DenV1 was 
determined through plaque assays. The titre is expressed as plaque forming units (PFU) per 
ml of supernatant. Autologous co-cultures were performed for 4 donors and each line 


























3.3 Microarray profiling reveals upregulation of NK cells activators in DenV1-infected 
DCs 
 
We had previously performed microarray experiments to profile differential gene 
expression patterns between uninfected, mock-infected and DenV1-infected DCs. However, 
the microarray results were met with a limitation. For infected samples, bystander  
(uninfectable) DCs invariably contributed to the extracted RNA because we were unable to 
reliably separate them from the infected DCs post-infection (results not shown). Hence, the 
results could reflect gene changes from different scenarios:  
1. Upregulation in both DenV1-infected and bystander DCs 
2. Downregulation in both DenV1-infected and bystander DCs 
3. Opposite gene transcription changes for DenV1-infected DCs versus bystander DCs, 
sometimes leading to a weak or zero net change compared to uninfected or mock-
infected DC samples 
Since we were unable to determine when scenario 3 had occurred, we chose to infect DCs 
with increasing MOI to investigate the trend of gene changes. By observing the trend of 
change for a gene, we could avoid falsely concluding that DenV infection did not affect its 
transcription. 
To determine how NK cells recognised DenV1-infected DCs, we mined the data set for 
upregulation of ligands for activating receptors and downregulation of ligands for inhibitory 
receptors of NK cells. Several candidate genes were identified to be differentially expressed 
in infected DCs, compared with either uninfected or mock-infected DCs (Fig. 3.3). Pro-
inflammatory TNF-α and type I interferon (subtypes IFNA1 and IFNB1) expression were 
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observed to be upregulated during DenV infection and their induction correlated with 
higher infection rates. The type III IFNs IL-28A and IL-28B were also expressed in a similar 
fashion. IL-28A/B share similar biological functions with type I IFNs (Kotenko 2011) and have 
been implicated in chronic Hepatitis C virus infections (Dolganiuc, Kodys et al. 2012).  
Importantly, our results show that IL-15 was upregulated in DenV1-infected DCs. DCs 
express IL-15Rα which has been demonstrated to chaperone IL-15 for trans-presentation to 
NK cells, promoting activation and proliferation in the latter (Lucas, Schachterle et al. 2007; 
Pillet, Bugault et al. 2009). Hence, IL-15 in its soluble or trans-presented forms may be 
responsible for the NK cell responses observed earlier.  
In addition, DenV1-infected DCs over-expressed IL-27 (a heterodimer of IL-27-p28 and EBI3), 
a cytokine shown to stimulate IFN-γ production and cytotoxicity in NK cells (Pflanz, Timans 
et al. 2002; Crabe, Guay-Giroux et al. 2009). 
Functional IL-12 exists as a heterodimer of p35 (IL12A) and p40 (IL12B) subunits. IL12A was 
found to be over-expressed in DenV1-infected DCs while IL12B transcription was not 
significantly upregulated (data not shown). This is surprising as IL12p35 is usually the rate-
limiting factor in the production of IL-12 cytokine (Luft, Luetjens et al. 2002; Napolitani, 







FIGURE 3.3. Heatmap representation of gene expression differences between uninfected, 
mock- and DenV1-infected DCs. Microarray data from 4 donors (A-D) was normalized and 
selected genes that experienced ≥ 2 fold change in expression are shown. Infection rate in DCs: A 
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MICA and MICB are both ligands of NKG2D (Cerwenka and Lanier 2001). MICB was observed 
to be slightly upregulated in some samples (Fig. 3.3, A and B for DenV1-infected), but not at 
higher infection rates of 50% and 70%. This hints that MICB is preferentially expressed by 
bystander DCs in the infected samples. 
Fas, a death receptor mediating apoptosis in the expressing cell (Falschlehner, Schaefer et al. 
2009), was over-expressed in DenV1-infected DCs and greater induction was again observed 
at higher infection rates. Its upregulation probably led to increased apoptosis of infected 
cells, halting of the replication of DenV. 
CRACC (SLAMF7), an NK cell-activating homophilic receptor (Tassi and Colonna 2005), was 
found to be upregulated on DenV1-infected DCs and its expression increased together with 
the infection rate. Its upregulated expression may trigger NK cell activity and also allow 
interactions between CRACC-bearing DCs. 
The cytotoxic activity of NK cells is augmented by lack of signals from their inhibitory 
receptors and their ligands chiefly belong to the MHC class I i.e. HLA-A, HLA-B, HLA-C, HLA-E, 
HLA-F and HLA-G (O'Callaghan and Bell 1998). With the exception of HLA-F, MHC class I 
molecules experienced an approximately 2-fold increase in expression in DenV1-infected 
DCs compared to uninfected or mock-infected DCs. However, upregulation of MHC class I 
became marginal at 70% infection rate. Since total sample mRNA was used in the microarray 
experiments, this observation may be resultant of the prevalence of DenV1-infected DCs 
which did not alter MHC class I expression and reduced numbers of activated bystander DCs 
which over-expressed these genes. 
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In our screening for ligands of NK cell receptors expressed by DenV1-infected DCs, we also 
detected downregulation of an activating ligand, NTB-A (data not shown). Other activating 
ligands such as UBBP1-6, PVR and Nectin-2 were unchanged compared to mock-infected or 
uninfected DCs (data not shown). 
DenV1-infected DC function was examined and co-stimulatory CD40 and markers of DC 
activation such as CD80, CD83 and CD86 were found to be increased in expression. 
Consistent with a previous report (Chen, Lu et al. 2006), CXCL10 (IP-10) was highly 
upregulated in DenV1-infected DCs and this was observed across all infection rates. Chen 
and colleagues have previously described CLEC5A to mediate pro-inflammatory cytokine 
release during DenV-infection of DCs as well as be involved in the pathogenesis of DenV in 
the STAT1-deficient mouse model (Chen, Lin et al. 2008). We therefore looked at the 
expression of C-type lectin family members during DenV infection. While most of the other 
C-type lectins were not detected to significantly change in expression, CLEC3B, CLEC4A, 
CLEC5A, CLEC7A, CLEC11A and CLEC12A were found to be mostly downregulated in DenV1-
infected DCs. Since C-type lectins have various roles in cellular activation and antigen 
internalization, the downregulation of these immunoreceptors could aid DenV in evasion of 
the host immune response. Particularly, downregulation of CLEC5A expression was more 
pronounced at lower infection rates and may have been contributed by the prevalence of 
bystander DCs. This is intriguing and we reasoned that bystander DCs downregulated 
CLEC5A to prevent cytokinemia in a situation when infection was low.  
Nevertheless, these data denote only gene level expression and we confirmed the results by 
assaying the actual protein levels on the DCs through ELISAs and flow cytometric staining 
(discussed in sections 3.4 and 3.6). 
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3.4 DenV1-infected DCs produce type I IFNs and TNF-α but not other monokines 
 
The mechanism by which DenV1-infected DCs induce IFN-γ production in NK cells remains to 
be elucidated. While our previous results showed it was contact-dependent, soluble factors 
secreted by DenV1-infected DCs were also implicated. This coincided with our microarray 
data which suggested that NK cell-activating cytokines such as type I IFNs were upregulated. 
We therefore assayed supernatant from DenV1-infected DCs for soluble activators of NK 
cells and they included IL-12p70, IL-15, IL-18, IL-21, IL-27, TNF-α and type I IFNs by ELISA (Fig. 
3.4). 
In line with other reports, DenV-infected DCs produced IFN-α, IFN-β and TNF-α but not IL-12 
or IL-15 (Ho, Wang et al. 2001; Libraty, Pichyangkul et al. 2001; Chen and Wang 2002; Ubol, 
Phuklia et al. 2010). Functional IL-12 was not detected even though the microarray results 
indicated upregulation of the p35 subunit. This may be a failure of infected DCs to produce 
p40 mRNA or that DenV interfered with the translation of IL-12 mRNA. To demonstrate the 
former, we performed RT-PCR on RNA from DenV1-infected DCs. Similar to the microarray 
results, we observed upregulation of p35 and the absence of p40 transcription (given in 
appendix, A5). Hence, DenV1 can interfere with IL-12 production in DCs, removing an 
important stimulus of NK cell activity. Since uninfected and mock-infected DCs did not 
produce significant amounts of IFN-α, IFN-β and TNF-α, NK cells could have been activated 
by DenV1-infected DCs through these cytokines. Interestingly, while our microarray data 
showed upregulation of IL-15 and IL-27 transcription, the proteins were absent in DenV1-
infected DC supernatant, implying post-transcriptional blockade by DenV. IL-18 and IL-21, 
cytokines which can enhance IFN-γ production in presence of other cytokines (Fehniger, 
Shah et al. 1999; Matikainen, Paananen et al. 2001; Strengell, Matikainen et al. 2003), did 
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not upregulate significantly through gene expression profiling (data not shown). 
Furthermore, DenV1-infected DCs hardly secreted IL-18 and IL-21 (Fig. 3.4), suggesting that 
these cytokines were probably not responsible for the NK cell responses observed earlier. 
Accordingly, DCs treated with LPS and IFN-γ were able to secrete IL-12, IL-15, IL-21, IL-27 




FIGURE 3.4. DenV1 infection of DCs results in cytokine production. 28h post-infection, cell-
free supernatant was collected from DCs that were either uninfected, mock- or DenV1-
infected. ELISAs were performed to determine supernatant cytokine concentrations. As a 
positive control, DCs were treated with 100ng/ml of both LPS and IFN-γ. To obtain a signal 
for IL-15, DCs were strongly stimulated with 1µg/ml of LPS and IFN-γ instead. For each 
































































3.5 NK cell IFN-γ response towards DenV1-infected DCs is dictated by synergism 
between TNF-α and type I IFNs 
 
Following our cytokine results, we investigated if DenV1-infected DCs induced IFN-γ 
production in NK cells via TNF-α or type I IFNs. We therefore blocked the IFN-αβ receptor 
chain 2 (IFNAR2) on NK cells and neutralized TNF-α in DenV1-infected DC supernatant with 
antibodies, before carrying out the co-cultures. 
 
FIGURE 3.5.1 TNF-α and type I interferons produced by DenV1-infected DCs induce IFN-γ 
production in naïve NK cells. A, NK cells were cultured with DenV1-infected DCs with 
cytokine blockade. 30min prior culture, neutralizing antibodies for TNF-α (IgG1 isotype) 
and/or blocking antibodies for IFNAR2 (IgG2a isotype) were added at 5μg/ml and 8μg/ml 
respectively. B, NK cells were stimulated with 100U/ml of recombinant human TNF-α and/or 
1000U/ml of universal type I interferon, either in the absence or presence of immature DCs 
(+imDC). In each experiment, n = 5 different donors and values shown are mean 
percentages ± SEM. * p < 0.05. 
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Either IFNAR2 blockade or TNF-α neutralization resulted in significant reduction of NK cell 
IFN-γ production (Fig. 3.5.1A). Blockade of both cytokines strongly suppressed the IFN-γ 
response. Our data indicate the synergism between TNF-α and type I IFNs in activation of NK 
cells and this observation is supported by previous work (Hunter, Gabriel et al. 1997; 
Marshall, Heeke et al. 2006). We have also performed such co-cultures experiments with 
DCs infected with additional clinical dengue virus isolates, DenV1-07K4383 and DenV3-
05K4176, and obtained similar results (data not shown). Furthermore, we performed 
neutralization of supernatant type I IFN by the addition of B18R, a vaccinia virus-encoded 
receptor with specificity for human type I and type III interferons (data not shown). In such 
experiments, NK cells were also unable to produce IFN-γ. Hence, it appears that during 
DenV infection, the NK cell IFN-γ response is induced by synergism between type I IFNs and 
TNF-α produced by infected cells.  
To recapitulate our observations of type I IFN and TNF-α synergism in inducing an IFN-γ 
response, we stimulated NK cells with only either universal type I interferon or TNF-α. As 
expected, addition of either type I IFNs or TNF-α alone did not induce significant IFN-γ 
production in NK cells (Fig. 3.5.1B). Incubating NK cells with both cytokines resulted in an 
appreciable IFN-γ response, showing synergism between type I IFNs and TNF-α in activating 
NK cells. Yet, the IFN-γ response was noticeably lower than that of NK cells cultured with 
DenV1-infected DCs (Fig. 3.5.1A). This could be a consequence of NK cells experiencing 
higher local concentrations of cytokines secreted by DCs during co-culture. Since the level of 
response mirrored our earlier results when NK cells were resuspended in cell-free 
supernatant from DenV1-infected DCs (Fig. 3.1.2A), we reasoned that membrane-bound 
factors on DCs were necessary to enhance IFN-γ production in cytokine-activated NK cells. In 
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order to prove this hypothesis, NK cells were co-cultured with immature DCs in the presence 
of type I IFNs and/or TNF-α. While the addition of either type I IFNs or TNF- α to these co-
cultures did not elicit much IFN-γ production in NK cells, we observed a dramatic IFN-γ 
response when both cytokines were present. Importantly, the level of IFN-γ was significantly 
higher in NK-DC co-cultures than in cultures of NK cells alone, confirming the requirement 
for cellular contact between NK cell and DCs. Interestingly, since immature DCs were used in 
these experiments, our results suggest that both immature and DenV1-infected DCs express 
membrane-bound ligands that can enhance TNF-α and type I IFN-induced IFN-γ production. 
It remains unknown whether the same ligand(s) is/are responsible and that it is 
differentially expressed in infected DCs over immature DCs. 
Although our microarray results suggested that DenV1-infected DCs produce IL-15 and IL-27, 
our ELISA data showed otherwise. To investigate whether membrane-bound IL-15 was 
responsible for enhancing the NK cell IFN-γ response, we attempted to neutralize both 
membrane-bound and soluble IL-15 with antibodies in co-culture experiments. However, 
addition of neutralizing antibodies for IL-15 as well as for IL-12, IL-18, and IL-27 did not 
affect the NK cell IFN-γ production (Fig. 3.5.2), affirming that TNF-α and type I IFNs are the 




FIGURE 3.5.2 NK cell IFN-γ response to DenV1-infected DCs is not affected by addition of 
neutralizing antibodies for IL-12, IL-15, IL-18 and IL-27. Neutralizing antibodies were added 
into cultures of DenV1-infected DCs 30mins before co-culture with NK cells. In each 
experiment, a reaction without addition of antibodies was created to establish the basal NK 
cell IFN-γ response (Plain). To block IL-27 from binding its receptor, NK cells were incubated 
with anti-gp130 for 30mins before co-culture. Antibodies against IL-12, IL-18 and gp-130 
were added to a final concentration of 5µg/ml while anti-IL-15 was used at 2µg/ml. The 
matching IgG1 isotype control antibody was used at a final concentration of 5µg/ml. After 
2h co-culture, NK cell were stained for intracellular IFN-γ and the results represent 
frequency of IFN-γ positive cells. The experiments was independently performed for 6 
donors, 1-way ANOVA was performed and means were found not to be significantly 






















































3. Results Part II 
 
The presence of DCs was earlier shown to enhance IFN-γ production in NK cells which were 
stimulated by both TNF-α and type I IFNs. This indicates that DenV-infected DCs expressed 
one or more membrane-bound factors capable of triggering NK cell activity. To uncover the 
unknown factors, DCs were surfaced-stained for known ligands of activating NK cell 
receptors. We had observed upregulation of CRACC and Fas in DenV-infected DCs. To 
determine if CRACC was involved in enhancing the NK cell IFN-γ response, antibody-
mediated blocking experiments were performed. Since Fas-bearing cells are marked for 
destruction, we further investigated if NK cells lysed DenV-infected DCs through Fas-




3.6 DenV1-infected DCs do not express ligands for most NK cell activating receptors 
 
 
FIGURE 3.6.1 Detection of selected DC membrane-bound ligands for NK cell receptors via 
Receptor-Fc proteins. 28h post-infection, both mock-infected and DenV1-infected DCs 
were assessed for infection rate by staining for intracellular DenV pre-membrane (prM) 
protein. DCs were assayed for surface expression of ligands (-L) for the activating NK cell 
receptors: DNAM-1, NKG2D and natural cytotoxicity receptors by incubation with receptor-
Fc fusion proteins. Human IgG1 Fc served as the isotype control. For each reagent, n ≥ 4 















We sought to identify the cell-bound factor on DCs that enhanced the NK cell IFN-γ response 
during DenV infection. NK cells are able to recognise virus-infected cells and interact with 
myeloid cells via natural cytotoxicity receptors (NCRs) (Bottino, Biassoni et al. 2000; Vitale, 
Della Chiesa et al. 2005; Welte, Kuttruff et al. 2006; Hershkovitz, Rosental et al. 2009; Magri, 
Muntasell et al. 2011). As the ligands for NCRs are not well defined, we attempted to stain 
for their expression on DenV-infected DCs using chimeric proteins consisting of the 
extracellular domain of NCRs fused to the Fc portion of human IgG1 (Fig . 3.6.1). Expression 
of the putative ligand will allow binding of the NCR-Fc protein which can be detected 
through secondary staining with Fc-specific antibodies. The NCR-Fc reagents (all from R&D 
Systems) were ascertained to be functional as we achieved positive staining using A549 cells 
(given in appendix, A6). We observed significant inter-donor variation in the expression of 
ligands for NKp30, NKp44 and NKp46 on both mock infected DCs and DenV1-infected DCs. 
The majority of replicates showed neither the presence of these ligands on mock infected 
DCs, nor the upregulated expression of these ligands on DenV1-infected DCs. NKp80 ligands 
were consistently expressed at low levels but not upregulated in DenV1-infected DCs. 
DNAM-1 and NKG2D are important activating receptors expressed on NK cells required for 
recognition of diseased cells. Crosslinking of either DNAM-1 or NKG2D has been shown to 
induce IFN-γ production in NK cells (Bryceson, March et al. 2006). We therefore stained for 
the ligands of DNAM-1 and NKG2D using similar receptor-Fc proteins and determined that 
they were absent on both mock-infected and DenV1-infected DCs (Fig. 3.6.1). The known 
ligands for DNAM-1 are polio virus receptor (PVR) and Nectin-2 (Bottino, Castriconi et al. 
2003); for NKG2D, the major ligands are MICA/B and ULBP1-6 in humans. To further confirm 
our results, we stained DenV1-infected DCs for these ligands and did not manage to detect 
them (given in appendix, A7).  
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The development and response of NK cells is regulated by KIRs. KIRs mostly deliver 
inhibitory signals upon engagement by their MHC ligand and help suppress NK cell 
cytotoxicity. Conversely, lack of KIR engagement enhances the activation state of stimulated 
NK cells (Purdy and Campbell 2009). We therefore examined the expression of their ligands, 
HLA-ABC and HLA-E, on DenV1-infected DCs. It should be noted that NK cells can be 
activated or inhibited by HLA-E depending on the co-receptor it utilizes for interaction 
(Gunturi, Berg et al. 2004). Nevertheless, HLA-E was expressed at low levels or absent in 
both mock- and DenV1-infected DCs (Fig. 3.6.2A and data not shown) and probably did not 
play a role in NK cell recognition of DenV1-infected DCs. DCs have been reported to express 
and shed cell surface HLA-G, a non-classical MHC class I molecule (Lopez, Alegre et al. 2006). 
The binding of soluble HLA-G to KIR2DL4 has also been shown to trigger NK cell production 
of IFN-γ (Rajagopalan, Bryceson et al. 2006). However, we ascertained that DCs did not 
interact with NK cells via membrane-bound HLA-G as its expression was neither detected in 
mock-infected DCs nor up-regulated by DenV1 infection (Fig. 3.6.2B). Most importantly, 
there was incomplete downregulation of HLA-ABC molecules on DenV1-infected DCs over 
mock-infected DCs (MFI: 107±33.97 versus 244.67±63.52, Fig. 3.6.2A). This observation 
suggests that NK cells can be released from inhibition to perform cytotoxicity on DenV1-





FIGURE 3.6.2 Flow cytometric analysis of selected DC membrane-bound ligands for NK 
cell receptors. 28h post-infection, both mock-infected and DenV1-infected DCs were 
assessed for infection rate by staining for intracellular DenV pre-membrane (prM) protein. 
A, DCs were stained for expression of HLA-ABC and HLA-E together with their respective 
IgG1-APC and IgG1-PE isotype controls (iso). B, staining of DCs for other ligands together 
with their IgG1-FITC isotype control. For each reagent, n ≥ 4 separate donors and 


















2B4, a SLAM family member, is ubiquitously expressed on NK cells and upon binding CD48, 
results in IFN-γ production (Tangye, Cherwinski et al. 2000). Unfortunately, CD48 was not 
detectable on both mock- and DenV1-infected DCs (Fig. 3.6.2B) and thus could not have 
contributed to the IFN-γ response in previous observations. Apart from inducers of IFN-γ 
production, we sought to characterize other ways DenV1-infected DCs could have interacted 
with NK cells. L-selectin was observed to be upregulated only in DenV1-infected DCs (Fig. 
3.6.2B), and may have been important for interaction with CD56dim NK cells expressing 
PEN5-PSGL-1 (Andre, Spertini et al. 2000). In addition, we observed that Fas expression was 
significantly higher on both infected and bystander (prM negative) DCs over mock-infected 
DCs (Fig. 3.6.2B) and may have rendered these cells susceptible to NK cell-induced apoptosis 




3.7 NK cell IFN-γ response towards DenV1-infected DCs is not elicited by FasL 
retrograde signalling 
 
We had earlier observed that DenV1-infected DCs strongly upregulated Fas expression (Fig. 
3.6.2B). While Fas ligand (FasL) has been well characterized for its induction of apoptosis 
through Fas, reports suggest that the FasL can also mediate retrograde signalling in the 
effector cells (Newell and Desbarats 1999; Janssen, Qian et al. 2003). To prevent undesired 
host damage, FasL expression is also tightly regulated in naïve NK cells and cytotoxic T 
lymphocytes and its surface expression can be rapidly induced by cytokine stimulation 
(Lettau, Paulsen et al. 2008). Interestingly, FasL is the only transmembrane protein in the 
tumor necrosis family factor (TNF) family to possess a proline-rich region in its cytoplasmic 
tail. This proline-rich domain has been predicted to interact with intracellular signalling 
proteins containing SH3 or WW domains such as Fyn and Grb2, possibly allowing reverse 
signal transduction in the FasL-expressing effector cell (Wenzel, Sanzenbacher et al. 2001; 
Sun, Lee et al. 2007). In fact, Sun et al. have demonstrated that FasL, together with CD28, 
acted as a co-receptor with TCR and was indeed able to drive phosphorylation of Akt, 
ERK1/2, JNK and FasL itself. The crosslinking of FasL led to nuclear translocation of NFAT and 
AP-1, augmenting T cell production of IFN-γ (Sun, Ames et al. 2006). Faced with our earlier 
observation, we hypothesized if FasL-Fas interaction with DCs was responsible for enhancing 





FIGURE 3.7 Blockade of Fas-FasL interaction and stimulation of FasL does not affect NK cell 
IFN-γ production. A, NK cells were co-cultured with DenV1-infected DCs as usual. To 
prevent FasL on NK cells from being engaged, DCs were pre-incubated with recombinant 
soluble FasL (sFasL, Peprotech) and the F(ab’)2 fragment of anti-Fas antibody for 30min prior 
co-culture. sFasL was used at 50ng/ml. Anti-Fas antibody (clone ZB4) was processed with the 
F(ab’)2 fragmentation kit (Thermo Fisher Scientific Inc.) and the resulting F(ab’)2 portion was 
used at 500ng/ml. Mouse IgG1 isotype control (iso) F(ab’)2 was created similarly and used at 
the same concentration. B, flat-bottomed wells of 96-well culture plates were coated with 
either 1µg/ml of recombinant human Fas-Fc protein or human IgG-Fc (both from R&D 
Systems) overnight. The Fc solutions were aspirated away and 105 NK cells were stimulated 
in these wells in presence of 1000U/ml of universal type I IFN and 100U/ml of TNF-α. A and 
B, after culture for 2h, samples were stained for intracellular IFN-γ. For A, n = 3 donors in 
separate experiments and 1-way ANOVA performed; for B, n = 8 donors in separate 
experiments and paired t-test performed. For A and B, no significant statistical differences 
were observed between groups. 
 
To prove our hypothesis, Fas receptor on DCs were blocked using either recombinant 
soluble Fas ligand (sFasL) or the F(ab’)2 fragment of anti-Fas antibody in order to prevent 
Fas-FasL interaction and interfere with any putative FasL reverse signalling in NK cells.  The 
presence of sFasL during co-culture with DenV1-infected DCs appeared to reduce IFN-γ 
production in NK cells compared to plain co-cultures (Fig. 3.7A). We also used the F(ab’)2 
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fragment of Fas blocking antibody to prevent possible NK cell activation but did not observe 
reduction in IFN-γ production (Fig. 3.7A). Overall, using either reagent did not significantly 
reduce the NK cell production of IFN-γ. 
Faced with the inconclusive results, we resorted to crosslinking FasL on NK cells instead. NK 
cells were cultured in the presence of immobilized recombinant Fas-Fc proteins with both 
type I IFNs and TNF-α, and immobilized human IgG1-Fc was used as a control. Immobilized 
Fas-Fc crosslinking of FasL on NK cells did not enhance the synergistic effects of type I IFNs 
and TNF-α on inducing an IFN-γ response in Fig. 3.7B. Combined with the observation that 
F(ab’)2-mediated blocking of FasL did not affect IFN-γ production (Fig. 3.7A), we concluded 
that DenV1-infected DCs probably did not induce IFN-γ production in NK cells through FasL-
Fas interactions. We speculated that the observed reduction in NK cell IFN-γ production 
mediated by soluble FasL (Fig. 3.7A) might be due to Fas-triggered apoptosis of DCs leading 
to downregulation of the unknown factor(s) on DCs responsible for enhancing IFN-γ 




3.8 NK cell lysis of DenV1-infected DCs is influenced by synergism between TNF-α and 
type I IFNs and occurs through Fas-mediated apoptosis 
 
NK cells are cytotoxic to infected cells as part of the innate immune response to impede the 
dissemination of virus infections. We performed in-vitro cytolysis experiments to determine 
whether NK cells were able to specifically lyse DenV1-infected DCs. 
We observed cytolysis of DenV1-infected DCs by NK cells and the effect was more apparent 
when the E:T ratio was increased (Fig. 3.8.1 A and B). In contrast, NK cells marginally killed 
mock-infected DCs. To ascertain if soluble factors were involved in NK cell-mediated 
cytotoxicity, conditioned supernatant from DenV1-infected DCs was washed off and the co-
cultures were performed in fresh media without cytokines. In such co-cultures, NK cells 
were unable to kill the infected DCs as the level of specific cytolysis was comparable to that 
of co-cultures with mock-infected DCs (Fig. 3.8.1B). To find out if cytolysis required 
membrane-bound factors on DenV1-infected DCs, we co-cultured NK cells with mock-
infected DCs in supernatant conditioned by DenV1-infected DCs. Notably, the degree of 
cytolysis was increased over plain mock-infected co-cultures but significantly lower than 
plain DenV1-infected co-cultures (Fig. 3.8.1B), indicating that NK cells were able to recognise 
DenV1-infected DCs through an unknown membrane-bound factor and exert cytolysis only 
when soluble factors were present. Moreover, we were unsure if this factor also triggered 





FIGURE 3.8.1 Naïve human NK cells lyse DenV1-infected DCs. A and B, NK cells were co-
cultured with autologous BATDA-loaded DCs with increasing effector to target (E:T) ratios. 
Co-cultures were also performed with mock-infected DCs in conditioned supernatant (spnt) 
from infected DCs and with infected DCs in fresh media without cytokines. n = 3 donors in 
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FIGURE 3.8.2 NK cell lysis of DenV1-infected DCs is influenced by synergism between TNF-
α and type I IFNs and occurs through Fas-mediated apoptosis. NK cells were co-cultured 
with DenV1-infected DCs with E:T ratio of 10:1, with cytokine and Fas ligand neutralization. 
Anti-TNF-α and anti-IFNAR2 antibodies were added at 5µg/ml and 8µg/ml respectively. Fas 
ligand on NK cells was masked by addition of soluble Fas receptor recombinant protein (sFas, 
Peprotech, Rocky Hill, CT, USA) at 2.5µg/ml. n = 3 donors in separate experiments and data 
represents mean percentages ± SEM. 1-way ANOVA with Bonferroni’s post-hoc test 
performed and * p < 0.05. 
 
Since TNF-α and type I IFNs were crucial in inducing IFN-γ production in NK cells during DenV 
infection, we asked if these cytokines were also important in cytolysis of DenV1-infected 
DCs. We therefore neutralized supernatant TNF-α and blocked NK cell IFNAR2 with 
antibodies before performing the cytolysis assays using an E:T ratio of 10:1. While our 
results showed that neutralization of either cytokine did reduce cytolysis, simultaneous 
neutralization of both cytokines resulted in a larger reduction in specific cytotoxic activity 
(Fig. 3.8.2). This is congruent with our previous observation that NK cells are unable to lyse 
infected DCs in the absence of culture supernatant conditioned by DenV1-infected DCs (Fig. 
3.8.1), and further supports the important role of type I IFNs and TNF-α in NK cell activity 
during DenV infection. Since stark Fas upregulation in DenV1-infected DCs was observed in 
Fig. 3.6.2B, we investigated if NK cell induced apoptosis on infected DCs through Fas-
programmed death. We therefore blocked NK cell FasL with recombinant soluble Fas 
Specific Lysis (%)












receptor proteins during the co-culture and achieved strong reduction in specific lysis of 
DenV1-infected DCs (Fig. 3.8.2). Putting together our results and based on a previous report 
(Lettau, Paulsen et al. 2008), we suspected that TNF-α and type I IFNs had mobilized NK cell 
lysosomal FasL to cell surface. The upregulation of surface FasL could have enabled NK cells 
to lyse DenV1-infected DCs as well as bystander cells which upregulated Fas  (Fig. 3.6.2B). 
This hypothesis is supported by the observation where blockade of Fas-FasL interactions 









FIGURE 3.9.1 Flow cytometric analysis of CRACC and CD84 expression on DCs. 28h P.I., 
immature (imDC), mock-infected and DenV1-infected DCs were stained for surface 
expression of (A) CRACC and (B) CD84. DCs were then assessed for infection rate by staining 
for intracellular DenV pre-membrane (prM) protein. Anti-CD84 was incubated with 
streptavidin-PE to enable its detection. The gating was based on their respective IgG2b-PE 
and IgG1-biotin isotype controls (iso). For each receptor, n = 3 donors and representative 
















FIGURE 3.9.2 Flow cytometric analysis of SLAM and Ly9 expression on DCs. 28h P.I., 
immature (imDC), mock-infected and DenV1-infected DCs were stained for surface 
expression of SLAM and Ly9. DCs were then assessed for infection rate by staining for 
intracellular DenV pre-membrane (prM) protein. The gating was based on the IgG1-PE 












FIGURE 3.9.3 Flow cytometric analysis of 2B4, NTBA and BLAME expression on DCs. 28h 
P.I., immature (imDC), mock-infected and DenV1-infected DCs were stained for surface 
expression of 2B4, NTBA and BLAME. DCs were then assessed for infection rate by staining 
for intracellular DenV pre-membrane (prM) protein. The gating was based on the IgG1-PE 
isotype control (iso). For each receptor, n = 3 donors and representative data shown. 
 
We first observed upregulation of CRACC, a homotypic cytotoxic receptor, in DenV1-
infected DCs through our microarray experiments (Fig. 3.3). Cruz-Munoz et al. reported that 
CRACC ligation positively regulated murine NK cell function by promoting IFN-γ secretion 











human NK cell cytotoxicity (Kumaresan, Lai et al. 2002; Tassi and Colonna 2005) but its 
function on regulating cytokine production is unknown. We hypothesized that NK cells could 
be activated to produce IFN-γ via CRACC-CRACC interactions with DenV1-infected DCs. Thus 
we sought to confirm our microarray results by staining DCs for cell surface expression of 
CRACC protein. At the same time, we were also interested if DC expression of other SLAM 
family members was upregulated following DenV infection. 
DCs were found to express CRACC moderately in their immature state and treatment with 
heat-inactivated DenV1 did not appear to upregulate its expression. Strikingly, DenV1 
infection caused DCs to strongly increase surface expression of CRACC, confirming our 
microarray results (Fig. 3.9.1A). The frequency of CRACC+ cells in the infected population 
was approximately the same as that of the bystander population. Because not all DenV1-
infected DCs expressed CRACC, this suggests that DenV infection itself was insufficient to 
induce CRACC upregulation. Post-infection events such as cytokine secretion could have 
acted on both the infected and bystander populations, resulting in equivalent CRACC 
expression. Since CRACC is expressed by both immature and DenV1-infected DCs, this 
molecule could have stimulated NK cells. This may have led to increased IFN-γ production in 
the presence of TNF-α and type I IFN, accounting for the observations earlier. 
We next looked at CD84 expression on DCs. Immature and mock-infected DCs were found to 
express low levels of CD84 (Fig. 3.9.1B). CD84 has not been extensively studied for DCs but it 
has been previously reported to be expressed on immature cells and upregulated after 
challenge with LPS (Romero, Benitez et al. 2004). In contrast, DenV1 infection diminished 
CD84 expression in both the infected and bystander DC populations . NK cells do not express 
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CD84 (Tangye, van de Weerdt et al. 2002) and could not have interacted with DCs through 
CD84 homophilic interaction.  
SLAM is not expressed on immature DCs, but is upregulated following CD40L-mediated 
activation or stimulation with cytokines (Bleharski, Niazi et al. 2001; Rethi, Gogolak et al. 
2006). We observed that SLAM expression was absent in resting DCs and remained so in 
mock- or DenV1-infected DCs (Fig. 3.9.2). NK cells do not express SLAM (Aversa, Chang et al. 
1997) and hence could not have interacted with DCs via this molecule. 
Ly9 has been observed to be expressed on NK cells (de la Fuente, Tovar et al. 2001) but not 
investigated on DCs. Its role for both NK cells and DCs has not yet been described. 
Nonetheless, we observed Ly9 expression in resting and mock-infected DCs, which was 
downregulated in DenV1-infected and bystander DCs (Fig. 3.9.2).  
We next looked at 2B4 and NTB-A expression on DCs. 2B4 was absent in all conditions  and 
there are currently no reports of 2B4 expression on DCs. All NK cells express NTB-A to a very 
high level (Falco, Marcenaro et al. 2004). However, we were unable to detect NTB-A on 
immature, mock- and DenV1-infected DCs (Fig. 3.9.3). 
BLAME, an immunoglobulin implicated in B cell trafficking (Kingsbury, Feeney et al. 2001), 
was not detectable in imDCs or in mock- and DenV1-infected DCs (Fig. 3.9.3). This is 
consistent with the report whereby CD34+ bone marrow-derived DCs, and not MoDCs, were 
able to express BLAME after LPS stimulation.  
In summary, CRACC was the only SLAM-related receptor expressed by imDCs that was 
upregulated upon DenV1 infection. In addition, DenV appeared to interfere with the 
expression of CD84 and Ly9.   
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3.10 IFN-γ response of NK cells is partially mediated by CRACC-CRACC interactions with 
DenV1-infected DCs 
 
Given that DenV1-infection upregulates CRACC in DCs, we wanted to investigate a role for it 
in NK-DC interactions. The kinetics of its expression on NK cells is unknown apart from 
reports that high frequencies of NK cells express CRACC (Boles, Stepp et al. 2001; Bouchon, 
Cella et al. 2001). We therefore stained NK cells for the expression of CRACC under several 
culture conditions. As expected, most naïve NK cells were found to be CRACC+ (Fig. 3.10A). 
Interestingly, NK cells co-cultured with either imDCs or mock-infected DCs slightly 
upregulated CRACC expression, as indicated by a rightward shift in fluorescence intensity, 
suggesting that the presence of DCs was sufficient to induce CRACC expression in NK cells. 
NK cells then further upregulated CRACC expression when activated by DenV1-infected DCs.  
We next tried to determine whether CRACC ligation during co-culture with DCs enhanced 
IFN-γ production in NK cells. Blocking anti-CRACC antibodies slightly decreased the IFN-γ 
response of NK cells co-cultured with DenV1-infected DCs (Fig. 3.10B). This incomplete 
elimination of NK cell IFN-γ response implies that CRACC is only part of a host of ligands 




FIGURE 3.10. Blocking of CRACC homotypic interactions between NK cells and DenV1-
infected DCs reduces IFN-γ production. A, representative plots for CRACC expression on NK 
cells in various culture conditions, as assessed by flow cytometry. Filled histograms 
represent the IgG2b staining isotype control and median fluorescence intensity (MFI) shown 
for samples. n = 3. B, to block CRACC molecules on DenV1-infected DCs, cells were 
incubated with 10µg/ml of 1G10 antibody 45mins before co-culture. Control reactions were 
set up by addition of 10µg/ml of mouse IgG1 isotype control antibody. n = 5 donors in 
separate experiments and values are shown as mean ± SE. 1-way ANOVA was performed 
with Bonferroni’s multiple comparison post-test. * Reduction in IFN-γ positive cells 
compared to normal co-culture or culture with added control antibody, at p < 0.05. 
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3.11 Ligation of CRACC on NK cells enhances IFN-γ production 
 
To further demonstrate that CRACC synergises with TNF-α and type I IFNs to enhance NK 
cell IFN-γ production, we co-cultured NK cells with cell lines over-expressing CRACC in the 
presence of these cytokines. SH-SY5Y and L929 cells were chosen as co-culture partners 
since NK cells were observed to be relatively non-reactive towards them. 
NK cells cultured with SH-SY5Y cells expressing CRACC were observed to have enhanced 
production of IFN-γ, compared to co-cultures with control-transduced SH-SY5Y cells (Fig. 
3.11 B and D). Additional co-cultures confirmed that CRACC activation significantly increased 
the production of IFN-γ in NK cells (Fig. 3.11D). Furthermore, CRACC ligation enhanced NK 
cell cytotoxicity, as shown by increased degranulation. NK cells cultured with CRACC-
expressing L929 cells showed a trend of increased IFN-γ production compared to co-cultures 
with control-transduced L929 cells (Fig. 3.11C). However, the difference did not reach 
statistical significance (data not shown). In contrast, NK cells failed to degranulate when 
cultured with both control-transduced and CRACC-expressing L929 cells. One explanation is 
that, compared to L929 cells, SH-SY5Y expresses additional ligands for NK cells that worked 
in tandem with CRACC to stimulate NK cell cytotoxicity, suggesting that CRACC acts as a co-
receptor. In summary, our results have confirmed that CRACC enhances IFN-γ production in 







FIGURE 3.11. Cell line-induced CRACC ligation in NK cells enhances IFN-γ production. A, 
staining isotype control. Representative flow cytometric analyses of intracellular IFN-γ and 
cell surface CD107a of NK cells co-cultured with (B) SH-SY5Y and (C) L929 cells are shown. 
These co-cultures were performed in the presence of universal type I IFNs (1000U/ml) and 
TNF-α (100U/ml). NK cells were co-cultured with control-transduced (CTX) cell lines to give 
the basal response. D, grouped analysis for IFN-γ production of NK cells cultured with 
either CRACC-expressing or control-transduced SH-SY5Y cells. n = 4 donors in separate 
experiments and values are shown as mean ± SE. Paired t-test performed and * p < 0.05. 
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3. Results Part III 
 
Infection by DenV has been observed to upregulate CRACC expression on DCs but the 
requirements of its induction remain unknown. Furthermore, little is known about its 
function in DCs. Hence, we investigated the induction requirements of CRACC on DCs and 
evaluated the effect of CRACC signalling on cytokine production. The mechanism of CRACC 




3.12 CRACC expression in MoDCs is under the influence of STAT1 and Toll-like receptor 
signalling  
 
With the role of CRACC established for NK cells, we sought to characterize CRACC in DCs. 
DenV1 was earlier observed to upregulate CRACC expression in both infected and bystander 
DCs (Fig. 3.9.1A). Since the rate of increase was similar for both infected and bystander DCs, 
we reasoned that post-infection events such as secreted cytokines acting in autocrine were 
responsible for increased CRACC expression. Alternatively, DenV was recognised by DCs to 
directly induce CRACC expression. 
In addition to other Toll-like receptors (TLRs), DCs express TLRs 3, 7 and 8, whose cognate 
ligands are ribonucleic acids. TLR 3 is specific for double-stranded (ds) RNA while single-
stranded (ss) RNA is the common ligand for the TLRs 7 and 8 (Alexopoulou, Holt et al. 2001; 
Diebold 2008; Hackstein, Knoche et al. 2011). Being restricted to endosomal compartments, 
encounter with endocytosed or replicating DenV by these receptors is very likely. If DenV 
indeed directly upregulated CRACC expression, it was possibly through activation of 
intracellular viral sensors such as the afore-mentioned TLRs. To investigate this possibility, 
we stimulated DCs with TLR agonists before assaying for changes in CRACC expression. 
TLR 3 signalling induces IRF3 in a TRIF-dependent manner, causing the transcription of IFN-β 
(O'Neill and Bowie 2007). Additionally, recruitment of TRAF6 to TLR 3 allows for activation 
of NF-κB, resulting in pro-inflammatory cytokine production (Keating, Maloney et al. 2007). 
TLRs 7 and 8 recruit MyD88 for signal transduction, which also ends in the activation of NF-
κB (Blasius and Beutler 2010). Thus, NF-κB may be crucial in the control of CRACC 
transcription. To induce TLR 3 signalling, we stimulated DCs with Poly I:C, a synthetic dsRNA 
114 
 
analogue. We also stimulated DCs through TLR 4 which signals through both the MyD88 and 
TRIF-dependent pathways (Shen, Tesar et al. 2008). Since DenV infection of DCs resulted in 
the secretion of both TNF-α and type I IFNs, we wondered if these cytokines could also 
induce CRACC expression. TNF-α signalling is also mediated through the NF-κB pathway 
(Silke 2011) while type I IFNs promote STAT homo- and heterodimer formation. An 
important transcription complex induced by type I IFN stimulation is the formation of the 
ISGF3 complex composing of the STAT1/2 heterodimer and IRF9 (Fu, Schindler et al. 1992). 
The translocation and binding of ISGF3 to IFN-stimulated response element (ISRE) on target 
gene promotes their transcription. Lastly, NK cells responded to DenV1-infected DCs with 
IFN-γ production and we investigated if this cytokine served to positively regulate CRACC 
expression in DCs as well. Being a type II IFN, IFN-γ induces transcription differently by 
promoting the homodimerization of STAT1 and the binding of this complex to IFN-γ-
activated sites (GAS) on interferon stimulated genes (ISGs) (Boehm, Klamp et al. 1997). 
DCs responded well to LPS stimulation, as 1ng/ml of the TLR agonist was sufficient to induce 
CRACC expression in 80% of the cells as compared to the imDC basal expression of 16.7% 
(Fig. 3.12A). A dosage of 100ng/ml rendered almost all DCs CRACC-positive. Since CRACC 
was readily inducible through TLR 4, its expression was possibly controlled by NF-κB. This 
observation was corroborated by TNF-α stimulation of DCs (Fig. 3.12B), which also strongly 






FIGURE 3.12. CRACC expression of DCs in response to stimuli. 105 DCs were stimulated with 
either (A) LPS, (B) TNF-α, (C) universal type I IFN, (D) IFN-γ or (E) Poly I:C in a dose-
dependent manner for 24h before being assessed for CRACC expression via flow cytometry. 
n = 4 donors in separate experiments. A-E, representative data shown from same donor, 

































































































Treatment of DCs with type I IFNs and IFN-γ saw induction in CRACC expression as 
evidenced in Fig. 3.12 C and D. CRACC expression increased in a dose-dependent manner for 
IFN-γ stimulation while the induction was abrupt for type I IFN stimulation. Treatment with 
10-1000U/ml of type I IFNs did not influence CRACC expression unless a concentration of 
10000U/ml was used. This may be due to the rate-limiting step of ISGF3 formation or 
perhaps a lack of the ISRE on the CRACC promoter region. In fact, type I IFN signalling was 
probably mediated by STAT1 homodimer binding to GAS on the CRACC gene as evidenced 
by IFN-γ readily upregulating CRACC at lower concentrations. 
Finally, stimulation with Poly I:C also induced CRACC expression (Fig. 3.12E), suggesting 
CRACC expression was either under the control of IRF3 and/or NF-κB. 
Amongst the stimulants used in this experiment, LPS and Poly I:C emerged as strongest 
inducers of CRACC. At 10ng/ml of either TLR agonist, the frequency of CRACC-positive cells 
nearly reached 100% and this is not matched by the other stimulants used at their highest 
concentrations in this study. In summary, TLR signalling leading to NF-κB activation and IRF3 
nuclear translocation was sufficient for transcription of CRACC. Furthermore, CRACC 





3.13 Autocrine action of TNF-α and type I IFNs upregulates CRACC on DenV1-infected 
DCs 
 
Our previous results suggested that CRACC transcription was under the control of TLR 
signalling and STAT1 signalling ways. CRACC expression in DCs was inducible by TNF-α and 
type I IFNs. Since these cytokines were produced by DCs following DenV1 infection, we 
asked if they acted in autocrine to upregulate CRACC expression in both the infected and 
bystander DC populations. To answer this, neutralizing reagents for type I IFNs and TNF-α 
were added to the culture medium of freshly-infected DCs and cell surface CRACC 
expression was assessed 28h later. Type I IFNs were neutralized by addition of B18R 
(eBioscience), a vaccinia virus-encoded receptor with high affinity for human type I IFN and 
neutralization of TNF-α was achieved with addition of anti-TNF-α antibodies (clone MAb1, 
eBioscience) 
From Fig. 3.13 A and B, the frequency of CRACC-positive imDCs and mock-infected DCs were 
35.6% and 29.7% respectively. Mock-infection of DCs did not cause downregulation of 
CRACC as there tended to be some slight differences between CRACC-positive cells in each 
treatment. As expected, DenV1 infection induced CRACC expression in both infected and 
bystander DCs, with the ratio of CRACC+/CRACC- cells in each population approximately the 
same (Fig. 3.13C). When type I IFNs were neutralized, the frequency of CRACC-positive cells 
was reduced from ~80% to ~70%, showing that type I IFNs produced during DenV infection 
were partly responsible for CRACC induction. As a side effect of type I IFN neutralization, the 
frequency of bystander cells was significantly reduced; its protective anti-viral effects on 
bystander cells were lost, rendering them susceptible to secondary infection from progeny 
virus produced by infected DCs. Neutralization of TNF-α also reduced the frequency of 
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CRACC-positive cells to ~70%, demonstrating its involvement in upregulation of CRACC. TNF-
α neutralization did not significantly affect the frequency of bystander cells  and this 
observation corroborated with a report that inhibition of endogenous TNF-α had little effect 
on DenV replication in macrophages (Wati, Li et al. 2007). Only the pre-treatment of DCs 
with type I IFNs was able to protect these cells from secondary DenV infections (Diamond, 
Roberts et al. 2000). When both type I IFNs and TNF-α were neutralized, there was a marked 
reduction in the frequency of CRACC-positive cells (Fig. 3.13C). This demonstrates that type I 
IFNs and TNF-α were independently capable of strongly inducing CRACC expression because 
neutralizing either cytokine only resulted in modest inhibition of CRACC expression. Also, 
the strong but incomplete blockade of CRACC upregulation that DenV entry and replication 







FIGURE 3.13. Neutralization of TNF-α and type I IFNs during DenV1 infection reduces 
CRACC upregulation in DCs. Cell surface expression of CRACC in A, imDCs and B, mock-
infected DCs together with their respective staining isotype controls. C, Cell surface 
expression of CRACC in DenV1-infected DCs in various conditions. Following infection, 
neutralizing antibodies for TNF-α and its matching isotype control (IgG1 control) were 
added to a final concentration of 5µg/ml. B18R recombinant protein was added to a final 










DenV1-infected DC Neutralize type I IFN
Neutralize TNF-α Neutralize both IgG1 control







3.14 MoDCs express only the functional splice form of CRACC 
 
NK cells have been shown to express 2 isoforms of CRACC (Lee, Boles et al. 2004) with the 
shorter splice variant having a truncated cytoplasmic region. The truncation is accompanied 
by the loss of the ITSM, rendering the shorter isoform of CRACC non-functional. We wanted 
to determine the CRACC isoform that was expressed on stimulated DCs, since exclusive or 
dominant expression of its short isoform would have no functional bearing on DCs. 
We performed RT-PCR on DCs under various conditions using the primer set employed by 
Lee, Boles et al. The CRACC-specific primers spanned across a region that is lacking in the 
short isoform. As a result, RT-PCR could discriminate the isoforms from one another by a 
difference of 104bp. 
From Fig. 3.14, it is evident that DCs, regardless of their maturation or infection status, 
exclusively expressed the longer, functional isoform of CRACC. imDCs showed some basal 
transcription of CRACC which was increased after treatment with LPS, as indicated by a 
thicker band. The expression of CRACC in mock-infected DCs was comparable to imDCs, 
suggesting that antigen uptake of heat-inactivated DenV1 was inadequate to induce 
transcription of CRACC. DenV1-infected DCs also upregulated the functional form of CRACC. 
RT-PCR was also performed with an equal amount of RNA from PBMCs. 2 bands could be 
observed for the PBMC lane corresponding to the long and short isoforms of CRACC, 






FIGURE 3.14. RT-PCR analysis of CRACC isoforms expressed in DCs. DCs were either 
cultured in complete medium (imDCs), stimulated with 100ng/ml of LPS, mock-infected or 
DenV1-infected. Total RNA was harvested from the DCs samples 28h later, as well as from 
unstimulated PBMCs. 200ng of each RNA sample was amplified using a 1-step RT-PCR. 
Samples were resolved in a 2% agarose gel containing GelGreen. A, primers designed were 
able to differentiate the long (229bp) and short (125bp) splice forms of CRACC. B, RT-PCR of 
GAPDH was performed to ensure equal loading of each sample, except for PBMCs. n = 2 
















3.15 CRACC negatively regulates pro-inflammatory cytokine production in MoDCs 
 
We assayed for cytokine secretion by DCs as a proxy measure of the functional outcome of 
CRACC-CRACC interaction in DCs. imDCs express low to moderate levels of CRACC at rest 
and its expression could be stimulated to increase the rate of inter-DC CRACC ligation. 
However, stimuli such as LPS which served to upregulate DC cell surface CRACC also 
promotes cytokine release. Thus, the comparison of cytokine production between CRACC hi 
and CRACClow/moderate DCs would be impossible. We thus resorted to performing co-cultures 
of DCs with 293T and L929 cell lines which were transduced to stably express high levels of 
CRACC. As a control, DCs were also co-cultured with cell lines transduced with viruses made 
from pQCXIH vector without CRACC inserted. Cytokine production by DCs was augmented 
by supplementation of LPS and IFN-γ during the co-cultures. This allowed a larger dynamic 
range to detect changes in cytokine production and importantly, also upregulated CRACC on 
the DCs. L929 mouse fibroblast cells were chosen based on a similar study done for the 
effect of SLAM-SLAM interactions on MoDC cytokine secretion (Rethi, Gogolak et al. 2006). 
Since L929 cells did not express SLAM even after incubation with LPS and IFN-γ, our results 
would not have been influenced by effects of SLAM-SLAM interactions. 293T cells were 
elected as they also did not express SLAM under stimulation with LPS and IFN-γ and were 







FIGURE 3.15. Cell line-induced CRACC ligation in DCs diminishes pro-inflammatory 
cytokine secretion (Part I). To establish the basal cytokine production, immature DCs (DC) 
were cultured in plain complete RPMI medium or stimulated with LPS and IFN-γ (both at 
100ng/ml). Co-cultures were performed with CRACC expressing (CRACC) or control-transduced 
(CTX) variants of 293T cells (left column, A, C, E, G, I) and L929 cells (right column, B, D, F, H, 
J). These co-cultures were and carried out either in the absence or presence of LPS and IFN-γ. 
Co-cultures were performed for 16h after which cell-free supernatant was harvested and 
assayed for IL-1β (not shown), IL-6, IL-8, IL-10, IL-12p70 and TNF-α levels using cytometric 
bead assay. n ≥ 5 donors for each cytokine and cell line. Paired t-tests were performed and * 











































































































































































































































































































FIGURE 3.15. Cell line-induced CRACC ligation in DCs diminishes pro-inflammatory 
cytokine secretion (Part II). To establish the basal cytokine production, immature DCs (DC) 
were cultured in plain complete RPMI medium or stimulated with LPS and IFN-γ (both at 
100ng/ml). Co-cultures were performed with CRACC expressing (CRACC) or control-transduced 
(CTX) variants of 293T cells (left column, A, C, E, G, I) and L929 cells (right column, B, D, F, H, 
J). These co-cultures were and carried out either in the absence or presence of LPS and IFN-γ. 
Co-cultures were performed for 16h after which cell-free supernatant was harvested and 
assayed for IL-1β (not shown), IL-6, IL-8, IL-10, IL-12p70 and TNF-α levels using cytometric 
bead assay. n ≥ 5 donors for each cytokine and cell line. Paired t-tests were performed and * 














































































































































































































































































































FIGURE 3.15. Cell line-induced CRACC ligation in DCs diminishes pro-inflammatory 
cytokine secretion (Part III). To establish the basal cytokine production, immature DCs (DC) 
were cultured in plain complete RPMI medium or stimulated with LPS and IFN-γ (both at 
100ng/ml). Co-cultures were performed with CRACC expressing (CRACC) or control-transduced 
(CTX) variants of 293T cells (left column, A, C, E, G, I) and L929 cells (right column, B, D, F, H, 
J). These co-cultures were and carried out either in the absence or presence of LPS and IFN-γ. 
Co-cultures were performed for 16h after which cell-free supernatant was harvested and 
assayed for IL-1β (not shown), IL-6, IL-8, IL-10, IL-12p70 and TNF-α levels using cytometric 
bead assay. n ≥ 5 donors for each cytokine and cell line. Paired t-tests were performed and * 
p < 0.05. 
 
CRACC-expressing and control-transduced variants of both 293T and L929 cells did not 
secrete any of the cytokines assayed in the panel (Fig. 3.15 A-J). Therefore, cytokines found 
in the co-culture supernatant were probably contributed only by DCs. imDCs cultured alone 
produced little or none of the cytokines in the panel but when stimulated with LPS and IFN-γ, 
considerably upregulated secretion of all the pro-inflammatory cytokines, including anti-
inflammatory IL-10 (Fig. 3.15 A-J). This is in line with established work as discussed in 
Section 3.3. DCs co-producing IL-10 with other pro-inflammatory cytokines may appear as a 
paradox but this observation has been previously reported (Yanagawa and Onoe 2007; Kang, 




















































































































































been shown that IFN-γ mitigates LPS-induced IL-10 production in DCs (Frasca, Nasso et al. 
2008; Hildenbrand, Lorenzen et al. 2008). The co-production of IL-10 with pro-inflammatory 
cytokines may act to impede excessive inflammatory reactions, protecting the host through 
tolerance. 
Cytokine levels in DC cultures alone did not differ significantly from co-cultures of DCs with 
293T cells (p > 0.05, Fig. 3.15 left column), suggesting that the addition of 293T cells 
probably did not trigger any undesired responses in the DCs. Likewise, L929 did not 
significantly modify cytokine production of DCs when cultured together with the exception 
for IL-6 (p < 0.05, Fig. 3.15 right column), compared to cultures of DCs alone (p > 0.05). 
Notably, stimulated DCs cultured with CRACC-expressing 293T cells secreted significantly 
less IL-6, IL-8 and IL-12p70 compared to DCs cultured with control-transduced 293T cells (Fig. 
3.15 A, C and G). However, the magnitude of the difference was not large. There was no 
significant difference for IL-10 and TNF-α levels between the 2 types of co-cultures (Fig. 3.15 
E and I). These observations indicate that cell line-induced CRACC signalling in DCs may 
inhibit the production of pro-inflammatory cytokines such as IL-6, IL-8 and IL-12p70 but not 
of TNF-α. This could be attributed to differential gene transcription control mechanisms 
between the cytokines. Even though CRACC shows immuno-suppressive effects in DCs, it 
probably acts by suppression of pro-inflammatory cytokine production and not in the 
induction of anti-inflammatory cytokines, as evidenced by lack of IL-10 upregulation. 
To ensure that the observations were not due to the cell line-specific effects of 293T cells, 
co-cultures were also performed with CRACC-expressing L929 cells. The results paralleled 
those of DC-293T co-cultures – production of IL-6, IL-8 and IL-12p70 was reduced in co-
cultures of DCs with CRACC-expressing L929 cells compared to co-cultures with control-
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transduced L929 cells (Fig. 3.15 B, D and H). CRACC stimulation given by L929 cells (over-
expressing CRACC) was again unable to influence TNF-α and IL-10 production in DCs (Fig. 




3.16 CRACC interferes with NF-κB activation in a myeloid cell line 
 
To provide some insight on how CRACC suppressed pro-inflammatory cytokine production, 
we looked at the expression requirements of IL-6, IL-8, IL-12p35 and p40 subunits. Since 
they were all NF-κB responsive genes (Libermann and Baltimore 1990; Kunsch and Rosen 
1993; Ma, Aste-Amezaga et al. 1996; Baltathakis, Alcantara et al. 2001), we investigated if 
CRACC ligation had inhibited NF-κB activation. To achieve this goal, we made use of THP1-
Blue, a human monocyte cell line expressing a NF-κB-inducible secreted alkaline 
phosphatase (SEAP) reporter gene. As THP1-Blue cells express TLR4, they can be stimulated 
to drive NF-κB activation and consequently the secretion of SEAP. Subsequently, NF-κB 
activation can be monitored by activity of SEAP which is measurable by a colorimetric 
enzyme assay. We created a THP1-Blue cell line stably expressing CRACC (THP1-BlueCRACC) as 
well as a control-transduced variant (THP1-BlueCTX). If self ligation of CRACC in the 
transduced cells causes interference of NF-κB activation, LPS stimulation of THP1-BlueCRACC 
will result in reduced supernatant SEAP compared to THP1-BlueCTX cells. 
From Fig. 3.16A, we observed that only THP1-BlueCRACC, but not THP1-BlueCTX, expressed 
CRACC without stimulation by LPS and IFN-γ. However, since THP-1 cells are of myeloid 
origin, they upregulated CRACC expression upon LPS and IFN-γ stimulation – THP1-BlueCRACC 
further increased CRACC expression while the frequency of CRACC-positive THP1-BlueCTX 
cells always trailed behind it at both stimulant concentrations. Hence, we realised that 
CRACC ligation will also occur in the stimulated THP1-BlueCTX cells but at a lower rate 
compared to THP1-BlueCRACC cells. Nevertheless, we proceeded to compare culture 
supernatant SEAP, acknowledging that the difference in NF-κB activation may not be as 
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marked as compared to the scenario where stimulated THP1-BlueCTX cells remained CRACC 
negative.  
At rest, THP1-Blue cells secreted very little SEAP, indicating that NF-κB activation was 
minimal (Fig. 3.16B). When stimulated with 0.1µg/ml of LPS and IFN-γ, both cell variants 
demonstrated increased levels of NF-κB activation, with the induction greater in THP1-
BlueCTX cells. Similarly, at 1µg/ml of LPS and IFN-γ, THP1-BlueCTX showed higher NF-κB 
activation compared to THP1-BlueCRACC cells. Bearing in mind that stimulated THP1-BlueCTX 
cells also upregulated CRACC expression (Fig. 3.16A), we still managed to observe a 
difference for CRACC-mediated inhibition of NF-κB activation between the two cell variants. 
The lowered NF-κB activation for THP1-BlueCRACC cells can be attributed to heightened 
CRACC signalling as they have a higher surface expression of CRACC over stimulated THP1-
BlueCTX cells. Therefore, our data suggests that CRACC suppressed IL-6, IL-8 and IL-12 
production by interfering with the activation of NF-κB. Interestingly, since CRACC 
expression was inducible by TLR agonists acting through the NF-κB pathway (Fig. 3.12 A 
and B), we propose that this interference also serves as a negative feedback loop to 





FIGURE 3.16. CRACC ligation reduces NF-κB activation. THP1-BlueCRACC cells expressing 
CRACC and control-transduced THP1-BlueCTX cells were either left unstimulated or treated 
with 0.1 or 1µg/ml of both LPS and IFN-γ. A, cells were cultured for 24h before assessment 
of CRACC expression via flow cytometry. Filled histograms represent the IgG2b staining 
isotype control and MFI shown for samples. B, 20µl aliquots of cell-free culture 
supernatant were taken from each culture condition and added to 200µl of QUANTI-Blue 
reagent (Invivogen). The mixtures were incubated at 37oC for 2.5h after which the colour 
change was measured by absorbance at 655nm wavelength. The readings were then 
normalized to the absorbance of plain culture medium added to QUANTI-Blue. The relative 
absorbance for stimulated THP1-BlueCRACC (open squares) and THP1-BlueCTX (closed circles) 




























































































































3.17 Summary of findings 
 
Our study has shown that during DenV infection, IFN-γ production by NK cells requires 
synergism between TNF-α and type I IFNs. While this synergism has been previously 
reported (Hunter, Gabriel et al. 1997; Marshall, Heeke et al. 2006), its crucial role in 
activating the NK response against DenV-infected cells has not been previously appreciated. 
The inability of DCs to produce functional IL-12, IL-15 or IL-27 during DenV infection also 
removes important stimulants of NK antiviral activity. Also, we have determined that 
membrane-bound factors contribute to the NK response towards DenV-infected DCs. 
NK cells exerted cytotoxicity on DenV-infected DCs through Fas-mediated apoptosis. 
Blocking of FasL-Fas interactions reduced the NK cell killing of infected DCs. We have little 
conclusive evidence that retrograde FasL signalling contributes significantly to the IFN-γ 
response of NK cells to DenV-infected DCs. 
CRACC expression on DCs and its consequent upregulation by DenV infection has proven to 
be partially responsible for NK cell activation. Blocking CRACC-CRACC interactions led to 
minor but reproducible reductions in IFN-γ response by NK cells. Furthermore, NK cells 
stimulated via CRACC show increased IFN-γ production and cytotoxicity. 
Lastly, CRACC expression is induced through STAT1 and NF-κB IRF3 signalling pathways. The 
autocrine action of TNF-α and type I IFNs produced during DenV infection was responsible 
for CRACC upregulation on DCs. Ligation of CRACC on these cells suppresses the production 
of several pro-inflammatory cytokines, including IL-6, IL-8 and IL-12p70. This is probably 












The role of NK cells in DenV infection 
Arguably the most important component of innate antiviral defence, NK cells are noted to 
suppress viral replication before an adaptive immune response can be mounted to 
effectively clear the infection. Based on previous reports, NK cells from dengue patients 
were activated, as given by upregulated CD69 expression, and this was mirrored in their 
murine counterparts which were also found to proliferate and secrete IFN-γ during DenV 
infection (Green, Pichyangkul et al. 1999; Shresta, Sharar et al. 2005; Azeredo, De Oliveira-
Pinto et al. 2006). We were able to recapitulate several of these observations in a simplified 
in vitro co-culture setting, using primary human cells. Chiefly, naïve NK cells were detected 
to readily produce IFN-γ in response to DenV-infected DCs. The antiviral role of IFN-γ has 
been discussed earlier but what is the relevance of this cytokine in DenV infection? Because 
DenV suppresses maturation of infected DCs, we propose that activated NK cells can rescue 
DCs from this suppression through the effects of IFN-γ. Infected DCs were noted not to be as 
matured as bystander DCs, given by differences in expression of co-stimulatory and MHC 
molecules, as well as their failure to produce IL-12, an important stimulator of NK and CD4+ 
T cell activity (Dejnirattisai, Duangchinda et al. 2008; Nightingale, Patkar et al. 2008). A study 
was undertaken by the Libraty group to show the beneficial effects of IFN-γ in dengue. IFN-γ 
interfered with the replication of DenV, as given by reduction of viral titre, and restored the 
maturation status of infected DCs. More importantly, in the presence of IFN-γ, DenV-
infected DCs regained their ability to secrete IL-12p70 (Libraty, Pichyangkul et al. 2001). 
These effects of IFN-γ on infected DCs must be emphasized – firstly, fully matured DCs will 
be spared from NK cell editing as they are fit to prime the adaptive immune response and 
secondly, such DCs possessing optimal levels of MHC molecules can effectively present 
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antigen, provide sufficient co-stimulation and appropriate cytokine environment for 
induction of T cell-mediated cytotoxicity. Since NK cells are activated early during viral 
infections, they are presumably the principal source of IFN-γ during the initial phase of 
dengue and can be helpful as such. However, the serum levels of IFN-γ from dengue 
patients were positively associated with disease severity (Green, Vaughn et al. 1999). It is 
unknown whether heightened systemic IFN-γ is resultant of increased disease severity or a 
contributor to disease progression. It is likely that during secondary infections, this cytokine 
is rapidly produced by memory T and NK cells, perhaps provoking aberrant IL-12 and TNF-α 
production by DCs. 
This current study has also contributed the observation that naïve human NK cells 
degranulate in response to infected DCs, as evidenced by upregulated surface CD107a 
expression. Degranulation is only a proxy measure of NK cell cytotoxicity and thus killing 
assays were performed in this study. While a report demonstrating that NK cells are 
involved in the killing DenV-infected cell lines through ADCC (Kurane, Hebblewaite et al. 
1984), our study provides firsthand evidence of NK cells specifically lysing DenV-infected DCs, 
through Fas-mediated apoptosis. Appreciable killing was observed for both infected DCs and 
imDCs using higher E:T ratios of 5:1 and 10:1. Although matured DCs are resistant to NK cell 
lysis (Wilson, Heffler et al. 1999), DenV-infected DCs had downregulated MHC class I and 
upregulated Fas, thereby encouraging their cytolysis by the NK cells. Our results suggest that 
once sufficient numbers of activated NK cells are recruited to the sites of infection, their 
cytolysis of DenV-infectable cells can prevent further viral dissemination.  
Even though our results demonstrate that NK cells produce IFN-γ and lyse infected DCs, we 
noted that their co-culture with infected DCs did not effectively abate the replication of 
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DenV. In retrospect, NK cells were not activated sufficiently early in these co-cultures to halt 
viral replication and confer resistance to bystander cells . This was due to the delay in 
generating adequate levels of type I IFNs and TNF-α by DenV-infected DCs. The lag in NK cell 
production of IFN-γ removes its effect as it has been demonstrated that pre-treating, but 
not subsequent exposure, of target cells with IFN-γ can block DenV infection (Diamond, 
Roberts et al. 2000). Hence, an experimental redesign that employs NK cells pre-activated 
with conditioned supernatant from DenV-infected DCs may yield better suppression of viral 
replication.  
The role of NK cells in anti-DenV defense probably contributes to a good disease prognosis 
as it has been noted that increased frequencies of activated peripheral NK cells are 
associated with mild dengue, in both humans and mice (Azeredo, De Oliveira-Pinto et al. 
2006). Interestingly, a recent study using tamarins as hosts for DenV infection has shown 
that depletion of CD16+ NK cells did not affect the kinetics of DenV infection as the animals 
were able to clear the infection as effectively as the controls (Yoshida, Omatsu et al. 2012). 
In these experiments, CD16- NK cells persisted but their role was not investigated. It is 
unknown if tamarin NK cell subsets strictly abide by their human counterparts through 
differences in phenotype and function. However, if they are indeed analogous, 
CD56brightCD16- NK cells may take centre stage in dengue suppression through their robust 
secretion of IFN-γ. Because depleting CD16+ NK cells did not affect disease outcome in 
tamarins, NK cells were probably less concerned in peripheral clearance of infected cells but 




The dependence of NK cells on cytokines during dengue 
Our study has shown that during DenV infection, NK cells need to be activated by both TNF-
α and type I IFNs to effectively produce IFN-γ and perform cytotoxicity. While this synergism 
has been previously reported (Hunter, Gabriel et al. 1997; Marshall, Heeke et al. 2006), its 
crucial role in activating the NK cell response against virus-infected cells has not been 
previously appreciated. TNF-α and type I IFNs were determined to have induced NK cell 
degranulation as their removal impaired NK cell killing of infected DCs. Even though we did 
not assay for surface expression of FasL, we hypothesized that the cytokines were also 
responsible for induction of surface FasL. Pre-formed FasL molecules stored in lytic granules 
in NK cells are rapidly exposed to cell surface following cytokine stimulation (Lettau, Paulsen 
et al. 2009). NK cells lysed DCs through Fas-mediated apoptosis as masking of NK cell FasL 
with soluble Fas receptor proteins abrogated the killing. NK cells hardly lysed imDCs in the 
presence of conditioned supernatant from DenV-infected DCs, indicating that the killing was 
specific and protective.  
The inability of DCs to produce functional IL-12 during DenV infection removes an important 
stimulant of NK antiviral activity (Ho, Wang et al. 2001). Furthermore, other cytokines with 
the ability to trigger NK cell activity during infections, e.g. IL-15, IL-18, IL-21, and IL-27, were 
either undetectable, or produced in only minute amounts by DenV1-infected DCs. The 
abrogation of these other compensatory mechanisms of activation makes the NK cell 
response to critically dependent on the combination of TNF-α and type I IFNs. Yet, our co-
culture system cannot fully replicate the cytokine milieu faced by NK cells during natural 
DenV infection. Hence, it would be inappropriate to discount the potential role of other 
cytokines capable of activating NK cells. 
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IL-15 is a pleiotropic cytokine produced by monocytes, epithelial cells and fibroblasts – cells 
which are coincidentally also targets of DenV infection (Musso, Calosso et al. 1999; Basok, 
Shnaider et al. 2001; Rappl, Kapsokefalou et al. 2001). Because IL-15 shares similarities with 
IL-2, its binding to the IL2βγ receptor complex also primes NK cells and stimulates their 
proliferation (Carson, Giri et al. 1994; Giri, Ahdieh et al. 1994). Even though infected DCs 
failed to secrete IL-15, DenV infection may induce production of IL-15 in these other cells. 
This is supported by the observation where serum IL-15 levels were increased in dengue 
patients (Azeredo, De Oliveira-Pinto et al. 2006). Furthermore, the authors showed that the 
serum concentrations of IL-15 were positively correlated to frequencies of activated (TIA-1 
positive) NK cells. Thus, whilst infected DCs did not secrete IL-15, they may have activated 
NK cells through trans-presentation of circulating IL-15. 
IL-12 and IL-18 are also cytokines not produced by infected DCs but found to be raised in the 
sera of dengue patients (Chaturvedi, Agarwal et al. 2000; Mustafa, Elbishbishi et al. 2001). 
The suppression of DC production of IL-12 by DenV has been noted but not investigated 
(Palmer, Sun et al. 2005; Nightingale, Patkar et al. 2008). Our microarray results saw 
upregulation of IL-12p35 but not of the p40 subunit. This is intriguingly as p35 is usually the 
rate-limiting factor in IL-12 production (Napolitani, Rinaldi et al. 2005) and suggests that 
DenV specifically interfered with p40 production, thereby preventing functional IL-12 
release. Aside from impairment of crosstalk with NK cells, the non-production of IL-12 by 
DCs in the lymphoid organs could favour the Th2 pathway, leading to immune deviation and 
pathology. The inability of infected DCs to secrete IL-12 has been documented before in 
studies of adenovirus (Rea, Schagen et al. 1999) and measles virus (Fugier-Vivier, Servet-
Delprat et al. 1997). However, these studies also showed that engagement of CD40 or IFN-γ 
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stimulation, both given by interacting T cells, restored DC IL-12 production. Hence, it would 
be mis-informative to state that during dengue, DCs do not trigger NK cell activation 
through IL-12. In our study, we did not explore whether IFN-γ produced by NK cells 
subsequently elicited DC production of IL-12. Perhaps by extending our co-culture duration 
beyond 2 hours, NK cells can reciprocally stimulate infected DCs to produce IL-12, allowing 
its detection as another stimulus of NK cell activity. 
DenV infection upregulated the p35 subunit which may have heterodimerized with EBI3 in 
the formation of IL-27. Researchers have also determined that p35 can heterodimerize with 
cytokine receptor-like factor (CLF), producing another isoform of IL-27 (Crabe, Guay-Giroux 
et al. 2009). In addition, both isoforms of IL-27 are producible by DCs and can stimulate NK 
cell activity. It is unknown if the ELISA we employed in this study was able to detect the 
p28/CLF isoform but we did find constitutive DC expression of CLF through RT-PCR (data not 
shown). Even if IL-27 was indeed produced by infected DCs in its alternative isoform, it was 
minute and did not enhance NK cell function in the presence of type I IFNs and TNF-α. This 
implies that p28 and/or CLF were hardly produced at the protein level. Since EBI3 was 
upregulated by DenV infection (as shown in the microarray experiments), we reasoned that 
DenV has post-translationally blocked both isoforms of IL-27 in DCs. A microarray study 
performed on whole blood samples of dengue patients had detected activation of signalling 
pathways downstream of IL-27 (Hoang, Lynn et al. 2010). Based on this study, we suggest 
that IL-27 levels may be elevated during dengue and could provide another source of 
stimulus for NK cells, with macrophages being a principal source of this cytokine (Kastelein, 
Hunter et al. 2007). 
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Initially characterized as IFN-γ inducing factor, IL-18 is able to induce either Th1 or Th2 
polarization, depending on the immunological context (Okamura, Tsutsi et al. 1995; 
Nakanishi, Yoshimoto et al. 2001). Although IL-18 alone can activate NK cells, its full 
potential is realized through synergism with IL-12 (Hyodo, Matsui et al. 1999). Accordingly, 
IL-12 and IL-18 stimulation results in reciprocal upregulation of their receptors, thereby 
increasing their potency (Xu, Chan et al. 1998). Furthermore, their synergism was 
determined to be responsible in the induction of IFN-γ which had rescued mice from severe 
dengue immunopathology (Fagundes, Costa et al. 2011). We have shown that DenV-
infected MoDCs do not produce substantial amounts of IL-18 while another group has noted 
that in vitro generated macrophages also do not produce IL-18 following infection (Wu, 
Chen et al. 2013). Yet, this cytokine was detected to be elevated in dengue patients 
(Mustafa, Elbishbishi et al. 2001; Azeredo, Zagne et al. 2006). It is unknown if type I IFNs, 
TNF-α, IL-15 or IL-27 can cooperate with IL-18 in the same manner as IL-12. It would be 
tempting to speculate that during dengue, NK cells are activated through the interplay of all 
these cytokines. 
The notion that NK cells having immunological memory, akin to B and T cells, is interesting 
and debatable. Experiments performed on mice have revealed that a subset of NK cells 
bearing Ly49H recognised the m157 protein of MCMV through this receptor. Such NK cells 
persisted and underwent clonal expansion after adoptive transfer into recipient mice. 
Furthermore, they exhibited “memory” by having improved effector functions in vivo, 
clearing subsequent viral infections more effectively than resting NK cells. “Memory” NK 
cells can also be generated ex vivo, through cytokine stimulation with IL-12 and IL-18. 
Adoptive transfer of these activated NK cells into RAG-deficient mice displayed enhanced 
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IFN-γ production, but not cytotoxicity, compared to naive NK cells when re-stimulated with 
IL-12 and IL-15 (Cooper, Elliott et al. 2009). In bridging their observations to humans, the 
authors rested cytokine-stimulated human NK cells for 3 weeks before re-stimulating them 
with IL-12 and IL-15 (Romee, Schneider et al. 2012). Compared to naïve NK cells, these pre-
activated NK cells showed “memory” by enhanced IFN-γ production, replicating the 
observations in mice. While not examined in dengue, the cytokine milieu during disease may 
create “trigger happy” NK cell clones that are persist in secondary DenV infections. Their 
propensity to produce IFN-γ when re-stimulated with cytokines may confer resistance or 




The membrane-bound activators of NK cells 
The vast availability of TNF-α and type I IFNs in DenV infection can non-specifically activate 
both lymphoid organ-resident and peripheral NK cells, which left unchecked, may contribute 
to immunopathology. Hence, there is a secondary requirement for membrane-bound 
factors which, when only co-presented with the cytokines, unleashes the full cytotoxic 
potential of the NK cells. We have observed this independently in IFN-γ production and in 
cytolysis. 
The downregulation of MHC class I molecules on infected DCs resulted in a lack of KIR 
engagement which had signalled NK cells for cytotoxicity. Moreover, we noted significant 
upregulation of Fas receptor expression on infected DCs which marked them for destruction. 
While not proven for NK cells, FasL binding to its receptor can result in bidirectional 
signalling, leading to increased IFN-γ production and degranulation in T cells (Sun, Ames et 
al. 2006). We had attempted to determine whether FasL retrograde signalling had invoked 
IFN-γ production in NK cells, but to no avail. However, in our killing assays, we did not make 
the distinction between FasL-mediated DC apoptosis and FasL-mediated NK cell activation. 
From the results, we could only draw the conclusion that NK cells killed infected DCs 
through ligation of Fas receptor. Our transwell experiments had indicated that NK cells 
required contact with DCs to degranulate. Therefore, it is conceivable that FasL retrograde 
signalling in NK cells preferentially activates actin reorganization and degranulation, but not 
cytokine production. We could have covered this gap in the study by repeating these co-
cultures, adding the afore-mentioned blocking reagents and observing degranulation.  
The requirement for contact with DCs for maximal IFN-γ production serves to prevent NK 
cells from deleterious cytokine over-secretion in a pro-inflammatory cytokine-rich 
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environment. This contact dependency results in localized secretion of IFN-γ, probably 
improving NK-DC crosstalk. We were deeply perplexed with the identity of DC-bound ligands 
expressed on either immature or DenV-infected DCs which were responsible for enhancing 
the cytokine synergism. Staining of both immature, mock- and DenV-infected DCs did not 
yield useful information as ligands for activating receptors on NK cells were mostly absent. 
Because the ligands for the NCRs are poorly characterized, we had used NCR-Fc proteins to 
broadly bind all possible ligands of that particular NCR, followed by secondary staining with 
fluorochrome-conjugated antibodies against the Fc portion. Unexpectedly, our results 
showed that NCR ligands were inconsistently expressed on DCs. While previous studies have 
determined NK cells to interact with DCs through NKp30 (Ferlazzo, Tsang et al. 2002; Vitale, 
Della Chiesa et al. 2005), we could not reliably detect NKp30 ligands on the DCs. The NKp30-
Fc reagents were ascertained to be functional as we could achieve positive staining on A549 
cells. So far, the known ligands of NKp30 are HCMV pp65 (Arnon, Achdout et al. 2005), BAT3 
(Pogge von Strandmann, Simhadri et al. 2007) and B7-H6 (Brandt, Baratin et al. 2009). B7-H6 
is not expressed by imDCs (Brandt, Baratin et al. 2009) while it is unlikely that DenV encodes 
a structural homologue of the HCMV pp65 protein; this leaves BAT3, a regulator of 
apoptosis (Wu, Shih et al. 2004), as the only candidate. Because BAT3 is found intracellularly 
as a nuclear factor, doubts have been raised on its expression on cell surface to ligate with 
NKp30. Initially presumed to be exposed on the DC surface following cellular damage or 
apoptosis, it is now known that DCs can secrete BAT3 in exosomes, secretory microvesicles 
that arise in endosomes (Simhadri, Reiners et al. 2008). In the report, exosomes carrying 
BAT3 were purified from heat-shocked DCs and their addition to NK cells induced 
production of IFN-γ. Since the kinetics of exosome production in DCs remains unexplored, 
the transience of BAT3 on exosomes harboured on the plasma membrane could have led to 
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our variable staining results. Another explanation is that DCs from different donors had 
varying viability – apoptotic or necrotic DCs may have exposed BAT3 to the surface and 
resulted in positive staining while experiments with healthy DCs yielded poor NKp30 
staining. Nevertheless, we did not fully investigate exosomal BAT3 in our co-culture system 
and this is a gap in our study. Not so much as a membrane-bound factor, BAT3 perchance 
could have been released by DCs during crosstalk with NK cells and enhanced IFN-γ 
production. In line with this hypothesis, IFN-γ has been demonstrated to upregulate BAT3 
expression in DCs (Kamper, Franken et al. 2012). 
Compared to NKp30, ligands for NKp80 were detectable in all replicates of DC staining. 
Activation-induced C-type lectin (AICL, CLEC2B) is the sole ligand for NKp80 thus far (Welte, 
Kuttruff et al. 2006). Because AICL is expressed on myeloid cells such as monocytes, we had 
most likely detected its expression on DCs through staining with NKp80-Fc reagents. AICL 
was discovered as a gene having an expressed sequence tag (EST) homologous to CD69, 
located in the NK gene complex (Hamann, Montgomery et al. 1997). Because prior studies in 
humans and mice have shown that receptor-ligand pairs can lie in proximity in the NKC (e.g. 
NKRP1 and LLT1), the “orphaned” status of AICL led to its discovery as a binding partner for 
NKp80 (Welte, Kuttruff et al. 2006). This discovery was accompanied by the observations 
that through AICL, monocytes triggered degranulation and IFN-γ production in cytokine-
activated NK cells. It was later revealed that NKp80 signals through an ITAM-like motif and 
recruits Syk and ZAP-70 to activate cytotoxicity in NK cells (Dennehy, Klimosch et al. 2011). 
Although the expression of NKp80 ligands on DCs was low and not upregulated after DenV 
infection, they could have worked in tandem with type I IFNs and TNF-α to trigger IFN-γ 
production in NK cells. 
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Despite our best efforts, we did not manage to stain for NKp44 ligands on both immature 
and DenV-infected DCs. We were concerned since NKp44 was reported to bind the E protein 
of flaviviruses, with a higher affinity for WNV compared to DenV (Hershkovitz, Rosental et al. 
2009). The authors also managed to stain WNV-infected Vero cells with NKp44-Ig constructs, 
much like the NKp44-Fc reagents used in this study. However, they did not demonstrate 
whether DenV-infected Vero cells could be similarly stained for DenV E protein. The 
glycosylation pattern of NCRs affects their signalling function and ability to bind ligands 
(Joyce and Sun 2011; Hartmann, Tran et al. 2012). Because the glycosylation status of 
commercial NKp44-Fc is uncertain, it is possible that NKp44-Fc chimeras (and other NCR-Fc 
reagents for that matter) did not undergo proper post-translational modification and failed 
to bind its ligands on infected DCs. With these issues in mind, we sought to address whether 
the IFN-γ response of NK cells was triggered through NKp80 recognition of DenV E protein 
on infected DCs. Firstly, while the E proteins of DenV and WNV share structural similarities, 
they remain distinct given by the differences in binding avidity with NKp44, as shown in the 
study by Hershkovitz et al. The interaction between cell surface DenV E protein and NKp44 
could have been too weak to enable positive staining and thus went unreported in their 
study. This could explain our failure to detect DenV E protein using NKp44-Fc reagents. 
Secondly, no glycosylation sites have been predicted for the extracellular domain of NKp44 
and thus post-translational modification could not have affected NKp44-Fc binding to DenV 
E protein (Cantoni, Ponassi et al. 2003). Therefore, our NKp44-Fc reagent (tested to be 
functional through positive staining of A549 cells) should have worked as well if the ligand 
was present. Thirdly, as the kinetics of DenV replication in DCs was not examined, we may 
have untimely stained for E protein when there were few budding virions on the DC 
membrane. In this scenario, lack of surface DenV E protein would not have activated NK 
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cells sufficiently to enhance the IFN-γ production. Lastly but most importantly, co-culturing 
NK cells with immature (uninfected) DCs reproduced enhanced IFN-γ production, thus 
detracting the role of E protein in triggering NK cell activation through NKp44.  
2B4 is a well-studied activating receptor on human NK cells but DenV infection did not 
induce expression of its ligand CD48, at the protein level. While our microarray results had 
showed diminutive upregulation of CD48 transcription in infected DCs, the level of 
transcription was probably below the threshold for its expression. We did not detect 
significant changes for transcription of other SLAM-related receptors with the sole 
exception of CRACC, whose mRNA was increased in DenV-infected DCs. Flow cytometric 
staining showed some degree of CRACC expression on both immature and mock-infected 
DCs and importantly, confirmed CRACC protein upregulation in both bystander and DenV-
infected DCs. We had also concurrently stained DCs and NK cells for the presence of other 
SLAM family proteins and the results are summarized in Table 4.1. 
Of note, SLAM remained absent on DCs even after DenV infection. This is interesting as DCs 
have been observed to upregulate SLAM expression upon maturation (Bleharski, Niazi et al. 
2001; Rethi, Gogolak et al. 2006). Since SLAM negatively modulates cytokine production in 
DCs, DenV interference with its expression may enhance its secretion of pro-inflammatory 
cytokines instead. It was unexpected that we could not detect NTB-A expression on DCs 
even though murine DCs have been reported to do so NTB-A (Griewank, Borowski et al. 
2007). Upon inspection, we felt that the data presented in the report appeared uncertain as 
the relevant isotype control was not included and positive staining seemed to be 
contributed by contaminating lymphocytes. Since the experiments were performed on 
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murine thymic DCs, the basis of comparison with human MoDCs is weak. Hence, we 
maintain that human myeloid DCs do not express NTB-A in resting or after maturation.  
 
TABLE 4.1. Frequencies of DCs and naïve NK cells expressing various SLAM-related 
receptors. Table represents data from several flow cytometric staining experiments, of 
which representatives are given in Fig. 3.10. Frequencies are rounded to the nearest 5%. 
Since immature and mock-infected DCs showed comparable expression of these receptors, 
only results for imDCs are given. The staining profiles of SLAM-related receptors in NK cells 
are found in the appendix, A8.  
Receptor imDCs DenV-infected DCs Naïve NK cells 
SLAM Absent Absent Absent 
CD48 Absent Absent Ubiquitous 
Ly9 10-30% Downregulated 35% 
2B4 Absent Absent Ubiquitous 
CD84 10-20% Downregulated Absent 
NTB-A Absent Absent Ubiquitous 
CRACC 25-50% Upregulated 75-90% 
BLAME Absent Absent Absent 
 
 
We can appreciate from Table 4.1 that, amongst the 9 SLAM-related proteins assayed for, 
NK cells could have only interacted with DCs through Ly9 and CRACC due to their mutual 
expression. Infected DCs had downregulated Ly9 but upregulated CRACC instead. 
Regrettably, the function of human Ly9 is  unknown for these 2 cell types and was not 
pursued in this study. We had decided to focus on CRACC as crosslinking of this molecule 
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has been demonstrated to induce cytotoxicity in human NK cells. In addition, evident 
stimulation of CRACC expression by DenV coupled with the fact that its function is 
undefined for DCs compelled us to investigate it further.  
In accordance with existing literature, we have also managed to detect ubiquitous 
expression of CD48 and NTB-A on NK cells. 2B4 and NTB-A signalling is dependent on the 
activation state of the NK cell, with SAP being the critical adaptor protein involved. SAP has 
been shown to be upregulated following NK cell activation (Endt, Eissmann et al. 2007). In 
addition, EAT-2 is constitutively expressed in resting NK cells and in the absence of SAP, is 
recruited to the ITSMs of 2B4 and NTB-A, inhibiting their function (Bottino, Falco et al. 2001; 
Roncagalli, Taylor et al. 2005). Hence, even though CD48 and NTB-A expression allows NK 
cells to act as their own stimulus, NK cells remain impervious to spontaneous activation. 
In summary, we have determined CRACC and NKp80 ligands to be candidates for DC 
membrane-bound factors that enhanced IFN-γ production in NK cells. Ligands for most 
activating receptors, including NKG2D, DNAM-1 and the NCRs, were neither present on 
imDCs nor were they induced following DenV infection. The lack of viral induced ligands for 




CRACC as a co-receptor in NK cells 
While CRACC ligation has been documented to stimulate cytotoxicity in humans (Stark and 
Watzl 2006), its ability to stimulate IFN-γ production has only been shown in mice (Cruz-
Munoz, Dong et al. 2009). Our study has covered this gap in knowledge by demonstrating 
CRACC to be involved in human NK cell IFN-γ production in the context of DenV infection. 
This was further confirmed by co-culturing cytokine-activated NK cells with cell lines over-
expressing CRACC. Because our primary motive was to identify membrane-bound ligands on 
DCs which enhanced NK cell IFN-γ production, we did not measure CRACC’s influence on 
degranulation and killing of DenV-infected DCs. In our co-cultures with CRACC-transduced 
cells, we did however observe increased NK cell degranulation. Based on its established role 
and our results, CRACC probably also influenced NK cell cytotoxicity in the co-cultures with 
DenV-infected DCs.  
More importantly, CRACC-bearing L929 cells stimulated IFN-γ production but not 
degranulation in NK cells. We therefore reasoned that the murine L929 cells lacked co-
stimulatory ligands which were recognisable by human NK cell receptors. This would also 
imply that CRACC functions as a co-receptor and synergises with other cytotoxic receptors 
to promote degranulation. Our hypothesis is supported by co-cultures with CRACC-bearing 
human SK-N-SH cells which had stimulated both IFN-γ and degranulation in NK cells. We had 
tried to replicate our results using 293T cells. However, the tumourigenic nature of these 
cells induced high degranulation in cytokine-activated NK cells and the effect of CRACC 
ligation was indiscernible amongst the high background response (data not shown).  
As NK cells express a host of activating and inhibitory receptors, it was difficult to determine 
the individual contribution of CRACC to NK cell function. To elucidate the co-stimulatory role 
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of CRACC, we had resorted to using S2 drosophila cells as co-culture partners. S2 cells have 
been previously exploited for characterization of NK cell receptors, including LFA-1 and 2B4 
(Bryceson, March et al. 2005). Drosophila cells represent an isolated system to study NK cell 
receptors because they have diverged greatly from mammals in evolution and should not 
express any ligand that influences NK cell function. Thus, S2 cells expressing CRACC in 
combination with other inhibitory and activating receptors can be a useful tool for analysis 
of NK cell activation. We were unable to stably express CRACC in S2 cells under an 
appropriate insect gene promoter. This could be due to differences in protein folding or 
post-translational modification, which rendered S2 cells unable to express CRACC on the 
surface. 
Nevertheless, we were mindful that CRACC is a homotypic receptor and NK cells also 
express CD48 and NTB-A. In the transwell experiments, NK cells exposed to DenV-infected 
DC supernatant had produced little IFN-γ. The results indicate that inter-NK cell CRACC 
ligations, together with 2B4-CD48 and homophilic NTB-A interactions, were insufficient for 
inducing IFN-γ production. Experiments have also shown that KIR engagement silences the 
activating effects brought on by inter-NK CRACC ligation (Stark and Watzl 2006). This was 
demonstrated through masking of MHC class I molecules which resulted in increased NK cell 
autolysis; the autolysis was reduced with additional masking of CRACC. Taken together, 
these observations indicate that CRACC ligation alone is weakly stimulating in NK cells and 
supports our hypothesis that CRACC is a co-receptor. The triggering of other activating 
receptors is required to exceed a certain threshold of stimulation in NK cells, beyond which 
the effects of CRACC ligation can only be observed. 
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The signalling mechanisms for SLAM-related receptors are a conundrum and the results 
gathered for humans and mice can be conflicting. All SLAM-related proteins, with the 
exception for CD48, carry ITSMs in their cytoplasmic domains, allowing the recruitment of 
adaptor proteins that have differential effects on downstream signalling. In human NK cells, 
SAP is recruited by 2B4 and NTB-A for induction of cytotoxicity. This was observed in NK 
cells from XLP patients, whose mutation of SAP results in impairment of cellular responses. 
Yet, the signalling capacity of CRACC was found to be maintained in such individuals 
(Bouchon, Cella et al. 2001). Thus, it would be prudent to elaborate on the signalling 
mechanisms of SLAM-related receptors expressed by NK cells. 
2B4 possesses four ITSMs of which one has been shown to preferentially bind EAT-2 instead 
of SAP, upon ligation with CD48 (Clarkson, Simmonds et al. 2007). This particular ITSM was 
determined to recruit SHP-1 and SHP-2 phosphatases and the binding was abrogated in the 
presence of SAP (Eissmann, Beauchamp et al. 2005). In resting NK cells, EAT-2 is 
preferentially associated with 2B4 while crosslinking of 2B4 leads to recruitment of SAP 
which disrupts this association (Tassi and Colonna 2005). Hence, 2B4 appears to mediate 
cytotoxicity through SAP and this function is blocked by EAT-2 binding. 
NTB-A has two ITSMs which bind both SAP and EAT-2 simultaneously upon ligation. A study 
undertaken by Eissmann et al has elucidated the signalling mechanisms of NTB-A. Ligation of 
NTB-A promotes binding of EAT-2 to the first ITSM and suffices to induce NK cell cytotoxicity 
(Eissmann and Watzl 2006). Further recruitment of SAP to the second ITSM serves to 
enhance NTB-A-mediated cytotoxicity. The adaptor function of SAP, but not EAT-2, was 
shown to be responsible for induction of IFN-γ production in NK cells. 
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The human CRACC receptor has four tyrosine residues in its cytoplasmic domain, of which 
one is embedded in the ITSM. Because CRACC retains its ability to stimulate cytotoxicity in 
NK cells of XLP patients (Bouchon, Cella et al. 2001), it must signal independently of SAP. 
Indeed, experiments have shown human CRACC to only associate with EAT-2 (Tassi and 
Colonna 2005). In contrast, murine CRACC can additionally bind SAP through a tyrosine 
residue located outside of the ITSM (Tovar, del Valle et al. 2002; Cruz-Munoz, Dong et al. 
2009).  
SAP has been mostly linked to cellular activation by association with SLAM, 2B4, NTB-A and 
CD84, while the role of EAT-2 is less linear. In a murine study, association of EAT-2 to 2B4 
inhibits proximal signalling by de-phosphorylation of tyrosine residues belonging to 
activating NK cell receptors (Roncagalli, Taylor et al. 2005). In human NK cells, EAT-2 
competes with SAP for binding to 2B4 and recruits SHP phosphatases  (Tassi and Colonna 
2005). However, the association of EAT-2 with NTB-A and CRACC results in enhanced NK cell 
cytotoxicity (Tassi and Colonna 2005; Eissmann and Watzl 2006). While SAP has been 
demonstrated to bind unphosphorylated SLAM receptors (Poy, Yaffe et al. 1999), EAT-2 
binding is reliant on phosphorylated tyrosine residues (Morra, Lu et al. 2001). EAT-2 also 
recruits Src kinases in a manner distinct from SAP – a singular tyrosine residue in the C-
terminal domain of EAT-2 becomes phosphorylated upon binding to SLAM-related receptors 
and has been shown to recruit Fyn (Clarkson, Simmonds et al. 2007). It is likely through EAT-
2 recruitment of Fyn that CRACC mediates NK cell cytotoxicity in a SAP-independent manner. 
Not observed in humans, the absence of EAT-2 switches murine CRACC function to 
inhibitory by allowing the binding of an unknown signalling protein (Cruz-Munoz, Dong et al. 
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2009). The authors also showed that CRACC functions as an inhibitory receptor in T cells 
which typically do not express EAT-2. 
Put together, it is evident that EAT-2 is an adaptor that can mediate both activating and 
inhibitory signalling in human NK cells. We can appreciate that EAT-2 and SAP adaptor 
proteins have distinct roles when coupled to different SLAM-related receptors, under 
different states of cellular activation. The complexity is further compounded by differential 
expression of adaptor proteins in various cell types and across species. With regards to our 
study, it suffices to say that CRACC is activating in human NK cells, as they cells express EAT-




CRACC as an inhibitory receptor in DCs? 
The upregulation of immuno-stimulatory molecules on virus-infected DCs has been 
extensively documented. Yet, our finding of CRACC upregulation during DenV infection is 
novel. The regulation of CRACC expression in DCs has not been studied nor has its function 
been described. Because bystander DCs also displayed CRACC upregulation, we had 
proposed that CRACC expression can be induced by cytokines produced by infected cells. 
Stimulating imDCs with TLR agonists, TNF-α, type I and II IFNs showed that CRACC 
expression was under the control of NF-κB and STAT1 signalling pathways. These results 
were confirmed when neutralizing reagents for TNF-α and type I IFNs were added to freshly 
infected DCs. Neutralizing either type I IFN or TNF-α could not abate CRACC upregulation in 
the pooled DCs while simultaneous neutralization of both cytokines led to a discernible 
reduction in CRACC+ cells. Furthermore, the incomplete blockade of CRACC upregulation in 
the infected population suggests that there are other mechanisms involved in regulating 
CRACC expression. Faced with our results, we were surprised that CRACC was not previously 
studied in DCs. Its upregulation would have been perceptible as DCs readily produce TNF-α 
and type I IFNs upon encounter with other pathogens such as influenza virus (Summerfield 
and McCullough 2009). Pyrogens such as LPS and Poly I:C, produced during bacterial and 
viral infections respectively, can also trigger upregulation of CRACC. Therefore, we propose 
that CRACC can act as a reliable marker of activation for DCs. 
Our investigations into CRACC function were encouraged by the finding that DCs expressed 
only the functional isoform of CRACC. Lacking the essential ITSM, the shorter splice form of 
CRACC was undetectable through RT-PCR of mRNA from immature and activated DCs. We 
were next faced with the uncertainty of EAT-2 expression in DCs. Human MoDCs were 
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ascertained not to express EAT-2 at rest or after challenge with LPS (Tassi and Colonna 
2005). It should also be noted that murine DCs can express EAT-2 (Roncagalli, Taylor et al. 
2005). This is crucial as previous studies have determined that in human NK cells, CRACC 
relies exclusively on the adaptor function of EAT-2 for signal transduction. Over-expression 
of EAT-2, but not SAP, results in phosphorylation of CRACC tyrosine residues (Tassi and 
Colonna 2005). Thus, the absence of EAT-2 in DCs would preclude CRACC signalling and 
render it as a redundant receptor.  
Yet, investigations of CRACC function in B cells may prove otherwise. Notwithstanding that 
EAT-2 is not expressed by human B lymphocytes (Roncagalli, Taylor et al. 2005; Tassi and 
Colonna 2005), a study has demonstrated B cell CRACC ligation to result in the production of 
TNF-α and flt3 ligand (Lee, Mathew et al. 2007). Unfortunately, the authors did not examine 
how CRACC signalling was preserved in the EAT-2-deficient B cells. Perhaps like its murine 
homologue, human B cell CRACC molecules can signal independently of EAT-2 and SAP, by 
an unidentified signalling molecule (Cruz-Munoz, Dong et al. 2009). It may behave like CD84 
by directly recruiting SHP phosphatases for signal transduction (Alvarez-Errico, Oliver-Vila et 
al. 2011). While deeply perplexed on the signalling mechanism of CRACC in DCs, we were 
unable to fully elucidate it in this study due to time constraints.  
We had opted to investigate if CRACC ligation could influence DC function, using CRACC-
transduced cell lines that were already available to us. Cell line-induced CRACC ligation on 
DCs was found to inhibit production of IL-6, IL-8 and IL-12, and the results were reproducible 
using 2 different cell lines. Notably, the effect of CRACC ligation on IL-12 production was 
weak compared to IL-6 and IL-8. This could be attributed to the production range of IL-12 
which was several orders below that of IL-6 and IL-8, thereby making it less discernible. 
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Overall, CRACC ligation appeared to be anti-inflammatory in DCs, without inhibiting TNF-α 
or inducing IL-10 production. To shed light on this peculiarity, we looked at their 
transcriptional requirements. IL-6, IL-8 and IL-12 are NF-κB-responsive genes (Libermann 
and Baltimore 1990; Kunsch and Rosen 1993; Ma, Aste-Amezaga et al. 1996; Baltathakis, 
Alcantara et al. 2001). Initial studies have shown myeloid cells to produce TNF-α following 
LPS challenge and concluded that its transcription was controlled by NF-κB (Beutler, Krochin 
et al. 1986; Bellezzo, Britton et al. 1996). Yet, selective deletions of putative NF-κB binding 
sites or removal of the entire distal TNF-α promoter region did not affect LPS-induced TNF-α 
production (Goldfeld, Doyle et al. 1990; Means, Pavlovich et al. 2000). ChiP assays 
(Schreiber, Jenner et al. 2006; El Gazzar, Yoza et al. 2007) and mice lacking NF-κB subunits 
(Bohuslav, Kravchenko et al. 1998; Wang, Wang et al. 2007) further demonstrated that TNF-
α regulation is independent of NF-κB activation. It is now recognised that TNF-α 
transcription is triggered by NFAT (Falvo, Tsytsykova et al. 2010). Also, IL-10 transcription is 
controlled by SP1 and SP3 (Tone, Powell et al. 2000). Given the differences in induction, 
CRACC selectively blocks production of pro-inflammatory cytokines by interfering with the 
NF-κB pathway. This was confirmed when we observed reduced NF-κB activation in CRACC-
expressing THP-1 monocytic cells compared to control-transduced cells. Since CRACC 
obstructs the NF-κB pathway, we propose that its ligation affects other NF-κB-responsive 
genes and may have profound effects on DCs. We re-examined the microarray results for 
members of the NF-κB and found that NF-κB2, Rel-A and Rel-B all remained 3.5-fold over-
expressed in DenV-infected DCs compared to uninfected or mock-infected DCs, despite 
upregulation of CRACC and its homotypic interaction between infected DCs (data not 
shown). Hence, DenV maintains activation of the NF-κB pathway in infected DCs despite 
interference given by CRACC ligation. 
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Our study focussed solely on cytokine production as a means of functional output of CRACC 
signalling in DCs but did not assay for possible alterations in DC maturation. Since NF-κB 
activation can be denied by CRACC, there may also be downregulated expression of its 
reliant proteins such as MHC and co-stimulatory molecules (Yoshimura, Bondeson et al. 
2001). Thus, we speculate that CRACC ligation impedes DC maturation and promotes 
immunological tolerance. Alternatively, CRACC only participates in a negative feedback loop 
to prevent deleterious over-secretion of cytokines and does not affect DC maturation.  
As SLAM family receptors have been detected to recruit SHP-1, SHP-2 and SHIP 
phosphatases to influence immune responses, we asked if CRACC signalling in DCs had 
occurred independently of EAT-2 through these phosphatases. While SHP-1 and SHP-2 
mediate signalling of myeloid inhibitory receptors such as ILT3 and CD33 (Cella, Dohring et 
al. 1997; Paul, Taylor et al. 2000), they are known to positively regulate myeloid cell 
production of IL-6 and IL-12 (You, Flick et al. 2001; Zhou, Collins et al. 2010; Rego, Kumar et 
al. 2011). Since our results show inhibition of IL-6 and IL-12 production, it is unlikely that 
CRACC had recruited SHP-1 and SHP-2 for signal transduction. In contrast, the presence of 
phosphorylated SHIP negatively influences IL-6 and IL-12 production in murine DCs (Neill, 
Tien et al. 2007; Maeda, Mehta et al. 2010). Furthermore, in bone marrow-derived mast 
cells, SHIP has been demonstrated to inhibit IL-6 production by interfering with NF-κB  
activation (Kalesnikoff, Baur et al. 2002). Although circumstantial, such evidence suggests 
SHIP to be a potential signalling molecule recruited by CRACC for the suppression of NF-κB-




CRACC in the crosstalk between NK cells and DCs 
Although not directly demonstrated in our study, it is reasonable to assume that CRACC 
participates in the crosstalk between NK cells and DCs. In addition, we have shown that NK 
cell expression of CRACC was upregulated in the presence of DenV-infected DCs as well as 
by imDCs, no less. This upregulation of CRACC in NK cells probably serves to increase the 
frequency of its ligation and reinforces the cytotoxic response. This intriguing observation 
also highlights the ability of DCs interact with NK cells in vivo. Because treatment of NK cells 
with IL-2 did not increase expression of CRACC (Lee, Boles et al. 2004), we reverted to its 
induction requirements in DCs – namely the NF-κB pathway. Also, the ligand which 
promoted NK cell CRACC expression must already be present on imDCs. Put together, we 
suspect that NKp30 ligands expressed by DCs are responsible. In support of this hypothesis, 
NKp30 ligation in NK cells has been observed to rapidly activate the NF-κB pathway (Pandey, 
DeStephan et al. 2007). 
It is curious that CRACC stimulates cytotoxicity in NK cells but inhibits DC production of pro-
inflammatory cytokines. Yet, SLAM family receptors have been noted to promote divergent 
immune responses in different cells. We have attempted to reconcile these findings in our 
co-culture system. Upon encounter with pathogens, DCs secrete cytokines such as type I 
IFNs and TNF-α which can self-upregulate CRACC and promote NK cell cytotoxicity. Auto-
ligation of CRACC in DCs is enhanced following the molecule’s upregulated expression and 
further helped by CRACC-bearing NK cells. This may limit pro-inflammatory cytokine 
production in an environment which is already conducive for immune clearance of pathogen. 
On the other hand, DC-produced cytokines and CRACC ligation primes NK cell to clear 
infected cells and secrete IFN-γ. Even though CRACC ligation attenuates DC production of NK 
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cell-activating cytokines (e.g. IL-12), it does not affect secretion of other cytokines such as 
TNF-α. While the transcription of IFN-β is partially driven by NF-κB (Kim and Maniatis 1997), 
the autocrine and paracrine actions of IFN-β on DCs activate IRF7 transcription, which in 
turn drives type I IFN production in a positive feedback loop (Marie, Durbin et al. 1998). The 
availability of TNF-α and type I IFNs, coupled with the inability of CRACC to fully suppress 
cytokine production in DCs, adequately stimulates NK cell activity. 
SLAM-related receptors can function as adhesion molecules – CD84 and NTB-A were shown 
to be involved in the establishment and maintenance of TFH-B cell contacts in the germinal 
centre (Cannons, Qi et al. 2010). Also, 2B4 acts in synergy with LFA-1 in NK cells to bind and 
kill target cells (Riteau, Barber et al. 2003; Bryceson, March et al. 2006). Hence, homophilic 




Conclusions, limitations and future directions 
The multi-faceted immune system continues to fascinate researchers by combining 
precision and malleability in pathogen targeting while constantly sparing the host. The 
integration of signals can already obscure innate immunology at the single cell level. 
Therefore, amalgamating all immune components to form a coherent story in any given 
disease setting by is challenging. Yet, immunologists are striving to decipher the individual 
mechanisms and integrating the pieces in animal models to understand diseases better. 
Dengue is such a disease being worked on. Our study has humbly contributed evidence of 
NK cells in anti-DenV defense; unsurprising, since NK cells are versatile lymphocytes that 
seek and eradicate both infected and transformed cells. Since we have demonstrated their 
antiviral activity, the subsequent questions would be: are NK cells indispensable during 
DenV infections? Are severe DenV infections resultant from maladaptive NK cell responses? 
The difficulty in answering these questions lies in the lack of suitable or accessible animal 
models. 
Because mice are not natural hosts of DenV, they are not readily infectable nor do they  
faithfully replicate disease pathology. DenV researchers therefore rely on immuno-
compromised mice (Zompi and Harris 2012). However, the removal of key immune genes 
such as IFN receptor or RAG makes the study of NK cells unreliable. While non-human 
primates (NHP) also do not develop overt clinical signs after DenV infection (Halstead, 
Shotwell et al. 1973; Marchette, Halstead et al. 1973), intravenous delivery of DenV in high 
doses induces haemorrhage (Onlamoon, Noisakran et al. 2010). As it is possible to 
adoptively transfer or deplete NHP NK cells in vivo (R P. Johnson 2012), further studies on 
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the impact of NK cells, as well as other immune cells, on severe dengue pathology can be 
conducted. 
The co-culture system in this study mitigates some drawbacks of studying dengue in animal 
models, but cannot be representative of DenV infection in vivo. While we have 
demonstrated that NK cells respond to DenV-infected DCs, it is unknown whether NK cells 
actively seek out DenV-infected DCs (or infected non-DC types) in vivo. DenV infection 
induces DC maturation and probably their migration to lymphoid organs as well. Can these 
be major sites of interaction of NK-DC interaction? Subsequently, because the CD56bright NK 
cell subset is enriched in the secondary lymphoid organs (Cooper, Fehniger et al. 2001), 
there may be marked differences in NK cell secretion of IFN-γ and cytolysis of infected DCs. 
Peripheral frequencies of NK cells were observed to be reduced in severe dengue patients 
compared to mild cases (Azeredo, De Oliveira-Pinto et al. 2006). This reduction may be 
explained by the migration of NK cells into tissues and could instead imply that their activity 
could have contributed to dengue severity. Next, MoDCs used in this study are distinct from 
Langerhans cells, which were observed to be infectable in vivo by DenV (Wu, Grouard-Vogel 
et al. 2000). Nevertheless, MoDCs generally resemble dermal/interstitial DCs, in phenotype 
and function, by expression of DC markers (eg. CD80, CD83, CD86, CD1a, DC-SIGN) and 
possessing the ability to phagocytose pathogen, present antigen and prime of naive T cell 
responses (Sallusto and Lanzavecchia 1994; Gluckman, Canque et al. 1997). Lastly, DCs are 
not the sole host for DenV infection and other cell types could have been used as co-culture 
partners for NK cells. Endothelial cells and macrophages have also been demonstrated to be 
infectable by DenV (Carr, Hocking et al. 2003; Wati, Li et al. 2007) and it would be 
informative to investigate whether NK cells also respond to them similarly. 
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The main mechanisms by which naïve human NK cells are activated to produce IFN-γ and 
perform cytotoxicity in response to DenV-infected DCs were revealed. However, several 
questions were left unanswered in our study and present as opportunities for future work. 
We had not fully investigated the role of NCRs in the NK cell response towards DenV-
infected DCs nor were we able to perform additional experiments to elaborate on the co-
receptor role of CRACC in NK cells. Lastly, although we have shown CRACC to down-regulate 
DC secretion of certain cytokines, we did not address whether ligation of the molecule 
affected the cytokine secretion profile of DenV-infected DCs. Did CRACC downregulate 
production of IL-6 and IL-8 in infected DCs? Did CRACC ligation also contribute to the strong 
suppression of IL-12 production? Was CRACC ligation responsible for the impaired 
maturation observed for DenV-infected DCs? Thus, it is imperative that we perform further 
experiments where CRACC molecules are blocked following DC infection to answer these 
questions. 
More importantly, we have described another avenue by which NK cells crosstalk with DCs. 
It is unlikely that the observations of NK cell responses triggered by cytokine synergism and 
CRACC ligation are limited to DenV infections; hence it may be useful to explore the 






Adema, G. J., F. Hartgers, et al. (1997). "A dendritic-cell-derived C-C chemokine that 
preferentially attracts naive T cells." Nature 387(6634): 713-717. 
Agaugue, S., E. Marcenaro, et al. (2008). "Human natural killer cells exposed to IL-2, IL-12, IL-
18, or IL-4 differently modulate priming of naive T cells by monocyte-derived 
dendritic cells." Blood 112(5): 1776-1783. 
Albuquerque, P. L., G. B. Silva Junior, et al. (2009). "Dengue and aplastic anemia--a rare 
association." Travel Med Infect Dis 7(2): 118-120. 
Alcami, A. and G. L. Smith (1995). "Cytokine receptors encoded by poxviruses: a lesson in 
cytokine biology." Immunol Today 16(10): 474-478. 
Alexopoulou, L., A. C. Holt, et al. (2001). "Recognition of double-stranded RNA and 
activation of NF-kappaB by Toll-like receptor 3." Nature 413(6857): 732-738. 
Ali, A., R. Lubong, et al. (2004). "Impacts of epitope expression kinetics and class I 
downregulation on the antiviral activity of human immunodeficiency virus type 1-
specific cytotoxic T lymphocytes." J Virol 78(2): 561-567. 
Alter, G., J. M. Malenfant, et al. (2004). "CD107a as a functional marker for the identification 
of natural killer cell activity." J Immunol Methods 294(1-2): 15-22. 
Alvarez-Errico, D., I. Oliver-Vila, et al. (2011). "CD84 negatively regulates IgE high-affinity 
receptor signaling in human mast cells." J Immunol 187(11): 5577-5586. 
Amberg, S. M., A. Nestorowicz, et al. (1994). "NS2B-3 proteinase-mediated processing in the 
yellow fever virus structural region: in vitro and in vivo studies." J Virol 68(6): 3794-
3802. 
Anderson, R., S. Wang, et al. (1997). "Activation of endothelial cells via antibody-enhanced 
dengue virus infection of peripheral blood monocytes." J Virol 71(6): 4226-4232. 
Andoniou, C. E., S. L. van Dommelen, et al. (2005). "Interaction between conventional 
dendritic cells and natural killer cells is integral to the activation of effective antiviral 
immunity." Nat Immunol 6(10): 1011-1019. 
Andre, P., O. Spertini, et al. (2000). "Modification of P-selectin glycoprotein ligand-1 with a 
natural killer cell-restricted sulfated lactosamine creates an alternate ligand for L-
selectin." Proc Natl Acad Sci U S A 97(7): 3400-3405. 
Ardavin, C., L. Wu, et al. (1993). "Thymic dendritic cells and T cells develop simultaneously in 
the thymus from a common precursor population." Nature 362(6422): 761-763. 
Arico, M., S. Imashuku, et al. (2001). "Hemophagocytic lymphohistiocytosis due to germline 
mutations in SH2D1A, the X-linked lymphoproliferative disease gene." Blood 97(4): 
1131-1133. 
Arnon, T. I., H. Achdout, et al. (2005). "Inhibition of the NKp30 activating receptor by pp65 
of human cytomegalovirus." Nat Immunol 6(5): 515-523. 
Arnon, T. I., M. Lev, et al. (2001). "Recognition of viral hemagglutinins by NKp44 but not by 
NKp30." Eur J Immunol 31(9): 2680-2689. 
Arulanandam, A. R., P. Moingeon, et al. (1993). "A soluble multimeric recombinant CD2 
protein identifies CD48 as a low affinity ligand for human CD2: divergence of CD2 
ligands during the evolution of humans and mice." J Exp Med 177(5): 1439-1450. 
Ashour, J., M. Laurent-Rolle, et al. (2009). "NS5 of dengue virus mediates STAT2 binding and 
degradation." J Virol 83(11): 5408-5418. 
163 
 
Ashour, J., J. Morrison, et al. (2010). "Mouse STAT2 restricts early dengue virus replication." 
Cell Host Microbe 8(5): 410-421. 
Aversa, G., C. C. Chang, et al. (1997). "Engagement of the signaling lymphocytic activation 
molecule (SLAM) on activated T cells results in IL-2-independent, cyclosporin A-
sensitive T cell proliferation and IFN-gamma production." J Immunol 158(9): 4036-
4044. 
Avirutnan, P., R. E. Hauhart, et al. (2011). "Complement-mediated neutralization of dengue 
virus requires mannose-binding lectin." MBio 2(6). 
Avirutnan, P., R. E. Hauhart, et al. (2011). "Binding of flavivirus nonstructural protein NS1 to 
C4b binding protein modulates complement activation." J Immunol 187(1): 424-433. 
Avirutnan, P., N. Punyadee, et al. (2006). "Vascular leakage in severe dengue virus infections: 
a potential role for the nonstructural viral protein NS1 and complement." J Infect Dis 
193(8): 1078-1088. 
Azeredo, E. L., L. M. De Oliveira-Pinto, et al. (2006). "NK cells, displaying early activation, 
cytotoxicity and adhesion molecules, are associated with mild dengue disease." Clin 
Exp Immunol 143(2): 345-356. 
Azeredo, E. L., S. M. Zagne, et al. (2006). "Activated peripheral lymphocytes with increased 
expression of cell adhesion molecules and cytotoxic markers are associated with 
dengue fever disease." Mem Inst Oswaldo Cruz 101(4): 437-449. 
Baltathakis, I., O. Alcantara, et al. (2001). "Expression of different NF-kappaB pathway genes 
in dendritic cells (DCs) or macrophages assessed by gene expression profiling." J Cell 
Biochem 83(2): 281-290. 
Bandyopadhyay, S., L. C. Lum, et al. (2006). "Classifying dengue: a review of the difficulties in 
using the WHO case classification for dengue haemorrhagic fever." Trop Med Int 
Health 11(8): 1238-1255. 
Bartenschlager, R. and S. Miller (2008). "Molecular aspects of Dengue virus replication." 
Future Microbiol 3(2): 155-165. 
Basok, A., A. Shnaider, et al. (2001). "CD40 is expressed on human peritoneal mesothelial 
cells and upregulates the production of interleukin-15 and RANTES." J Am Soc 
Nephrol 12(4): 695-702. 
Basu, S., R. J. Binder, et al. (2000). "Necrotic but not apoptotic cell death releases heat shock 
proteins, which deliver a partial maturation signal to dendritic cells and activate the 
NF-kappa B pathway." Int Immunol 12(11): 1539-1546. 
Becerra, A., R. V. Warke, et al. (2009). "Gene expression profiling of dengue infected human 
primary cells identifies secreted mediators in vivo." J Med Virol 81(8): 1403-1411. 
Bekisz, J., H. Schmeisser, et al. (2004). "Human interferons alpha, beta and omega." Growth 
Factors 22(4): 243-251. 
Bellezzo, J. M., R. S. Britton, et al. (1996). "LPS-mediated NF-kappa beta activation in rat 
Kupffer cells can be induced independently of CD14." Am J Physiol 270(6 Pt 1): G956-
961. 
Berger, S. B., X. Romero, et al. (2010). "SLAM is a microbial sensor that regulates bacterial 
phagosome functions in macrophages." Nat Immunol 11(10): 920-927. 
Beutler, B., N. Krochin, et al. (1986). "Control of cachectin (tumor necrosis factor) synthesis: 
mechanisms of endotoxin resistance." Science 232(4753): 977-980. 
Biassoni, R. (2009). "Human natural killer receptors, co-receptors, and their ligands." Curr 
Protoc Immunol Chapter 14: Unit 14 10. 
164 
 
Billadeau, D. D. and P. J. Leibson (2002). "ITAMs versus ITIMs: striking a balance during cell 
regulation." J Clin Invest 109(2): 161-168. 
Biron, C. A., K. S. Byron, et al. (1989). "Severe herpesvirus infections in an adolescent 
without natural killer cells." N Engl J Med 320(26): 1731-1735. 
Biron, C. A., K. B. Nguyen, et al. (1999). "Natural killer cells in antiviral defense: function and 
regulation by innate cytokines." Annu Rev Immunol 17: 189-220. 
Blasius, A. L. and B. Beutler (2010). "Intracellular toll-like receptors." Immunity 32(3): 305-
315. 
Bleharski, J. R., K. R. Niazi, et al. (2001). "Signaling lymphocytic activation molecule is 
expressed on CD40 ligand-activated dendritic cells and directly augments production 
of inflammatory cytokines." J Immunol 167(6): 3174-3181. 
Boehm, U., T. Klamp, et al. (1997). "Cellular responses to interferon-gamma." Annu Rev 
Immunol 15: 749-795. 
Bohuslav, J., V. V. Kravchenko, et al. (1998). "Regulation of an essential innate immune 
response by the p50 subunit of NF-kappaB." J Clin Invest 102(9): 1645-1652. 
Bokisch, V. A., F. H. Top, Jr., et al. (1973). "The potential pathogenic role of complement in 
dengue hemorrhagic shock syndrome." N Engl J Med 289(19): 996-1000. 
Boles, K. S., S. E. Stepp, et al. (2001). "2B4 (CD244) and CS1: novel members of the CD2 
subset of the immunoglobulin superfamily molecules expressed on natural killer cells 
and other leukocytes." Immunol Rev 181: 234-249. 
Bolland, S. and J. V. Ravetch (1999). "Inhibitory pathways triggered by ITIM-containing 
receptors." Adv Immunol 72: 149-177. 
Bossi, G. and G. M. Griffiths (1999). "Degranulation plays an essential part in regulating cell 
surface expression of Fas ligand in T cells and natural killer cells." Nat Med 5(1): 90-
96. 
Bottino, C., R. Biassoni, et al. (2000). "The human natural cytotoxicity receptors (NCR) that 
induce HLA class I-independent NK cell triggering." Hum Immunol 61(1): 1-6. 
Bottino, C., R. Castriconi, et al. (2003). "Identification of PVR (CD155) and Nectin-2 (CD112) 
as cell surface ligands for the human DNAM-1 (CD226) activating molecule." J Exp 
Med 198(4): 557-567. 
Bottino, C., M. Falco, et al. (2001). "NTB-A [correction of GNTB-A], a novel SH2D1A-
associated surface molecule contributing to the inability of natural killer cells to kill 
Epstein-Barr virus-infected B cells in X-linked lymphoproliferative disease." J Exp Med 
194(3): 235-246. 
Bouchon, A., M. Cella, et al. (2001). "Activation of NK cell-mediated cytotoxicity by a SAP-
independent receptor of the CD2 family." J Immunol 167(10): 5517-5521. 
Bozza, S., R. Gaziano, et al. (2002). "Dendritic cells transport conidia and hyphae of 
Aspergillus fumigatus from the airways to the draining lymph nodes and initiate 
disparate Th responses to the fungus." J Immunol 168(3): 1362-1371. 
Braga, E. L., P. Moura, et al. (2001). "Detection of circulant tumor necrosis factor-alpha, 
soluble tumor necrosis factor p75 and interferon-gamma in Brazilian patients with 
dengue fever and dengue hemorrhagic fever." Mem Inst Oswaldo Cruz 96(2): 229-
232. 
Brandt, C. S., M. Baratin, et al. (2009). "The B7 family member B7-H6 is a tumor cell ligand 




Brocker, T., A. Gulbranson-Judge, et al. (1999). "CD4 T cell traffic control: in vivo evidence 
that ligation of OX40 on CD4 T cells by OX40-ligand expressed on dendritic cells leads 
to the accumulation of CD4 T cells in B follicles." Eur J Immunol 29(5): 1610-1616. 
Brown, M. H., K. Boles, et al. (1998). "2B4, the natural killer and T cell immunoglobulin 
superfamily surface protein, is a ligand for CD48." J Exp Med 188(11): 2083-2090. 
Bryceson, Y. T., M. E. March, et al. (2005). "Cytolytic granule polarization and degranulation 
controlled by different receptors in resting NK cells." J Exp Med 202(7): 1001-1012. 
Bryceson, Y. T., M. E. March, et al. (2006). "Activation, coactivation, and costimulation of 
resting human natural killer cells." Immunol Rev 214: 73-91. 
Bryceson, Y. T., M. E. March, et al. (2006). "Synergy among receptors on resting NK cells for 
the activation of natural cytotoxicity and cytokine secretion." Blood 107(1): 159-166. 
Bugert, J. J., N. V. Melquiot, et al. (2000). "Mapping of mRNA transcripts in the genome of 
molluscum contagiosum virus: transcriptional analysis of the viral slam gene family." 
Virus Genes 21(3): 189-192. 
Burke, D. S., A. Nisalak, et al. (1988). "A prospective study of dengue infections in Bangkok." 
Am J Trop Med Hyg 38(1): 172-180. 
Butthep, P., A. Bunyaratvej, et al. (1993). "Dengue virus and endothelial cell: a related 
phenomenon to thrombocytopenia and granulocytopenia in dengue hemorrhagic 
fever." Southeast Asian J Trop Med Public Health 24 Suppl 1: 246-249. 
Calder, V. L., J. Bondeson, et al. (2003). "Antigen-specific T-cell downregulation by human 
dendritic cells following blockade of NF-kappaB." Scand J Immunol 57(3): 261-270. 
Calpe, S., E. Erdos, et al. (2006). "Identification and characterization of two related murine 
genes, Eat2a and Eat2b, encoding single SH2-domain adapters." Immunogenetics 
58(1): 15-25. 
Calpe, S., N. Wang, et al. (2008). "The SLAM and SAP gene families control innate and 
adaptive immune responses." Adv Immunol 97: 177-250. 
Cannons, J. L., H. Qi, et al. (2010). "Optimal germinal center responses require a multistage T 
cell:B cell adhesion process involving integrins, SLAM-associated protein, and CD84." 
Immunity 32(2): 253-265. 
Cannons, J. L., S. G. Tangye, et al. (2011). "SLAM family receptors and SAP adaptors in 
immunity." Annu Rev Immunol 29: 665-705. 
Cannons, J. L., L. J. Yu, et al. (2004). "SAP regulates T(H)2 differentiation and PKC-theta-
mediated activation of NF-kappaB1." Immunity 21(5): 693-706. 
Cantoni, C., M. Ponassi, et al. (2003). "The three-dimensional structure of the human NK cell 
receptor NKp44, a triggering partner in natural cytotoxicity." Structure 11(6): 725-
734. 
Cao, E., U. A. Ramagopal, et al. (2006). "NTB-A receptor crystal structure: insights into 
homophilic interactions in the signaling lymphocytic activation molecule receptor 
family." Immunity 25(4): 559-570. 
Cardosa, M. J., J. S. Porterfield, et al. (1983). "Complement receptor mediates enhanced 
flavivirus replication in macrophages." J Exp Med 158(1): 258-263. 
Carr, J. M., H. Hocking, et al. (2003). "Supernatants from dengue virus type-2 infected 
macrophages induce permeability changes in endothelial cell monolayers." J Med 
Virol 69(4): 521-528. 
Carson, W. E., J. G. Giri, et al. (1994). "Interleukin (IL) 15 is a novel cytokine that activates 




Cattand, P., P. Desjeux, et al. (2006). "Tropical Diseases Lacking Adequate Control Measures: 
Dengue, Leishmaniasis, and African Trypanosomiasis." 
Caux, C., B. Vanbervliet, et al. (1996). "CD34+ hematopoietic progenitors from human cord 
blood differentiate along two independent dendritic cell pathways in response to 
GM-CSF+TNF alpha." J Exp Med 184(2): 695-706. 
Cella, M., C. Dohring, et al. (1997). "A novel inhibitory receptor (ILT3) expressed on 
monocytes, macrophages, and dendritic cells involved in antigen processing." J Exp 
Med 185(10): 1743-1751. 
Cerwenka, A. and L. L. Lanier (2001). "Ligands for natural killer cell receptors: redundancy or 
specificity." Immunol Rev 181: 158-169. 
Chan, A. H., H. C. Tan, et al. (2012). "A human PrM antibody that recognizes a novel cryptic 
epitope on dengue E glycoprotein." PLoS One 7(4): e33451. 
Chan, B., A. Lanyi, et al. (2003). "SAP couples Fyn to SLAM immune receptors." Nat Cell Biol 
5(2): 155-160. 
Chan, M. and M. A. Johansson (2012). "The incubation periods of dengue viruses." PLoS One 
7(11): e50972. 
Charnsilpa, W., R. Takhampunya, et al. (2005). "Nitric oxide radical suppresses replication of 
wild-type dengue 2 viruses in vitro." J Med Virol 77(1): 89-95. 
Chase, A. J., F. A. Medina, et al. (2011). "Impairment of CD4+ T cell polarization by dengue 
virus-infected dendritic cells." J Infect Dis 203(12): 1763-1774. 
Chaturvedi, U. C., R. Agarwal, et al. (2000). "Cytokine cascade in dengue hemorrhagic fever: 
implications for pathogenesis." FEMS Immunol Med Microbiol 28(3): 183-188. 
Chen, H. C., F. M. Hofman, et al. (2007). "Both virus and tumor necrosis factor alpha are 
critical for endothelium damage in a mouse model of dengue virus -induced 
hemorrhage." J Virol 81(11): 5518-5526. 
Chen, J. P., H. L. Lu, et al. (2006). "Dengue virus induces expression of CXC chemokine lig and 
10/IFN-gamma-inducible protein 10, which competitively inhibits viral binding to cell 
surface heparan sulfate." J Immunol 177(5): 3185-3192. 
Chen, M. C., C. F. Lin, et al. (2009). "Deletion of the C-terminal region of dengue virus 
nonstructural protein 1 (NS1) abolishes anti-NS1-mediated platelet dysfunction and 
bleeding tendency." J Immunol 183(3): 1797-1803. 
Chen, S. T., Y. L. Lin, et al. (2008). "CLEC5A is critical for dengue-virus-induced lethal 
disease." Nature 453(7195): 672-676. 
Chen, Y. C. and S. Y. Wang (2002). "Activation of terminally differentiated human 
monocytes/macrophages by dengue virus: productive infection, hierarchical 
production of innate cytokines and chemokines, and the synergistic effect of 
lipopolysaccharide." J Virol 76(19): 9877-9887. 
Churdboonchart, V., N. Bhamarapravati, et al. (1983). "Crossed immunoelectrophoresis for 
the detection of split products of the third complement in dengue hemorrhagic fever. 
I. Observations in patients' plasma." Am J Trop Med Hyg 32(3): 569-576. 
Clarkson, N. G., S. J. Simmonds, et al. (2007). "Direct and indirect interactions of the 
cytoplasmic region of CD244 (2B4) in mice and humans with FYN kinase." J Biol Chem 
282(35): 25385-25394. 
Clement, M. V., P. Haddad, et al. (1990). "Involvement of granzyme B and perforin gene 




Clyde, K., J. L. Kyle, et al. (2006). "Recent advances in deciphering viral and host 
determinants of dengue virus replication and pathogenesis." J Virol 80(23): 11418-
11431. 
Cocks, B. G., C. C. Chang, et al. (1995). "A novel receptor involved in T-cell activation." 
Nature 376(6537): 260-263. 
Colonna, M., G. Trinchieri, et al. (2004). "Plasmacytoid dendritic cells in immunity." Nat 
Immunol 5(12): 1219-1226. 
Content, J. (2009). "Mechanisms of induction and action of interferons." Verh K Acad 
Geneeskd Belg 71(1-2): 51-71. 
Cooper, M. A., J. M. Elliott, et al. (2009). "Cytokine-induced memory-like natural killer cells." 
Proc Natl Acad Sci U S A 106(6): 1915-1919. 
Cooper, M. A., T. A. Fehniger, et al. (2001). "The biology of human natural killer-cell 
subsets." Trends Immunol 22(11): 633-640. 
Cooper, M. A., T. A. Fehniger, et al. (2001). "Human natural killer cells: a unique innate 
immunoregulatory role for the CD56(bright) subset." Blood 97(10): 3146-3151. 
Crabe, S., A. Guay-Giroux, et al. (2009). "The IL-27 p28 subunit binds cytokine-like factor 1 to 
form a cytokine regulating NK and T cell activities requiring IL-6R for signaling." J 
Immunol 183(12): 7692-7702. 
Cruz-Munoz, M. E., Z. Dong, et al. (2009). "Influence of CRACC, a SLAM family receptor 
coupled to the adaptor EAT-2, on natural killer cell function." Nat Immunol 10(3): 
297-305. 
Cyster, J. G. (2010). "B cell follicles and antigen encounters of the third kind." Nat Immunol  
11(11): 989-996. 
Daffis, S., M. A. Samuel, et al. (2008). "Toll-like receptor 3 has a protective role against West 
Nile virus infection." J Virol 82(21): 10349-10358. 
de-Oliveira-Pinto, L. M., M. Gandini, et al. (2012). "Profile of circulating levels of IL-1Ra, 
CXCL10/IP-10, CCL4/MIP-1beta and CCL2/MCP-1 in dengue fever and parvovirosis." 
Mem Inst Oswaldo Cruz 107(1): 48-56. 
De Carvalho Bittencourt, M., J. Martial, et al. (2012). "Decreased peripheral dendritic cell 
numbers in dengue virus infection." J Clin Immunol 32(1): 161-172. 
de la Fuente, M. A., V. Tovar, et al. (2001). "Molecular characterization and expression of a 
novel human leukocyte cell-surface marker homologous to mouse Ly-9." Blood 
97(11): 3513-3520. 
Dejnirattisai, W., T. Duangchinda, et al. (2008). "A complex interplay among virus, dendritic 
cells, T cells, and cytokines in dengue virus infections." J Immunol 181(9): 5865-5874. 
Del Valle, J. M., P. Engel, et al. (2003). "The cell surface expression of SAP-binding receptor 
CD229 is regulated via its interaction with clathrin-associated adaptor complex 2 (AP-
2)." J Biol Chem 278(19): 17430-17437. 
Demangel, C., P. Bertolino, et al. (2002). "Autocrine IL-10 impairs dendritic cell (DC)-derived 
immune responses to mycobacterial infection by suppressing DC trafficking to 
draining lymph nodes and local IL-12 production." Eur J Immunol 32(4): 994-1002. 
Dennehy, K. M., S. N. Klimosch, et al. (2011). "Cutting edge: NKp80 uses an atypical hemi-
ITAM to trigger NK cytotoxicity." J Immunol 186(2): 657-661. 
Denzer, K., M. van Eijk, et al. (2000). "Follicular dendritic cells carry MHC class II-expressing 
microvesicles at their surface." J Immunol 165(3): 1259-1265. 
Diamond, M. S., T. G. Roberts, et al. (2000). "Modulation of Dengue virus infection in human 
cells by alpha, beta, and gamma interferons." J Virol 74(11): 4957-4966. 
168 
 
Diebold, S. S. (2008). "Recognition of viral single-stranded RNA by Toll-like receptors." Adv 
Drug Deliv Rev 60(7): 813-823. 
Dieu-Nosjean, M. C., A. Vicari, et al. (1999). "Regulation of dendritic cell trafficking: a 
process that involves the participation of selective chemokines." J Leukoc Biol 66(2): 
252-262. 
Dolganiuc, A., K. Kodys, et al. (2012). "Type III Interferons, IL-28 and IL-29, Are Increased in 
Chronic HCV Infection and Induce Myeloid Dendritic Cell-Mediated FoxP3+ 
Regulatory T Cells." PLoS One 7(10): e44915. 
Draghi, M., A. Pashine, et al. (2007). "NKp46 and NKG2D recognition of infected dendritic 
cells is necessary for NK cell activation in the human response to influenza infection." 
J Immunol 178(5): 2688-2698. 
Eissmann, P., L. Beauchamp, et al. (2005). "Molecular basis for positive and negative 
signaling by the natural killer cell receptor 2B4 (CD244)." Blood 105(12): 4722-4729. 
Eissmann, P. and C. Watzl (2006). "Molecular analysis of NTB-A signaling: a role for EAT-2 in 
NTB-A-mediated activation of human NK cells." J Immunol 177(5): 3170-3177. 
El Gazzar, M., B. K. Yoza, et al. (2007). "Epigenetic silencing of tumor necrosis factor alpha 
during endotoxin tolerance." J Biol Chem 282(37): 26857-26864. 
Endt, J., P. Eissmann, et al. (2007). "Modulation of 2B4 (CD244) activity and regulated SAP 
expression in human NK cells." Eur J Immunol 37(1): 193-198. 
Endy, T. P., A. Nisalak, et al. (2004). "Relationship of preexisting dengue virus (DV) 
neutralizing antibody levels to viremia and severity of disease in a prospective cohort 
study of DV infection in Thailand." J Infect Dis 189(6): 990-1000. 
Engel, P., M. J. Eck, et al. (2003). "The SAP and SLAM families in immune responses and X-
linked lymphoproliferative disease." Nat Rev Immunol 3(10): 813-821. 
Fadilah, S. A. and S. K. Cheong (2007). "Dendritic cell immunobiology and potential roles in 
immunotherapy." Malays J Pathol 29(1): 1-18. 
Fadilah, S. A., S. Sahrir, et al. (1999). "Quantitation of T lymphocyte subsets helps to 
distinguish dengue hemorrhagic fever from classic dengue fever during the acute 
febrile stage." Southeast Asian J Trop Med Public Health 30(4): 710-717. 
Fagundes, C. T., V. V. Costa, et al. (2011). "IFN-gamma production depends on IL-12 and IL-
18 combined action and mediates host resistance to dengue virus infection in a nitric 
oxide-dependent manner." PLoS Negl Trop Dis 5(12): e1449. 
Falco, M., E. Marcenaro, et al. (2004). "Homophilic interaction of NTBA, a member of the 
CD2 molecular family: induction of cytotoxicity and cytokine release in human NK 
cells." Eur J Immunol 34(6): 1663-1672. 
Falconar, A. K. (1997). "The dengue virus nonstructural-1 protein (NS1) generates antibodies 
to common epitopes on human blood clotting, integrin/adhesin proteins and binds 
to human endothelial cells: potential implications in haemorrhagic fever 
pathogenesis." Arch Virol 142(5): 897-916. 
Falgout, B., M. Pethel, et al. (1991). "Both nonstructural proteins NS2B and NS3 are required 
for the proteolytic processing of dengue virus nonstructural proteins." J Virol 65(5): 
2467-2475. 
Falschlehner, C., U. Schaefer, et al. (2009). "Following TRAIL's path in the immune system." 
Immunology 127(2): 145-154. 
Falvo, J. V., A. V. Tsytsykova, et al. (2010). "Transcriptional control of the TNF gene." Curr Dir 
Autoimmun 11: 27-60. 
169 
 
Fehniger, T. A., M. H. Shah, et al. (1999). "Differential cytokine and chemokine gene 
expression by human NK cells following activation with IL-18 or IL-15 in combination 
with IL-12: implications for the innate immune response." J Immunol 162(8): 4511-
4520. 
Ferlazzo, G., B. Morandi, et al. (2003). "The interaction between NK cells and dendritic cells 
in bacterial infections results in rapid induction of NK cell activation and in the lysis 
of uninfected dendritic cells." Eur J Immunol 33(2): 306-313. 
Ferlazzo, G., M. L. Tsang, et al. (2002). "Human dendritic cells activate resting natural killer 
(NK) cells and are recognized via the NKp30 receptor by activated NK cells." J Exp 
Med 195(3): 343-351. 
Fernandez-Mestre, M. T., K. Gendzekhadze, et al. (2004). "TNF-alpha-308A allele, a possible 
severity risk factor of hemorrhagic manifestation in dengue fever patients." Tissue 
Antigens 64(4): 469-472. 
Fernandez, N. C., A. Lozier, et al. (1999). "Dendritic cells directly trigger NK cell functions: 
cross-talk relevant in innate anti-tumor immune responses in vivo." Nat Med 5(4): 
405-411. 
Flaig, R. M., S. Stark, et al. (2004). "Cutting edge: NTB-A activates NK cells via homophilic 
interaction." J Immunol 172(11): 6524-6527. 
Flamand, M., F. Megret, et al. (1999). "Dengue virus type 1 nonstructural glycoprotein NS1 is 
secreted from mammalian cells as a soluble hexamer in a glycosylation-dependent 
fashion." J Virol 73(7): 6104-6110. 
Frasca, L., M. Nasso, et al. (2008). "IFN-gamma arms human dendritic cells to perform 
multiple effector functions." J Immunol 180(3): 1471-1481. 
Fu, X. Y., C. Schindler, et al. (1992). "The proteins of ISGF-3, the interferon alpha-induced 
transcriptional activator, define a gene family involved in signal transduction." Proc 
Natl Acad Sci U S A 89(16): 7840-7843. 
Fugier-Vivier, I., C. Servet-Delprat, et al. (1997). "Measles virus suppresses cell-mediated 
immunity by interfering with the survival and functions of dendritic and T cells." J 
Exp Med 186(6): 813-823. 
Gagnon, S. J., F. A. Ennis, et al. (1999). "Bystander target cell lysis and cytokine production 
by dengue virus-specific human CD4(+) cytotoxic T-lymphocyte clones." J Virol 73(5): 
3623-3629. 
Gagnon, S. J., W. Zeng, et al. (1996). "Identification of two epitopes on the dengue 4 virus 
capsid protein recognized by a serotype-specific and a panel of serotype-cross-
reactive human CD4+ cytotoxic T-lymphocyte clones." J Virol 70(1): 141-147. 
Garcia-Bates, T. M., M. T. Cordeiro, et al. (2013). "Association between Magnitude of the 
Virus-Specific Plasmablast Response and Disease Severity in Dengue Patients." J 
Immunol 190(1): 80-87. 
Garg, A., P. F. Barnes, et al. (2006). "Vimentin expressed on Mycobacterium tuberculosis -
infected human monocytes is involved in binding to the NKp46 receptor." J Immunol  
177(9): 6192-6198. 
Garni-Wagner, B. A., A. Purohit, et al. (1993). "A novel function-associated molecule related 
to non-MHC-restricted cytotoxicity mediated by activated natural killer cells and T 
cells." J Immunol 151(1): 60-70. 
Gasser, S., S. Orsulic, et al. (2005). "The DNA damage pathway regulates innate immune 
system ligands of the NKG2D receptor." Nature 436(7054): 1186-1190. 
170 
 
Gatti, E., M. A. Velleca, et al. (2000). "Large-scale culture and selective maturation of human 
Langerhans cells from granulocyte colony-stimulating factor-mobilized CD34+ 
progenitors." J Immunol 164(7): 3600-3607. 
Ge, M. Q., A. W. Ho, et al. (2012). "NK cells regulate CD8+ T cell priming and dendritic cell 
migration during influenza A infection by IFN-gamma and perforin-dependent 
mechanisms." J Immunol 189(5): 2099-2109. 
Gerosa, F., B. Baldani-Guerra, et al. (2002). "Reciprocal activating interaction between 
natural killer cells and dendritic cells." J Exp Med 195(3): 327-333. 
Giri, J. G., M. Ahdieh, et al. (1994). "Utilization of the beta and gamma chains of the IL -2 
receptor by the novel cytokine IL-15." EMBO J 13(12): 2822-2830. 
Gluckman, J. C., B. Canque, et al. (1997). "In vitro generation of human dendritic cells and 
cell therapy." Cytokines Cell Mol Ther 3(3): 187-196. 
Goldfeld, A. E., C. Doyle, et al. (1990). "Human tumor necrosis factor alpha gene regulation 
by virus and lipopolysaccharide." Proc Natl Acad Sci U S A 87(24): 9769-9773. 
Goodbourn, S., L. Didcock, et al. (2000). "Interferons: cell signalling, immune modulation, 
antiviral response and virus countermeasures." J Gen Virol 81(Pt 10): 2341-2364. 
Graham, D. B., M. P. Bell, et al. (2006). "Ly9 (CD229)-deficient mice exhibit T cell defects yet 
do not share several phenotypic characteristics associated with SLAM- and SAP-
deficient mice." J Immunol 176(1): 291-300. 
Green, S., S. Pichyangkul, et al. (1999). "Early CD69 expression on peripheral blood 
lymphocytes from children with dengue hemorrhagic fever." J Infect Dis 180(5): 
1429-1435. 
Green, S., D. W. Vaughn, et al. (1999). "Early immune activation in acute dengue illness is 
related to development of plasma leakage and disease severity." J Infect Dis 179(4): 
755-762. 
Green, S., D. W. Vaughn, et al. (1999). "Elevated plasma interleukin-10 levels in acute 
dengue correlate with disease severity." J Med Virol 59(3): 329-334. 
Griewank, K., C. Borowski, et al. (2007). "Homotypic interactions mediated by Slamf1 and 
Slamf6 receptors control NKT cell lineage development." Immunity 27(5): 751-762. 
Gunturi, A., R. E. Berg, et al. (2004). "The role of CD94/NKG2 in innate and adaptive 
immunity." Immunol Res 30(1): 29-34. 
Hackstein, H., A. Knoche, et al. (2011). "The TLR7/8 ligand resiquimod targets monocyte-
derived dendritic cell differentiation via TLR8 and augments functional dendritic cell 
generation." Cell Immunol 271(2): 401-412. 
Halstead, S. B. (1979). "In vivo enhancement of dengue virus infection in rhesus monkeys by 
passively transferred antibody." J Infect Dis 140(4): 527-533. 
Halstead, S. B. (2007). "Dengue." Lancet 370(9599): 1644-1652. 
Halstead, S. B. (2008). "Dengue virus-mosquito interactions." Annu Rev Entomol 53: 273-291.  
Halstead, S. B., S. Nimmannitya, et al. (1970). "Observations related to pathogenesis of 
dengue hemorrhagic fever. IV. Relation of disease severity to antibody response and 
virus recovered." Yale J Biol Med 42(5): 311-328. 
Halstead, S. B., H. Shotwell, et al. (1973). "Studies on the pathogenesis of dengue infection 
in monkeys. I. Clinical laboratory responses to primary infection." J Infect Dis 128(1): 
7-14. 
Hamann, J., K. T. Montgomery, et al. (1997). "AICL: a new activation-induced antigen 
encoded by the human NK gene complex." Immunogenetics 45(5): 295-300. 
171 
 
Hanna, J., D. Goldman-Wohl, et al. (2006). "Decidual NK cells regulate key developmental 
processes at the human fetal-maternal interface." Nat Med 12(9): 1065-1074. 
Hartmann, J., T. V. Tran, et al. (2012). "The stalk domain and the glycosylation status of the 
activating natural killer cell receptor NKp30 are important for ligand binding." J Biol 
Chem 287(37): 31527-31539. 
Hemmi, H., T. Kaisho, et al. (2003). "The roles of Toll-like receptor 9, MyD88, and DNA-
dependent protein kinase catalytic subunit in the effects of two distinct CpG DNAs 
on dendritic cell subsets." J Immunol 170(6): 3059-3064. 
Hengel, H., T. Flohr, et al. (1996). "Human cytomegalovirus inhibits peptide translocation 
into the endoplasmic reticulum for MHC class I assembly." J Gen Virol 77 ( Pt 9): 
2287-2296. 
Herrero, L. J., A. Zakhary, et al. (2012). "Dengue virus therapeutic intervention strategies 
based on viral, vector and host factors involved in disease pathogenesis." Pharmacol 
Ther. 
Hershkovitz, O., B. Rosental, et al. (2009). "NKp44 receptor mediates interaction of the 
envelope glycoproteins from the West Nile and dengue viruses with NK cells." J 
Immunol 183(4): 2610-2621. 
Hidari, K. I. and T. Suzuki (2011). "Dengue virus receptor." Trop Med Health 39(4 Suppl): 37-
43. 
Hildenbrand, B., D. Lorenzen, et al. (2008). "IFN-y enhances T(H)1 polarisation of monocyte-
derived dendritic cells matured with clinical-grade cytokines using serum-free 
conditions." Anticancer Res 28(3A): 1467-1476. 
Ho, L. J., J. J. Wang, et al. (2001). "Infection of human dendritic cells by dengue virus causes 
cell maturation and cytokine production." J Immunol 166(3): 1499-1506. 
Hoang, L. T., D. J. Lynn, et al. (2010). "The early whole-blood transcriptional signature of 
dengue virus and features associated with progression to dengue shock syndrome in 
Vietnamese children and young adults." J Virol 84(24): 12982-12994. 
Hori, H. and C. J. Lai (1990). "Cleavage of dengue virus NS1-NS2A requires an octapeptide 
sequence at the C terminus of NS1." J Virol 64(9): 4573-4577. 
Howie, D., F. S. Laroux, et al. (2005). "Cutting edge: the SLAM family receptor Ly108 controls 
T cell and neutrophil functions." J Immunol 174(10): 5931-5935. 
Howie, D., S. Okamoto, et al. (2002). "The role of SAP in murine CD150 (SLAM)-mediated T-
cell proliferation and interferon gamma production." Blood 100(8): 2899-2907. 
Howie, D., M. Simarro, et al. (2002). "Molecular dissection of the signaling and costimulatory 
functions of CD150 (SLAM): CD150/SAP binding and CD150-mediated costimulation." 
Blood 99(3): 957-965. 
Huang, K. J., S. Y. Li, et al. (2000). "Manifestation of thrombocytopenia in dengue-2-virus-
infected mice." J Gen Virol 81(Pt 9): 2177-2182. 
Hunter, C. A., K. E. Gabriel, et al. (1997). "Type I interferons enhance production of IFN-
gamma by NK cells." Immunol Lett 59(1): 1-5. 
Hyodo, Y., K. Matsui, et al. (1999). "IL-18 up-regulates perforin-mediated NK activity without 
increasing perforin messenger RNA expression by binding to constitutively expressed 
IL-18 receptor." J Immunol 162(3): 1662-1668. 
Isomaki, P., G. Aversa, et al. (1999). "Expression of soluble human signaling lymphocytic 
activation molecule in vivo." J Allergy Clin Immunol 103(1 Pt 1): 114-118. 
172 
 
Ito, T., Y. H. Wang, et al. (2005). "Plasmacytoid dendritic cell precursors/type I interferon-
producing cells sense viral infection by Toll-like receptor (TLR) 7 and TLR9." Springer 
Semin Immunopathol 26(3): 221-229. 
Iyngkaran, N., M. Yadav, et al. (1995). "Augmented inflammatory cytokines in primary 
dengue infection progressing to shock." Singapore Med J 36(2): 218-221. 
Jansen, C. C. and N. W. Beebe (2010). "The dengue vector Aedes aegypti: what comes next." 
Microbes Infect 12(4): 272-279. 
Janssen, O., J. Qian, et al. (2003). "CD95 ligand--death factor and costimulatory molecule?" 
Cell Death Differ 10(11): 1215-1225. 
Jarahian, M., C. Watzl, et al. (2009). "Activation of natural killer cells by newcastle disease 
virus hemagglutinin-neuraminidase." J Virol 83(16): 8108-8121. 
Johnson, A. J. and J. T. Roehrig (1999). "New mouse model for dengue virus vaccine testing." 
J Virol 73(1): 783-786. 
Joncas, J., Y. Monczak, et al. (1989). "Brief report: killer cell defect and persistent 
immunological abnormalities in two patients with chronic active Epstein-Barr virus 
infection." J Med Virol 28(2): 110-117. 
Jonuleit, H., E. Schmitt, et al. (2000). "Induction of interleukin 10-producing, 
nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation 
with allogeneic immature human dendritic cells." J Exp Med 192(9): 1213-1222. 
Joyce, M. G. and P. D. Sun (2011). "The structural basis of ligand recognition by natural killer 
cell receptors." J Biomed Biotechnol 2011: 203628. 
Juffrie, M., G. M. van Der Meer, et al. (2000). "Inflammatory mediators in dengue virus 
infection in children: interleukin-8 and its relationship to neutrophil degranulation." 
Infect Immun 68(2): 702-707. 
Kalesnikoff, J., N. Baur, et al. (2002). "SHIP negatively regulates IgE + antigen-induced IL-6 
production in mast cells by inhibiting NF-kappa B activity." J Immunol 168(9): 4737-
4746. 
Kamper, N., S. Franken, et al. (2012). "gamma-Interferon-regulated chaperone governs 
human lymphocyte antigen class II expression." FASEB J 26(1): 104-116. 
Kanai, R., K. Kar, et al. (2006). "Crystal structure of west nile virus envelope glycoprotein 
reveals viral surface epitopes." J Virol 80(22): 11000-11008. 
Kang, J. W., S. C. Choi, et al. (2009). "A proinflammatory cytokine interleukin-32beta 
promotes the production of an anti-inflammatory cytokine interleukin-10." 
Immunology 128(1 Suppl): e532-540. 
Kastelein, R. A., C. A. Hunter, et al. (2007). "Discovery and biology of IL-23 and IL-27: related 
but functionally distinct regulators of inflammation." Annu Rev Immunol 25: 221-242.  
Kato, N., J. Tanaka, et al. (2007). "Regulation of the expression of MHC class I-related chain A, 
B (MICA, MICB) via chromatin remodeling and its impact on the susceptibility of 
leukemic cells to the cytotoxicity of NKG2D-expressing cells." Leukemia 21(10): 2103-
2108. 
Katou, F., H. Ohtani, et al. (2001). "Macrophage-derived chemokine (MDC/CCL22) and CCR4 
are involved in the formation of T lymphocyte-dendritic cell clusters in human 
inflamed skin and secondary lymphoid tissue." Am J Pathol 158(4): 1263-1270. 
Keating, S. E., G. M. Maloney, et al. (2007). "IRAK-2 participates in multiple toll-like receptor 




Kim, T. K. and T. Maniatis (1997). "The mechanism of transcriptional synergy of an in vitro 
assembled interferon-beta enhanceosome." Mol Cell 1(1): 119-129. 
Kingsbury, G. A., L. A. Feeney, et al. (2001). "Cloning, expression, and function of BLAME, a 
novel member of the CD2 family." J Immunol 166(9): 5675-5680. 
Kliks, S. C., S. Nimmanitya, et al. (1988). "Evidence that maternal dengue antibodies are 
important in the development of dengue hemorrhagic fever in infants." Am J Trop 
Med Hyg 38(2): 411-419. 
Koh, B. K., L. C. Ng, et al. (2008). "The 2005 dengue epidemic in Singapore: epidemiology, 
prevention and control." Ann Acad Med Singapore 37(7): 538-545. 
Kotenko, S. V. (2011). "IFN-lambdas." Curr Opin Immunol 23(5): 583-590. 
Kou, Z., M. Quinn, et al. (2008). "Monocytes, but not T or B cells, are the principal target 
cells for dengue virus (DV) infection among human peripheral blood mononuclear 
cells." J Med Virol 80(1): 134-146. 
Kumar, K. R., L. Li, et al. (2006). "Regulation of B cell tolerance by the lupus susceptibility 
gene Ly108." Science 312(5780): 1665-1669. 
Kumaresan, P. R., W. C. Lai, et al. (2002). "CS1, a novel member of the CD2 family, is 
homophilic and regulates NK cell function." Mol Immunol 39(1-2): 1-8. 
Kumaresan, P. R. and P. A. Mathew (2000). "Structure of the human natural killer cell 
receptor 2B4 gene and identification of a novel alternative transcript." 
Immunogenetics 51(11): 987-992. 
Kunsch, C. and C. A. Rosen (1993). "NF-kappa B subunit-specific regulation of the 
interleukin-8 promoter." Mol Cell Biol 13(10): 6137-6146. 
Kurane, I., M. A. Brinton, et al. (1991). "Dengue virus-specific, human CD4+ CD8- cytotoxic T-
cell clones: multiple patterns of virus cross-reactivity recognized by NS3-specific T-
cell clones." J Virol 65(4): 1823-1828. 
Kurane, I., L. C. Dai, et al. (1993). "Definition of an HLA-DPw2-restricted epitope on NS3, 
recognized by a dengue virus serotype-cross-reactive human CD4+ CD8- cytotoxic T-
cell clone." J Virol 67(10): 6285-6288. 
Kurane, I., D. Hebblewaite, et al. (1984). "Lysis of dengue virus-infected cells by natural cell-
mediated cytotoxicity and antibody-dependent cell-mediated cytotoxicity." J Virol  
52(1): 223-230. 
Kurosu, T., P. Chaichana, et al. (2007). "Secreted complement regulatory protein clusterin 
interacts with dengue virus nonstructural protein 1." Biochem Biophys Res Commun 
362(4): 1051-1056. 
Kushwah, R. and J. Hu (2011). "Complexity of dendritic cell subsets and their function in the 
host immune system." Immunology 133(4): 409-419. 
La Russa, V. F. and B. L. Innis (1995). "Mechanisms of dengue virus -induced bone marrow 
suppression." Baillieres Clin Haematol 8(1): 249-270. 
Lanier, L. L. (2009). "DAP10- and DAP12-associated receptors in innate immunity." Immunol 
Rev 227(1): 150-160. 
Le Drean, E., F. Vely, et al. (1998). "Inhibition of antigen-induced T cell response and 
antibody-induced NK cell cytotoxicity by NKG2A: association of NKG2A with SHP-1 
and SHP-2 protein-tyrosine phosphatases." Eur J Immunol 28(1): 264-276. 
Leclerc, C., E. Deriaud, et al. (1993). "Identification of helper T cell epitopes of dengue virus 
E-protein." Mol Immunol 30(7): 613-625. 
174 
 
Lee, J. K., K. S. Boles, et al. (2004). "Molecular and functional characterization of a CS1 
(CRACC) splice variant expressed in human NK cells that does not contain 
immunoreceptor tyrosine-based switch motifs." Eur J Immunol 34(10): 2791-2799. 
Lee, J. K., S. O. Mathew, et al. (2007). "CS1 (CRACC, CD319) induces proliferation and 
autocrine cytokine expression on human B lymphocytes." J Immunol 179(7): 4672-
4678. 
Lee, K. M., J. P. Forman, et al. (2006). "Requirement of homotypic NK-cell interactions 
through 2B4(CD244)/CD48 in the generation of NK effector functions." Blood 107(8): 
3181-3188. 
Lee, K. M., M. E. McNerney, et al. (2004). "2B4 acts as a non-major histocompatibility 
complex binding inhibitory receptor on mouse natural killer cells." J Exp Med 199(9): 
1245-1254. 
Lee, K. S., Y. L. Lai, et al. (2010). "Dengue virus surveillance for early warning, Singapore." 
Emerg Infect Dis 16(5): 847-849. 
Lettau, M., M. Paulsen, et al. (2008). "Storage, expression and function of Fas ligand, the key 
death factor of immune cells." Curr Med Chem 15(17): 1684-1696. 
Lettau, M., M. Paulsen, et al. (2009). "FasL expression and reverse signalling." Results Probl 
Cell Differ 49: 49-61. 
Libermann, T. A. and D. Baltimore (1990). "Activation of interleukin-6 gene expression 
through the NF-kappa B transcription factor." Mol Cell Biol 10(5): 2327-2334. 
Libraty, D. H., S. Pichyangkul, et al. (2001). "Human dendritic cells are activated by dengue 
virus infection: enhancement by gamma interferon and implications for disease 
pathogenesis." J Virol 75(8): 3501-3508. 
Lin, C. F., S. C. Chiu, et al. (2005). "Expression of cytokine, chemokine, and adhesion 
molecules during endothelial cell activation induced by antibodies against dengue 
virus nonstructural protein 1." J Immunol 174(1): 395-403. 
Lin, C. F., H. Y. Lei, et al. (2001). "Generation of IgM anti-platelet autoantibody in dengue 
patients." J Med Virol 63(2): 143-149. 
Lin, Y. W., K. J. Wang, et al. (2002). "Virus replication and cytokine production in dengue 
virus-infected human B lymphocytes." J Virol 76(23): 12242-12249. 
Lindenbach, B. D. and C. M. Rice (1999). "Genetic interaction of flavivirus nonstructural 
proteins NS1 and NS4A as a determinant of replicase function." J Virol 73(6): 4611-
4621. 
Ljunggren, H. G. and K. Karre (1990). "In search of the 'missing self': MHC molecules and NK 
cell recognition." Immunol Today 11(7): 237-244. 
Lohr, J., B. Knoechel, et al. (2004). "Role of B7 in T cell tolerance." J Immunol 173(8): 5028-
5035. 
Loo, Y. M. and M. Gale, Jr. (2011). "Immune signaling by RIG-I-like receptors." Immunity 
34(5): 680-692. 
Lopez, A. S., E. Alegre, et al. (2006). "Regulatory role of tryptophan degradation pathway in 
HLA-G expression by human monocyte-derived dendritic cells." Mol Immunol 43(14): 
2151-2160. 
Lozach, P. Y., L. Burleigh, et al. (2005). "Dendritic cell-specific intercellular adhesion 
molecule 3-grabbing non-integrin (DC-SIGN)-mediated enhancement of dengue virus 




Lucas, M., W. Schachterle, et al. (2007). "Dendritic cells prime natural killer cells by trans -
presenting interleukin 15." Immunity 26(4): 503-517. 
Luft, T., P. Luetjens, et al. (2002). "IFN-alpha enhances CD40 ligand-mediated activation of 
immature monocyte-derived dendritic cells." Int Immunol 14(4): 367-380. 
Luplertlop, N., D. Misse, et al. (2006). "Dengue-virus-infected dendritic cells trigger vascular 
leakage through metalloproteinase overproduction." EMBO Rep 7(11): 1176-1181. 
Lutz, M. B. (2004). "IL-3 in dendritic cell development and function: a comparison with GM-
CSF and IL-4." Immunobiology 209(1-2): 79-87. 
Ma, X., M. Aste-Amezaga, et al. (1996). "Regulation of interleukin-12 production." Ann N Y 
Acad Sci 795: 13-25. 
MacDonald, A. S., A. D. Straw, et al. (2002). "Cutting edge: Th2 response induction by 
dendritic cells: a role for CD40." J Immunol 168(2): 537-540. 
Mackensen, A., B. Herbst, et al. (1995). "Delineation of the dendritic cell lineage by 
generating large numbers of Birbeck granule-positive Langerhans cells from human 
peripheral blood progenitor cells in vitro." Blood 86(7): 2699-2707. 
Mady, B. J., D. V. Erbe, et al. (1991). "Antibody-dependent enhancement of dengue virus 
infection mediated by bispecific antibodies against cell surface molecules other than 
Fc gamma receptors." J Immunol 147(9): 3139-3144. 
Maeda, K., H. Mehta, et al. (2010). "IL-6 increases B-cell IgG production in a feed-forward 
proinflammatory mechanism to skew hematopoiesis and elevate myeloid 
production." Blood 115(23): 4699-4706. 
Magri, G., A. Muntasell, et al. (2011). "NKp46 and DNAM-1 NK-cell receptors drive the 
response to human cytomegalovirus-infected myeloid dendritic cells overcoming 
viral immune evasion strategies." Blood 117(3): 848-856. 
Mailliard, R. B., S. M. Alber, et al. (2005). "IL-18-induced CD83+CCR7+ NK helper cells." J Exp 
Med 202(7): 941-953. 
Mandelboim, O., N. Lieberman, et al. (2001). "Recognition of haemagglutinins on virus -
infected cells by NKp46 activates lysis by human NK cells." Nature 409(6823): 1055-
1060. 
Marcenaro, E., B. Ferranti, et al. (2005). "NK-DC interaction: on the usefulness of auto-
aggression." Autoimmun Rev 4(8): 520-525. 
Marchette, N. J., S. B. Halstead, et al. (1973). "Studies on the pathogenesis of dengue 
infection in monkeys. 3. Sequential distribution of virus in primary and heterologous 
infections." J Infect Dis 128(1): 23-30. 
Marie, I., J. E. Durbin, et al. (1998). "Differential viral induction of distinct interferon-alpha 
genes by positive feedback through interferon regulatory factor-7." EMBO J 17(22): 
6660-6669. 
Maris, C. H., C. P. Chappell, et al. (2007). "Interleukin-10 plays an early role in generating 
virus-specific T cell anergy." BMC Immunol 8: 8. 
Marshall, J. D., D. S. Heeke, et al. (2006). "Induction of interferon-gamma from natural killer 
cells by immunostimulatory CpG DNA is mediated through plasmacytoid-dendritic-
cell-produced interferon-alpha and tumour necrosis factor-alpha." Immunology 
117(1): 38-46. 
Martin, M., J. M. Del Valle, et al. (2005). "Identification of Grb2 as a novel binding partner of 
the signaling lymphocytic activation molecule-associated protein binding receptor 
CD229." J Immunol 174(10): 5977-5986. 
176 
 
Martins Sde, T., G. F. Silveira, et al. (2012). "Dendritic cell apoptosis and the pathogenesis of 
dengue." Viruses 4(11): 2736-2753. 
Marzio, R., J. Mauel, et al. (1999). "CD69 and regulation of the immune function." 
Immunopharmacol Immunotoxicol 21(3): 565-582. 
Mathew, A., I. Kurane, et al. (1999). "Impaired T cell proliferation in acute dengue infection." 
J Immunol 162(9): 5609-5615. 
Mathew, A., I. Kurane, et al. (1996). "Dominant recognition by human CD8+ cytotoxic T 
lymphocytes of dengue virus nonstructural proteins NS3 and NS1.2a." J Clin Invest 
98(7): 1684-1691. 
Mathew, A., K. West, et al. (2011). "B-cell responses during primary and secondary dengue 
virus infections in humans." J Infect Dis 204(10): 1514-1522. 
Mathew, S. O., K. K. Rao, et al. (2009). "Functional role of human NK cell receptor 2B4 
(CD244) isoforms." Eur J Immunol 39(6): 1632-1641. 
Matikainen, S., A. Paananen, et al. (2001). "IFN-alpha and IL-18 synergistically enhance IFN-
gamma production in human NK cells: differential regulation of Stat4 activation and 
IFN-gamma gene expression by IFN-alpha and IL-12." Eur J Immunol 31(7): 2236-
2245. 
Maus, M. V., A. K. Thomas, et al. (2002). "Ex vivo expansion of polyclonal and antigen-
specific cytotoxic T lymphocytes by artificial APCs expressing ligands for the T -cell 
receptor, CD28 and 4-1BB." Nat Biotechnol 20(2): 143-148. 
Mavaddat, N., D. W. Mason, et al. (2000). "Signaling lymphocytic activation molecule 
(CDw150) is homophilic but self-associates with very low affinity." J Biol Chem 
275(36): 28100-28109. 
Mazzon, M., M. Jones, et al. (2009). "Dengue virus NS5 inhibits interferon-alpha signaling by 
blocking signal transducer and activator of transcription 2 phosphorylation." J Infect 
Dis 200(8): 1261-1270. 
Means, T. K., R. P. Pavlovich, et al. (2000). "Activation of TNF-alpha transcription utilizes 
distinct MAP kinase pathways in different macrophage populations." J Leukoc Biol 
67(6): 885-893. 
Merad, M., M. G. Manz, et al. (2002). "Langerhans cells renew in the skin throughout life 
under steady-state conditions." Nat Immunol 3(12): 1135-1141. 
Mikhalap, S. V., L. M. Shlapatska, et al. (1999). "CDw150 associates with src-homology 2-
containing inositol phosphatase and modulates CD95-mediated apoptosis." J 
Immunol 162(10): 5719-5727. 
Mikhalap, S. V., L. M. Shlapatska, et al. (2004). "The adaptor protein SH2D1A regulates 
signaling through CD150 (SLAM) in B cells." Blood 104(13): 4063-4070. 
Miller, J. L., B. J. de Wet, et al. (2008). "The mannose receptor mediates dengue virus 
infection of macrophages." PLoS Pathog 4(2): e17. 
Miller, S., S. Kastner, et al. (2007). "The non-structural protein 4A of dengue virus is an 
integral membrane protein inducing membrane alterations in a 2K-regulated 
manner." J Biol Chem 282(12): 8873-8882. 
Moi, M. L., C. K. Lim, et al. (2011). "Detection of higher levels of dengue viremia using 
FcgammaR-expressing BHK-21 cells than FcgammaR-negative cells in secondary 
infection but not in primary infection." J Infect Dis 203(10): 1405-1414. 
Mongkolsapaya, J., W. Dejnirattisai, et al. (2003). "Original antigenic sin and apoptosis in the 
pathogenesis of dengue hemorrhagic fever." Nat Med 9(7): 921-927. 
177 
 
Mooney, J. M., J. Klem, et al. (2004). "The murine NK receptor 2B4 (CD244) exhibits 
inhibitory function independent of signaling lymphocytic activation molecule-
associated protein expression." J Immunol 173(6): 3953-3961. 
Moretta, A., E. Marcenaro, et al. (2005). "Early liaisons between cells of the innate immune 
system in inflamed peripheral tissues." Trends Immunol 26(12): 668-675. 
Morra, M., J. Lu, et al. (2001). "Structural basis for the interaction of the free SH2 domain 
EAT-2 with SLAM receptors in hematopoietic cells." EMBO J 20(21): 5840-5852. 
Mukhopadhyay, S., R. J. Kuhn, et al. (2005). "A structural perspective of the flavivirus life 
cycle." Nat Rev Microbiol 3(1): 13-22. 
Munoz-Jordan, J. L., G. G. Sanchez-Burgos, et al. (2003). "Inhibition of interferon signaling by 
dengue virus." Proc Natl Acad Sci U S A 100(24): 14333-14338. 
Murgue, B., C. Roche, et al. (2000). "Prospective study of the duration and magnitude of 
viraemia in children hospitalised during the 1996-1997 dengue-2 outbreak in French 
Polynesia." J Med Virol 60(4): 432-438. 
Murray, P. G., C. M. Constandinou, et al. (1998). "Analysis of major histocompatibility 
complex class I, TAP expression, and LMP2 epitope sequence in Epstein-Barr virus-
positive Hodgkin's disease." Blood 92(7): 2477-2483. 
Musso, T., L. Calosso, et al. (1999). "Human monocytes constitutively express membrane-
bound, biologically active, and interferon-gamma-upregulated interleukin-15." Blood 
93(10): 3531-3539. 
Mustafa, A. S., E. A. Elbishbishi, et al. (2001). "Elevated levels of interleukin-13 and IL-18 in 
patients with dengue hemorrhagic fever." FEMS Immunol Med Microbiol 30(3): 229-
233. 
Nakajima, H., M. Cella, et al. (2000). "Patients with X-linked lymphoproliferative disease 
have a defect in 2B4 receptor-mediated NK cell cytotoxicity." Eur J Immunol 30(11): 
3309-3318. 
Nakamura, K., H. Okamura, et al. (1993). "Purification of a factor which provides a 
costimulatory signal for gamma interferon production." Infect Immun 61(1): 64-70. 
Nakanishi, K., T. Yoshimoto, et al. (2001). "Interleukin-18 regulates both Th1 and Th2 
responses." Annu Rev Immunol 19: 423-474. 
Nanda, N., P. Andre, et al. (2005). "Platelet aggregation induces platelet aggregate stability 
via SLAM family receptor signaling." Blood 106(9): 3028-3034. 
Napolitani, G., A. Rinaldi, et al. (2005). "Selected Toll-like receptor agonist combinations 
synergistically trigger a T helper type 1-polarizing program in dendritic cells." Nat 
Immunol 6(8): 769-776. 
Nasirudeen, A. M., H. H. Wong, et al. (2011). "RIG-I, MDA5 and TLR3 synergistically play an 
important role in restriction of dengue virus infection." PLoS Negl Trop Dis 5(1): e926. 
Nathan, C. (2006). "Neutrophils and immunity: challenges and opportunities." Nat Rev 
Immunol 6(3): 173-182. 
Neill, L., A. H. Tien, et al. (2007). "SHIP-deficient mice provide insights into the regulation of 
dendritic cell development and function." Exp Hematol 35(4): 627-639. 
Newell, M. K. and J. Desbarats (1999). "Fas ligand: receptor or ligand?" Apoptosis 4(5): 311-
315. 
Nightingale, Z. D., C. Patkar, et al. (2008). "Viral replication and paracrine effects result in 
distinct, functional responses of dendritic cells following infection with dengue 2 
virus." J Leukoc Biol 84(4): 1028-1038. 
178 
 
O'Callaghan, C. A. and J. I. Bell (1998). "Structure and function of the human MHC class Ib 
molecules HLA-E, HLA-F and HLA-G." Immunol Rev 163: 129-138. 
O'Neill, L. A. and A. G. Bowie (2007). "The family of five: TIR-domain-containing adaptors in 
Toll-like receptor signalling." Nat Rev Immunol 7(5): 353-364. 
Okamura, H., H. Tsutsi, et al. (1995). "Cloning of a new cytokine that induces IFN-gamma 
production by T cells." Nature 378(6552): 88-91. 
Onlamoon, N., S. Noisakran, et al. (2010). "Dengue virus-induced hemorrhage in a 
nonhuman primate model." Blood 115(9): 1823-1834. 
Onoguchi, K., M. Yoneyama, et al. (2011). "Retinoic acid-inducible gene-I-like receptors." J 
Interferon Cytokine Res 31(1): 27-31. 
Orange, J. S. and C. A. Biron (1996). "Characterization of early IL-12, IFN-alphabeta, and TNF 
effects on antiviral state and NK cell responses during murine cytomegalovirus 
infection." J Immunol 156(12): 4746-4756. 
Pacsa, A. S., R. Agarwal, et al. (2000). "Role of interleukin-12 in patients with dengue 
hemorrhagic fever." FEMS Immunol Med Microbiol 28(2): 151-155. 
Palmer, D. R., P. Sun, et al. (2005). "Differential effects of dengue virus on infected and 
bystander dendritic cells." J Virol 79(4): 2432-2439. 
Pandey, R., C. M. DeStephan, et al. (2007). "NKp30 ligation induces rapid activation of the  
canonical NF-kappaB pathway in NK cells." J Immunol 179(11): 7385-7396. 
Parolini, S., C. Bottino, et al. (2000). "X-linked lymphoproliferative disease. 2B4 molecules 
displaying inhibitory rather than activating function are responsible for the inability 
of natural killer cells to kill Epstein-Barr virus-infected cells." J Exp Med 192(3): 337-
346. 
Pasquier, B., L. Yin, et al. (2005). "Defective NKT cell development in mice and humans 
lacking the adapter SAP, the X-linked lymphoproliferative syndrome gene product." J 
Exp Med 201(5): 695-701. 
Paul, S. P., L. S. Taylor, et al. (2000). "Myeloid specific human CD33 is an inhibitory receptor 
with differential ITIM function in recruiting the phosphatases SHP-1 and SHP-2." 
Blood 96(2): 483-490. 
Perera, R. and R. J. Kuhn (2008). "Structural proteomics  of dengue virus." Curr Opin 
Microbiol 11(4): 369-377. 
Perry, S. T., M. D. Buck, et al. (2011). "STAT2 mediates innate immunity to Dengue virus in 
the absence of STAT1 via the type I interferon receptor." PLoS Pathog 7(2): e1001297.  
Pflanz, S., J. C. Timans, et al. (2002). "IL-27, a heterodimeric cytokine composed of EBI3 and 
p28 protein, induces proliferation of naive CD4(+) T cells." Immunity 16(6): 779-790. 
Pichyangkul, S., T. P. Endy, et al. (2003). "A blunted blood plasmacytoid dendritic cell 
response to an acute systemic viral infection is associated with increased disease 
severity." J Immunol 171(10): 5571-5578. 
Pillet, A. H., F. Bugault, et al. (2009). "A programmed switch from IL-15- to IL-2-dependent 
activation in human NK cells." J Immunol 182(10): 6267-6277. 
Pogge von Strandmann, E., V. R. Simhadri, et al. (2007). "Human leukocyte antigen-B-
associated transcript 3 is released from tumor cells and engages the NKp30 receptor 
on natural killer cells." Immunity 27(6): 965-974. 
Poy, F., M. B. Yaffe, et al. (1999). "Crystal structures of the XLP protein SAP reveal a class of 
SH2 domains with extended, phosphotyrosine-independent sequence recognition." 
Mol Cell 4(4): 555-561. 
179 
 
Punnonen, J., B. G. Cocks, et al. (1997). "Soluble and membrane-bound forms of signaling 
lymphocytic activation molecule (SLAM) induce proliferation and Ig synthesis by 
activated human B lymphocytes." J Exp Med 185(6): 993-1004. 
Purdy, A. K. and K. S. Campbell (2009). "Natural killer cells and cancer: regulation by the 
killer cell Ig-like receptors (KIR)." Cancer Biol Ther 8(23): 2211-2220. 
R P. Johnson, H. S. H., Premeela Rajakumar, James M. Billingsley and R. Keith Reeves (2012). 
"No monkey business: why studying NK cells in nonhuman primates pays off." 
Frontiers in Immunology. 
Rajagopalan, S., Y. T. Bryceson, et al. (2006). "Activation of NK cells by an endocytosed 
receptor for soluble HLA-G." PLoS Biol 4(1): e9. 
Rappl, G., A. Kapsokefalou, et al. (2001). "Dermal fibroblasts sustain proliferation of 
activated T cells via membrane-bound interleukin-15 upon long-term stimulation 
with tumor necrosis factor-alpha." J Invest Dermatol 116(1): 102-109. 
Rea, D., F. H. Schagen, et al. (1999). "Adenoviruses activate human dendritic cells without 
polarization toward a T-helper type 1-inducing subset." J Virol 73(12): 10245-10253. 
Rego, D., A. Kumar, et al. (2011). "IL-6 production is positively regulated by two distinct Src 
homology domain 2-containing tyrosine phosphatase-1 (SHP-1)-dependent 
CCAAT/enhancer-binding protein beta and NF-kappaB pathways and an SHP-1-
independent NF-kappaB pathway in lipopolysaccharide-stimulated bone marrow-
derived macrophages." J Immunol 186(9): 5443-5456. 
Restrepo, B. N., D. M. Isaza, et al. (2008). "Serum levels of interleukin-6, tumor necrosis 
factor-alpha and interferon-gamma in infants with and without dengue." Rev Soc 
Bras Med Trop 41(1): 6-10. 
Rethi, B., P. Gogolak, et al. (2006). "SLAM/SLAM interactions inhibit CD40-induced 
production of inflammatory cytokines in monocyte-derived dendritic cells." Blood 
107(7): 2821-2829. 
Riteau, B., D. F. Barber, et al. (2003). "Vav1 phosphorylation is induced by beta2 integrin 
engagement on natural killer cells upstream of actin cytoskeleton and lipid raft 
reorganization." J Exp Med 198(3): 469-474. 
Rodhain, F. and L. Rosen (2001). "Mosquito Vectors and Dengue Virus -Vector Relationships." 
Dengue and Dengue Hemorrhagic Fever: 45–60. 
Rodriguez-Madoz, J. R., A. Belicha-Villanueva, et al. (2010). "Inhibition of the type I 
interferon response in human dendritic cells by dengue virus infection requires a 
catalytically active NS2B3 complex." J Virol 84(19): 9760-9774. 
Romagnani, C., M. Della Chiesa, et al. (2005). "Activation of human NK cells by plasmacytoid 
dendritic cells and its modulation by CD4+ T helper cells and CD4+ CD25hi T 
regulatory cells." Eur J Immunol 35(8): 2452-2458. 
Romani, N., S. Gruner, et al. (1994). "Proliferating dendritic cell progenitors in human 
blood." J Exp Med 180(1): 83-93. 
Romee, R., S. E. Schneider, et al. (2012). "Cytokine activation induces human memory-like 
NK cells." Blood 120(24): 4751-4760. 
Romero, X., D. Benitez, et al. (2004). "Differential expression of SAP and EAT-2-binding 
leukocyte cell-surface molecules CD84, CD150 (SLAM), CD229 (Ly9) and CD244 
(2B4)." Tissue Antigens 64(2): 132-144. 
Romero, X., N. Zapater, et al. (2005). "CD229 (Ly9) lymphocyte cell surface receptor 
interacts homophilically through its N-terminal domain and relocalizes to the 
immunological synapse." J Immunol 174(11): 7033-7042. 
180 
 
Roncagalli, R., J. E. Taylor, et al. (2005). "Negative regulation of natural killer cell function by 
EAT-2, a SAP-related adaptor." Nat Immunol 6(10): 1002-1010. 
Rook, A. H., J. H. Kehrl, et al. (1986). "Effects of transforming growth factor beta on the 
functions of natural killer cells: depressed cytolytic activity and blunting of interferon 
responsiveness." J Immunol 136(10): 3916-3920. 
Rothman, A. L. (2011). "Immunity to dengue virus: a tale of original antigenic sin and tropical 
cytokine storms." Nat Rev Immunol 11(8): 532-543. 
Rothman, A. L., I. Kurane, et al. (1996). "Multiple specificities in the murine CD4+ and CD8+ 
T-cell response to dengue virus." J Virol 70(10): 6540-6546. 
Rothman, A. L., I. Kurane, et al. (1989). "Dengue virus-specific murine T-lymphocyte 
proliferation: serotype specificity and response to recombinant viral proteins." J Virol  
63(6): 2486-2491. 
Sallusto, F. and A. Lanzavecchia (1994). "Efficient presentation of soluble antigen by cultured 
human dendritic cells is maintained by granulocyte/macrophage colony-stimulating 
factor plus interleukin 4 and downregulated by tumor necrosis factor alpha." J Exp 
Med 179(4): 1109-1118. 
Sangkawibha, N., S. Rojanasuphot, et al. (1984). "Risk factors in dengue shock syndrome: a 
prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak." Am J 
Epidemiol 120(5): 653-669. 
Sayos, J., M. Martin, et al. (2001). "Cell surface receptors Ly-9 and CD84 recruit the X-linked 
lymphoproliferative disease gene product SAP." Blood 97(12): 3867-3874. 
Sayos, J., C. Wu, et al. (1998). "The X-linked lymphoproliferative-disease gene product SAP 
regulates signals induced through the co-receptor SLAM." Nature 395(6701): 462-
469. 
Scheeren, R. A., G. Koopman, et al. (1991). "Adhesion receptors involved in clustering of 
blood dendritic cells and T lymphocytes." Eur J Immunol 21(5): 1101-1105. 
Schreiber, J., R. G. Jenner, et al. (2006). "Coordinated binding of NF-kappaB family members 
in the response of human cells to lipopolysaccharide." Proc Natl Acad Sci U S A 
103(15): 5899-5904. 
Schroder, K., P. J. Hertzog, et al. (2004). "Interferon-gamma: an overview of signals, 
mechanisms and functions." J Leukoc Biol 75(2): 163-189. 
Schuhmachers, G., K. Ariizumi, et al. (1995). "Activation of murine epidermal gamma delta T 
cells through surface 2B4." Eur J Immunol 25(4): 1117-1120. 
Sharifi, R., J. C. Sinclair, et al. (2004). "SAP mediates specific cytotoxic T-cell functions in X-
linked lymphoproliferative disease." Blood 103(10): 3821-3827. 
Shen, H., B. M. Tesar, et al. (2008). "Dual signaling of MyD88 and TRIF is critical for maximal 
TLR4-induced dendritic cell maturation." J Immunol 181(3): 1849-1858. 
Shibata, Y., L. A. Foster, et al. (1998). "Immunoregulatory roles of IL-10 in innate immunity: 
IL-10 inhibits macrophage production of IFN-gamma-inducing factors but enhances 
NK cell production of IFN-gamma." J Immunol 161(8): 4283-4288. 
Shigematsu, H., B. Reizis, et al. (2004). "Plasmacytoid dendritic cells activate lymphoid-
specific genetic programs irrespective of their cellular origin." Immunity 21(1): 43-53. 
Shortman, K. and Y. J. Liu (2002). "Mouse and human dendritic cell subtypes." Nat Rev 
Immunol 2(3): 151-161. 
Shresta, S., K. L. Sharar, et al. (2005). "Critical roles for both STAT1-dependent and STAT1-
independent pathways in the control of primary dengue virus infection in mice." J 
Immunol 175(6): 3946-3954. 
181 
 
Silke, J. (2011). "The regulation of TNF signalling: what a tangled web we weave." Curr Opin 
Immunol 23(5): 620-626. 
Silveira, G. F., F. Meyer, et al. (2011). "Dengue virus type 3 isolated from a fatal case with 
visceral complications induces enhanced proinflammatory responses and apoptosis 
of human dendritic cells." J Virol 85(11): 5374-5383. 
Simarro, M., A. Lanyi, et al. (2004). "SAP increases FynT kinase activity and is required for 
phosphorylation of SLAM and Ly9." Int Immunol 16(5): 727-736. 
Simhadri, V. R., K. S. Reiners, et al. (2008). "Dendritic cells release HLA-B-associated 
transcript-3 positive exosomes to regulate natural killer function." PLoS One 3(10): 
e3377. 
Sintes, J., M. Cuenca, et al. (2012). "Cutting Edge: Ly9 (CD229), a SLAM Family Receptor, 
Negatively Regulates the Development of Thymic Innate Memory-like CD8+ T and 
Invariant NKT Cells." J Immunol. 
Sivori, S., M. Falco, et al. (2002). "Early expression of triggering receptors and regulatory role 
of 2B4 in human natural killer cell precursors undergoing in vitro differentiation." 
Proc Natl Acad Sci U S A 99(7): 4526-4531. 
Spriggs, M. K. (1996). "One step ahead of the game: viral immunomodulatory molecules." 
Annu Rev Immunol 14: 101-130. 
St John, A. L., A. P. Rathore, et al. (2011). "Immune surveillance by mast cells during dengue 
infection promotes natural killer (NK) and NKT-cell recruitment and viral clearance." 
Proc Natl Acad Sci U S A 108(22): 9190-9195. 
Stark, S. and C. Watzl (2006). "2B4 (CD244), NTB-A and CRACC (CS1) stimulate cytotoxicity 
but no proliferation in human NK cells." Int Immunol 18(2): 241-247. 
Steinman, R. M. and H. Hemmi (2006). "Dendritic cells: translating innate to adaptive 
immunity." Curr Top Microbiol Immunol 311: 17-58. 
Steinman, R. M., K. Inaba, et al. (1999). "Antigen capture, processing, and presentation by 
dendritic cells: recent cell biological studies." Hum Immunol 60(7): 562-567. 
Stephens, H. A., R. Klaythong, et al. (2002). "HLA-A and -B allele associations with secondary 
dengue virus infections correlate with disease severity and the infecting viral 
serotype in ethnic Thais." Tissue Antigens 60(4): 309-318. 
Strengell, M., S. Matikainen, et al. (2003). "IL-21 in synergy with IL-15 or IL-18 enhances IFN-
gamma production in human NK and T cells." J Immunol 170(11): 5464-5469. 
Suaya, J. A., D. S. Shepard, et al. (2009). "Cost of dengue cases in eight countries in the 
Americas and Asia: a prospective study." Am J Trop Med Hyg 80(5): 846-855. 
Summerfield, A. and K. C. McCullough (2009). "Dendritic Cells in Innate and Adaptive 
Immune Responses against Influenza Virus." Viruses 1(3): 1022-1034. 
Sun, M., K. T. Ames, et al. (2006). "The cytoplasmic domain of Fas ligand costimulates TCR 
signals." J Immunol 177(3): 1481-1491. 
Sun, M., S. Lee, et al. (2007). "Cutting edge: two distinct motifs within the Fas ligand tail 
regulate Fas ligand-mediated costimulation." J Immunol 179(9): 5639-5643. 
Surasombatpattana, P., R. Hamel, et al. (2011). "Dengue virus replication in infected human 
keratinocytes leads to activation of antiviral innate immune responses." Infect Genet 
Evol 11(7): 1664-1673. 
Suwannasaen, D., A. Romphruk, et al. (2010). "Bystander T cells in human immune 
responses to dengue antigens." BMC Immunol 11: 47. 
Tangye, S. G., H. Cherwinski, et al. (2000). "2B4-mediated activation of human natural killer 
cells." Mol Immunol 37(9): 493-501. 
182 
 
Tangye, S. G., K. E. Nichols, et al. (2003). "Functional requirements for interactions between 
CD84 and Src homology 2 domain-containing proteins and their contribution to 
human T cell activation." J Immunol 171(5): 2485-2495. 
Tangye, S. G., B. C. van de Weerdt, et al. (2002). "CD84 is up-regulated on a major 
population of human memory B cells and recruits the SH2 domain containing 
proteins SAP and EAT-2." Eur J Immunol 32(6): 1640-1649. 
Tassaneetrithep, B., T. H. Burgess, et al. (2003). "DC-SIGN (CD209) mediates dengue virus 
infection of human dendritic cells." J Exp Med 197(7): 823-829. 
Tassi, I. and M. Colonna (2005). "The cytotoxicity receptor CRACC (CS-1) recruits EAT-2 and 
activates the PI3K and phospholipase Cgamma signaling pathways in human NK 
cells." J Immunol 175(12): 7996-8002. 
Tel, J., A. M. van der Leun, et al. (2012). "Harnessing human plasmacytoid dendritic cells as 
professional APCs." Cancer Immunol Immunother 61(8): 1279-1288. 
Teles, F. R., D. M. Prazeres, et al. (2005). "Trends in dengue diagnosis." Rev Med Virol 15(5): 
287-302. 
Theofilopoulos, A. N., W. E. Brandt, et al. (1976). "Replication of dengue-2 virus in cultured 
human lymphoblastoid cells and subpopulations of human peripheral leukocytes." J 
Immunol 117(3): 953-961. 
Tissot, C., C. Rebouissou, et al. (1997). "Both human alpha/beta and gamma interferons 
upregulate the expression of CD48 cell surface molecules." J Interferon Cytokine Res 
17(1): 17-26. 
Tone, M., M. J. Powell, et al. (2000). "IL-10 gene expression is controlled by the transcription 
factors Sp1 and Sp3." J Immunol 165(1): 286-291. 
Tovar, V., J. del Valle, et al. (2002). "Mouse novel Ly9: a new member of the expanding 
CD150 (SLAM) family of leukocyte cell-surface receptors." Immunogenetics 54(6): 
394-402. 
Trinchieri, G. (1989). "Biology of natural killer cells." Adv Immunol 47: 187-376. 
Trinchieri, G. (1995). "The two faces of interleukin 12: a pro-inflammatory cytokine and a 
key immunoregulatory molecule produced by antigen-presenting cells." Ciba Found 
Symp 195: 203-214; discussion 214-220. 
Tsai, J. J., Y. H. Jen, et al. (2011). "Frequency alterations in key innate immune cell 
components in the peripheral blood of dengue patients detected by FACS analysis." J 
Innate Immun 3(5): 530-540. 
Tsai, Y. T., S. Y. Chang, et al. (2009). "Human TLR3 recognizes dengue virus and modulates 
viral replication in vitro." Cell Microbiol 11(4): 604-615. 
Ubol, S., W. Phuklia, et al. (2010). "Mechanisms of immune evasion induced by a complex of 
dengue virus and preexisting enhancing antibodies." J Infect Dis 201(6): 923-935. 
Umareddy, I., K. F. Tang, et al. (2008). "Dengue virus regulates type I interferon signalling in 
a strain-dependent manner in human cell lines." J Gen Virol 89(Pt 12): 3052-3062. 
Valiante, N. M. and G. Trinchieri (1993). "Identification of a novel signal transduction surface 
molecule on human cytotoxic lymphocytes." J Exp Med 178(4): 1397-1406. 
Valladeau, J., C. Dezutter-Dambuyant, et al. (2003). "Langerin/CD207 sheds light on 
formation of birbeck granules and their possible function in Langerhans cells." 
Immunol Res 28(2): 93-107. 
van der Schaar, H. M., M. J. Rust, et al. (2007). "Characterization of the early events in 




van Nierop, K. and C. de Groot (2002). "Human follicular dendritic cells: function, origin and 
development." Semin Immunol 14(4): 251-257. 
Vasilakis, N., J. Cardosa, et al. (2011). "Fever from the forest: prospects for the continued 
emergence of sylvatic dengue virus and its impact on public health." Nat Rev 
Microbiol 9(7): 532-541. 
Vaughn, D. W., S. Green, et al. (2000). "Dengue viremia titer, antibody response pattern, and 
virus serotype correlate with disease severity." J Infect Dis 181(1): 2-9. 
Veillette, A. (2006). "NK cell regulation by SLAM family receptors and SAP-related adapters." 
Immunol Rev 214: 22-34. 
Velikovsky, C. A., L. Deng, et al. (2007). "Structure of natural killer receptor 2B4 bound to 
CD48 reveals basis for heterophilic recognition in signaling lymphocyte activation 
molecule family." Immunity 27(4): 572-584. 
Vitale, M., M. Della Chiesa, et al. (2005). "NK-dependent DC maturation is mediated by 
TNFalpha and IFNgamma released upon engagement of the NKp30 triggering 
receptor." Blood 106(2): 566-571. 
Vivier, E., H. Spits, et al. (2009). "Interleukin-22-producing innate immune cells: new players 
in mucosal immunity and tissue repair?" Nat Rev Immunol 9(4): 229-234. 
Wang, G., A. C. Abadia-Molina, et al. (2012). "Cutting edge: Slamf8 is a negative regulator of 
Nox2 activity in macrophages." J Immunol 188(12): 5829-5832. 
Wang, J., X. Wang, et al. (2007). "Distinct roles of different NF-kappa B subunits in regulating 
inflammatory and T cell stimulatory gene expression in dendritic cells." J Immunol 
178(11): 6777-6788. 
Wang, N., S. Calpe, et al. (2010). "Cutting edge: The adapters EAT-2A and -2B are positive 
regulators of CD244- and CD84-dependent NK cell functions in the C57BL/6 mouse." 
J Immunol 185(10): 5683-5687. 
Wang, N., A. Satoskar, et al. (2004). "The cell surface receptor SLAM controls T cell and 
macrophage functions." J Exp Med 199(9): 1255-1264. 
Wang, W. K., D. Y. Chao, et al. (2003). "High levels of plasma dengue viral load during 
defervescence in patients with dengue hemorrhagic fever: implications for 
pathogenesis." Virology 305(2): 330-338. 
Wati, S., P. Li, et al. (2007). "Dengue virus (DV) replication in monocyte-derived 
macrophages is not affected by tumor necrosis factor alpha (TNF-alpha), and DV 
infection induces altered responsiveness to TNF-alpha stimulation." J Virol 81(18): 
10161-10171. 
Watzl, C. and E. O. Long (2010). "Signal transduction during activation and inhibition of 
natural killer cells." Curr Protoc Immunol Chapter 11: Unit 11 19B. 
Weiss-Steider, B., I. Soto-Cruz, et al. (2011). "Expression of MICA, MICB and NKG2D in 
human leukemic myelomonocytic and cervical cancer cells." J Exp Clin Cancer Res 30: 
37. 
Welte, S., S. Kuttruff, et al. (2006). "Mutual activation of natural killer cells  and monocytes 
mediated by NKp80-AICL interaction." Nat Immunol 7(12): 1334-1342. 
Wenzel, J., R. Sanzenbacher, et al. (2001). "Multiple interactions of the cytosolic polyproline 
region of the CD95 ligand: hints for the reverse signal transduction capacity of a 
death factor." FEBS Lett 509(2): 255-262. 
Westaway, E. G. B., J. (1997). "Taxonomy and evolutionary relationships of flaviviruses." 
Dengue and Dengue Hemorrhagic Fever: 147-173. 
184 
 
WHO (2009). World Health Organization. Dengue: guidelines for diagnosis, treatment, 
prevention and control.  
Wichmann, O., S. Hongsiriwon, et al. (2004). "Risk factors and clinical features associated 
with severe dengue infection in adults and children during the 2001 epidemic in 
Chonburi, Thailand." Trop Med Int Health 9(9): 1022-1029. 
Wilson, J. L., L. C. Heffler, et al. (1999). "Targeting of human dendritic cells by autologous NK 
cells." J Immunol 163(12): 6365-6370. 
Wong, B. R., R. Josien, et al. (1997). "TRANCE (tumor necrosis factor [TNF]-related 
activation-induced cytokine), a new TNF family member predominantly expressed in 
T cells, is a dendritic cell-specific survival factor." J Exp Med 186(12): 2075-2080. 
Wu, M. F., S. T. Chen, et al. (2013). "CLEC5A is critical for dengue virus -induced 
inflammasome activation in human macrophages." Blood 121(1): 95-106. 
Wu, S. J., G. Grouard-Vogel, et al. (2000). "Human skin Langerhans cells are targets of 
dengue virus infection." Nat Med 6(7): 816-820. 
Wu, W. L., L. J. Ho, et al. (2009). "Triggering of DC migration by dengue virus stimulation of 
COX-2-dependent signaling cascades in vitro highlights the significance of these 
cascades beyond inflammation." Eur J Immunol 39(12): 3413-3422. 
Wu, Y. H., S. F. Shih, et al. (2004). "Ricin triggers apoptotic morphological changes through 
caspase-3 cleavage of BAT3." J Biol Chem 279(18): 19264-19275. 
Xu, D., W. L. Chan, et al. (1998). "Selective expression and functions of interleukin 18 
receptor on T helper (Th) type 1 but not Th2 cells." J Exp Med 188(8): 1485-1492. 
Xu, J., A. K. Chakrabarti, et al. (2007). "Essential role of the TNF-TNFR2 cognate interaction in 
mouse dendritic cell-natural killer cell crosstalk." Blood 109(8): 3333-3341. 
Xu, M., V. Hadinoto, et al. (2012). "Plasmablasts Generated during Repeated Dengue 
Infection Are Virus Glycoprotein-Specific and Bind to Multiple Virus Serotypes." J 
Immunol 189(12): 5877-5885. 
Yamanaka, A., S. Kosugi, et al. (2008). "Infection-enhancing and -neutralizing activities of 
mouse monoclonal antibodies against dengue type 2 and 4 viruses are controlled by 
complement levels." J Virol 82(2): 927-937. 
Yan, Q., V. N. Malashkevich, et al. (2007). "Structure of CD84 provides insight into SLAM 
family function." Proc Natl Acad Sci U S A 104(25): 10583-10588. 
Yanagawa, Y. and K. Onoe (2007). "Enhanced IL-10 production by TLR4- and TLR2-primed 
dendritic cells upon TLR restimulation." J Immunol 178(10): 6173-6180. 
Yap, T. L., T. Xu, et al. (2007). "Crystal structure of the dengue virus RNA-dependent RNA 
polymerase catalytic domain at 1.85-angstrom resolution." J Virol 81(9): 4753-4765. 
Yokoyama, W. M. and S. Kim (2006). "Licensing of natural killer cells by self-major 
histocompatibility complex class I." Immunol Rev 214: 143-154. 
Yoon, S. R., J. W. Chung, et al. (2007). "Development of natural killer cells from 
hematopoietic stem cells." Mol Cells 24(1): 1-8. 
Yoshida, T., T. Omatsu, et al. (2012). "CD16(+) natural killer cells play a limited role against 
primary dengue virus infection in tamarins." Arch Virol 157(2): 363-368. 
Yoshimura, S., J. Bondeson, et al. (2001). "Effective antigen presentation by dendritic cells is 
NF-kappaB dependent: coordinate regulation of MHC, co-stimulatory molecules and 
cytokines." Int Immunol 13(5): 675-683. 
You, M., L. M. Flick, et al. (2001). "Modulation of the nuclear factor kappa B pathway by Shp-
2 tyrosine phosphatase in mediating the induction of interleukin (IL)-6 by IL-1 or 
tumor necrosis factor." J Exp Med 193(1): 101-110. 
185 
 
Yusuf, I., R. Kageyama, et al. (2010). "Germinal center T follicular helper cell IL -4 production 
is dependent on signaling lymphocytic activation molecule receptor (CD150)." J 
Immunol 185(1): 190-202. 
Zhang, Z. and F. S. Wang (2005). "Plasmacytoid dendritic cells act as the most competent cell 
type in linking antiviral innate and adaptive immune responses." Cell Mol Immunol  
2(6): 411-417. 
Zhao, F., J. L. Cannons, et al. (2012). "Positive and negative signaling through SLAM 
receptors regulate synapse organization and thresholds of cytolysis." Immunity 36(6): 
1003-1016. 
Zhou, D., C. A. Collins, et al. (2010). "Protein tyrosine phosphatase SHP-1 positively regulates 
TLR-induced IL-12p40 production in macrophages through inhibition of 
phosphatidylinositol 3-kinase." J Leukoc Biol 87(5): 845-855. 
Zhou, L. J. and T. F. Tedder (1995). "A distinct pattern of cytokine gene expression by human 
CD83+ blood dendritic cells." Blood 86(9): 3295-3301. 
Zivna, I., S. Green, et al. (2002). "T cell responses to an HLA-B*07-restricted epitope on the 
dengue NS3 protein correlate with disease severity." J Immunol 168(11): 5959-5965. 




















After 6-7 days of differentiation with 500U/ml of IL-4 and 800U/ml of GM-CSF, monocyte-
derived DCs were assayed for their extent of differentiation and maturation. The DC 
population was gated based on their forward and side scatter profiles to exclude cell debris. 
Such DCs were usually low in surface CD14 expression and had high expression of DC-SIGN 
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A – C, surface CRACC expression of transduced SH-SY5Y, L929 and 293T cells. D, surface 
SLAM expression of stimulated 293T cells. L929 and 293T cells were used in co-culture 
experiments with DCs. Since SLAM has been shown to influence DC cytokine secretion, 
transduced 293T cells were stimulated with LPS and IFN-γ (both at 100µg/ml) before 
assaying for SLAM expression. L929 cells have been previously tested not to express SLAM 
(Rethi, Gogolak et al. 2006). Filled histograms represent the IgG2b staining isotype control 

















































































































































A4) Gating for NK cells during flow cytometric analysis 
 
 
Lymphocytes were gated based on their forward and side scatter profiles. In most co-culture 
experiments, this allowed initial separation of NK cells from their co-culture partners (ie. 
DCs). NK cells were further selected for analysis by their surface expression of CD56 and 














Semi-quantitative RT-PCR was performed on mRNA from mock- and DenV1-infected DCs. 
Functional IL-12 is a heterodimer of p35 and p40 while functional IL-27 is a heterodimer of 
















A549 adenocarcinomic human alveolar basal epithelial cells have been shown to express 
ligands for NKp30, NKp44 and NKp46 (Jarahian, Watzl et al. 2009). These cells were 
employed as positive controls because we experienced variability in staining for NCR ligands 
on DCs using the NCR-Fc chimeric proteins (all from R&D Systems). A549 cells were stained 
with the NCR-Fc proteins and secondary staining was performed using PE-conjugated goat 
anti-human IgG antibodies (Jackson ImmunoResearch Laboratories). This experiment 
confirmed that the NCR-Fc reagents were functional and, more importantly, DenV1-infected 
DCs did not upregulate ligands for NKp30, NKp44 and NKp46. NKp80-Fc was not tested as 
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Immature, mock- and DenV1-infected DCs were stained for the ligands of DNAM-1: Nectin-2 
and PVR. Intracellular staining for DenV prM followed by secondary staining with FITC-
conjugated anti-mouse IgG2a was performed to determine the infection rate.   
prM

























Flow cytometric staining of naïve human NK cells for SLAM family receptors. Filled 
histograms represent the relevant staining isotype control.  
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